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Abstract
This thesis is divided into four Chapters. The first Chapter begins with a brief 
introduction to the area of coronary heart disease and hypercholesterolemia prior to an 
overview of the isolation, structure determination and biological properties of the zaragozic 
acids/squalestatins. Following a review of model core syntheses, followed by total syntheses, 
of the zaragozic acids, our retrosynthetic analysis is given.
The second Chapter describes the successful synthesis of a model core system of the 
zaragozic acids. Stille coupling methodology, followed by use of a double Sharpless 
asymmetric dihydroxylation to incorporate four contiguous stereocentres, and elaboration to 
the model bicyclic core is reported.
Chapter Three describes our attempts to elaborate the synthesis toward a total synthesis 
of zaragozic acid D. The preparation of the Cl sidechain, and its attempted coupling to a key 
aldehyde are reported.
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Stereochemical Notation and Compound Numbering
Throughout this thesis, the graphical representation of stereochemistry is in accord with 
the conventions proposed by Maehr.t Thus, solid and broken wedges denote absolute 
configuration and solid and broken bold lines denote racemates. For the former, greater 
narrowing of both solid and broken wedges indicates increasing distance from the viewer.
& &
racemic single enantiomer
In Chapters 1,2 and 3 of this thesis, the zaragozic acid numbering system shown below 
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CHAPTER 1
Introduction and review of the Zaragozic acids/Squalestatins
1
1.1 Coronary Heart Disease
Coronary heart disease (CHD) remains the leading cause of death in the Western world. 
In fact statistics show that the majority of Western people are more likely to die from 
cardiovascular diseases each year than from all other diseases combined.
Atherosclerosis is a major risk factor for CHD, and it is now generally accepted that high 
levels of low density lipoprotein (LDL) cholesterol in the bloodstream, a condition known as 
hypercholesterolemia, plays a major role in the onset of atherosclerosis. There is a clear 
connection between the incidence of CHD and hypercholesterolemia. Numerous clinical trials 
have shown that lowering of serum cholesterol levels by either dietary or pharmacological 
intervention reduces the incidence of CHD in hypercholesterolemic patients and leads to a 
significant reduction in deaths from cardiovascular diseases. 1
Atherosclerosis is a chronic disease in which cholesterol accumulates in the walls of the 
arteries forming bulky plaques. Over time, these arterial plaques grow and inhibit blood flow. 
It is a slow process, but ultimately if a blood clot forms and blocks the artery, a heart attack or 
stroke results which may prove fatal.
The arterial plaques are believed to be initiated by damage to the thin layer of endothelial 
cells lining the blood vessels which causes them to become permeable. This allows penetration 
of the cells by LDL particles and blood platelets. In response to this invasion, smooth-muscle 
cells in the layer below the endothelium multiply and migrate into the damaged area, along with 
scavenger cells called macrophages. The smooth muscle cells and the macrophages become 
foam cells as a response to their ingestion and degradation of the invasive LDL. If high serum 
levels of LDL are present then LDL cholesterol accumulates in and around the foam cells. This 
accumulation of cholesterol, cells and debris is what constitutes an atheroma, and the higher 
the serum levels of LDL, then the more rapid is the onset of the disease.2
Therefore, therapeutic intervention by either dietary or pharmacological means, to reduce 
plasma levels of LDL and hence greatly reduce the rate and extent to which atherosclerosis 
occurs, has been an area of intensive study.
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1.2 Treatment for Hypercholesterolemia
Hypercholesterolemia is a term used to describe the condition of elevated serum 
cholesterol levels giving rise to a significantly increased risk of CHD. The National Institutes 
of Health Consensus conference on cholesterol3 defined plasma levels exceeding 200 mg/dl 
for 20-29 year olds, 220 mg/dl for 30-39 year olds and 240 mg/dl for 40+ year olds to be 
moderately hypercholesterolemic. Patients having levels of 20 mg/dl above the moderate cases 
were deemed as having severe hypercholesterolemia. These differing risk levels require 
differing levels of treatment in accordance with the severity of the case. In patients where the 
disease is not in the advanced stages, dietary intervention will play an important role in 
treatment. High cholesterol diets fill the liver cells with cholesterol and so reduce LDL receptor 
synthesis, which leads to increased levels of LDL in the blood. Careful control of the dietary 
intake levels of cholesterol can make considerable reductions in serum cholesterol levels, but in 
more severe cases, pharmacological intervention is required.
In humans, 70% of total body cholesterol is derived from de novo biosynthesis in the 
liver, and so the inhibition of cholesterol biosynthesis constitutes an important approach to the 
lowering of elevated serum cholesterol levels. The biosynthetic pathway leading to cholesterol 
(Scheme 1) commences with self-condensation of acetyl Co-A to give acetoacetyl Co-A, which 
itself undergoes further condensation with another acetyl Co-A molecule mediated by the 
enzyme HMG-CoA synthase, to form hydroxymethyl glutaryl-CoA (HMG-CoA). HMG-CoA 
is then reduced to mevalonic acid 1 by HMG-CoA reductase, and it is this point of the sterol 
pathway that is believed to be the major rate limiting step. Mevalonic acid 1 is then converted 
into isopentenyl pyrophosphate (IPP) 2, which dimerises to give geranyl pyrophosphate 
(GPP) 3 which in turn joins with another IPP molecule to give famesyl pyrophosphate (FPP) 
4. Apart from its role in cholesterol biosynthesis, FPP plays a very important role in protein 
isoprenylation, and is a substrate for both the cis- and trans-prenyl transferase enzymes, which 
give rise to very important dolichols and ubiquinone. In the first committed step in the sterol 
biosynthetic pathway, FPP next undergoes a reductive head to head dimerisation catalysed by 
the enzyme squalene synthase (SQS), to give squalene 5, which undergoes a whole series of 
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Scheme 1: The biosynthetic pathway leading to cholesterol
4
Clinical studies have shown reduction in the incidence of cardiovascular mortality from 
pharmacological intervention, with one such drug, Mevacor (Lovastatin) 6 being one of the 
pharmaceutical industry's best selling products (Figure 1). The fungal metabolite lovastatin 6, 
the microbially transformed product pravastatin 7, and the semi-synthetic analogue, 
simvastatin 8, are potent hypocholesterolemic agents. This class of compound inhibits 3- 
hydroxy-3-methylglutaryl CoA reductase (HMGR), a major rate limiting enzyme in cholesterol 
biosynthesis, and has also been shown to induce the expression of hepatic low-density 






R = H ; Lovastatin (Mevacor) 6 Pravastatin 7
R = Me ; Simvastatin (Zocor) 8
Figure 1: HMGR inhibitors
However, inhibition of a branched biosynthetic pathway at such an early stage can have 
disadvantages. In this instance, early inhibition puts a block on other important biosynthetic 
precursors, such as dolichol, ubiquinone, and isopentenyl lRNA. Furthermore, mevalonic acid 
1 is required for production of geranyl pyrophosphate (GPP) 3, and famesyl pyrophosphate 
(FPP) 4, the terpenoid substrates for protein prenylation. Therefore, pharmaceutical 
companies have turned their attention to inhibition of enzymes that are unique to the steroid 
biosynthetic pathway at a later stage.
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1.2.1 Squalene Synthase (SQS) inhibitors.
Squalene synthase (SQS) occupies a key branchpoint in the isoprenoid pathway, 
catalysing the first committed step in the biosynthesis of sterols. SQS catalyses the reductive 
dimerisation of FPP 4 to squalene 5 via the intermediate cyclopropane, presqualene 
pyrophosphate (PSPP) 9 (Scheme 2). Because of its key position in the cholesterol 


















Many inhibitors of SQS have been screened, most of which are based on FPP mimetics 
and hence contain diphosphate groups which are crucial for substrate binding. However, the 
activity of this type of compound to date does not offer a useful therapy in the treatment of the 
disease.
1.3 The Zaragozic Acids and the Squalestatins
In 1992, two independent groups observed high levels of inhibitory activity during 
screening programmes for inhibitors of SQS. Merck isolated an active component from an 
unidentified sterile fungal culture isolated from a water sample from the Jalon River in 
Zaragoza, Spain,5 whilst Glaxo isolated three active components from a fungus strain Phoma 
sp. C2932 from a soil sample collected at Armacao de Pera, Portugal.6 Merck designated this 
new class of compound as the zaragozic acids, and Glaxo named them the squalestatins. 
Shortly after the initial screening, Merck was to isolate four more fungal metabolites which 
possessed SQS inhibitory activity. The first of these (zaragozic acid B) was isolated from a 
coprophilous fungus, ATCC 20985, subsequently identified as Sporormiella intermedia, 
which came from cottontail rabbit dung collected near Tucson, AZ.5 The second (zaragozic 
acid C) came from a strain of Leptodontium elatius var. elatius, ATCC 70411, isolated from 
wood in the Joyce Kilmer Forest in North Carolina.7 The last two (zaragozic acid D and D2) 
both came from the keratinophilic fungus Amauroascus niger, ATCC 74156, from forest soil 
in Los Montes de Poblet, Tarragona, Spain.8
Table 1 shows the zaragozic acids and Table 2 shows the squalestatins.
7





















Zaragozic acid A resisted early efforts by Merck workers to obtain it in crystalline form 
and so the structural assignment was based on advanced 2D-NMR, mass spectrometry and 
chemical degradation studies.5’9*10 The absolute stereochemistry was obtained from CD 
experiments. However, unequivocal confirmation was realised afterwards by single crystal X- 
ray diffraction of a suitable derivative.10 Likewise, Glaxo carried out extensive 2D-NMR work 
but were able to get the full relative stereochemistry from single crystal X-ray diffraction of the 
crystalline S2 tri-methyl ester derivative.11 The absolute configuration of SI and S2 was 
obtained by degradation studies and was found to be [IS (4'S, 5'R), 3S, 4S, 5R, 6R (2"E, 
4"S, 6"S), 7R].
Of the 7 zaragozic acids and the majority of the 27 naturally occurring squalestatins, the 
highly functionalised [lS -(la , 3a, 40, 5a, 6a , 70)]-4, 6, 7-trihydroxy- 2, 8-dioxabicyclo 
[3.2.1]octane-3, 4, 5-tricarboxylic acid "core" is common to all. Furthermore, these studies 
showed that zaragozic acid A and squalestatin 1 are identical.
The 2, 8-dioxobicyclo[3.2.1]octane core possessed by all these compounds is rare in 
nature, and has never been so highly substituted before. It can be found in the shellfish toxins 
pectenotoxin I, n  and III (10a-c),12 the alkaloids daphniphylline13 and codaphniphylline14, 
an ionone 11 isolated from the brandy of quince fruit,15 and the recently reported16 banana 
weevil pheromone sordinin 12, (Figure 2). The 2,8-dioxobicyclo[3.2.1]octane core has 
occurred more often in carbohydrate chemistry, particularly as 1,6-anhydrofuranose 
derivatives,17 but never as heavily substituted as the zaragozic acids.
o
R
10a: R = CH2OH, pectenotoxin I 
10b: R = CH3, pectenotoxin II 
10c: R = CHO, pectenotoxin III
11 ionone 12 sordinin
Figure 2
The 1,6-anhydrofuranoses are commonly prepared via an intramolecular acid-catalysed 
procedure. For example, Lafont and co-workers18 isolated l,6-anhydro-2,3-isopropylidene-P- 
D-allofuranose 13 on heating 14 at reflux with tosic acid in xylene (Scheme 3).




Reagents and conditions: i) p-TsOH, xylene, reflux.
Compounds such as the zaragozic acids raise interesting questions as to their 
biosynthesis. Zaragozic acid A is derived from two polyketide chains. One chain begins with 
an aromatic ring derived from benzoic acid, itself derived from phenylalanine, the remaining
Merck with [1-13C] and [1, 2-13C2]acetic acid identified the direction and position of ten 
acetate units, and showed that the other polyketide chain is formed by condensation of four 
acetate units and two C-methylations from L-methionine.19 Glaxo’s studies20 with [1-13C, 
1802] acetate and 18C>2 indicated that five of the oxygens, including both of the heterocyclic 
oxygens, were derived from atmospheric oxygen, and the oxygens at the two ester carbonyls 
were derived from acetate (Figure 3).







oxygen atom derived 
from acetate
oxygen atom derived 
from atmosphere
Figure 3: Biosynthesis of zaragozic acid A
However, zaragozic acid F is the First zaragozic acid isolated possessing a non-aromatic 
terminus of the Cl sidechain,21 which suggests it is biosynthesised from acetate as a starter 
unit.
Glaxo20 have postulated a possible mechanism for the formation of the bicyclic system 
(Scheme 4). They envisaged the bicyclic core to arise via an acid-catalysed tandem cyclisation 




1.4 Biological Properties of the zaragozic acids
The zaragozic acid/squalestatin family have been shown to be picomolar competitive 
inhibitors of mouse, rat, and HEPG2 squalene synthase (e.g. zaragozic acid A: ki = 78 pM rat 
microsomal SQS)5-8. This novel class of natural products are 103 to 106-fold more potent as 
enzyme inhibitors of SQS than previous SQS inhibitors which have employed pyrophosphate 
or pyrophosphate analogue containing compounds.
The zaragozic acids / squalestatins have quite a remarkable biological profile as in 
addition to this very potent SQS inhibitory activity, the family displays broad spectrum 
antifungal activity against both yeast and filamentous fungi. Also, certain members of the 
family, in particular, zaragozic acid D and D2,8 inhibit the enzyme ray-famesyl-protein 
transferase (IC50=100 nM), which has implications in the development of anticancer agents, 
particularly for colon and pancreatic cancer.
It is thought that the zaragozic acids competitively inhibit SQS by mimicking PSPP. 
Structural similarities can be seen in that they both consist of a polar tri-acid core flanked by 














Extensive work by both the Merck and Glaxo groups directed towards a better 
understanding of the structure-activity relationship (SAR) yielded valuable information about 
the key functional groups essential for activity. It was found that for zaragozic acid A / SI, 
removal of the C6 acyloxy sidechain resulted in activity approximately equipotent to the parent 
compound. However, if the sidechain was retained, then modification to it critically influenced 
the SAR for modifications made elsewhere.
The high potency of zaragozic acid F illustrates that a terminal phenyl group in the C l 
sidechain is not required to maintain potent activity.21 Removal of functionality at C6 and C l 
to give the 6,7 di-deoxy analogue,22 and modification at C3 in the form of the C3 
decarboxy,23’ 24 C3 methyl ester,24 or C3 hydroxymethyl and its derivatives is well 
tolerated 25
The bicyclic core itself is essential, as the monocyclic core analogues containing only the 
6-membered ring were orders of magnitude less active.26 The nature of the tri-carboxylic acid 
moiety was probed27’28 and it was found that the C3 acid is not essential. Esterification of the 
C3 and C4 acids gave compounds which lacked substantial in vitro enzyme inhibitory activity, 
although the in vivo activity was enhanced due to increased bioavailability. However, from all 
these studies it was apparent that the C5 carboxylic acid must be retained in order to maintain 
potent activity; modification at this position is not well tolerated by the enzyme.
1.5 Published syntheses of the Zaragozic acids
In view of their interesting and potent biological activity along with their remarkable 
structural features, the zaragozic acids have attracted the attention of the synthetic community.
Before discussing our route to the zaragozic acids, it is worthwhile to examine the 
strategies developed by other workers.
Initially, attention focused on the synthesis of model core systems with varying degrees 
of substitution about the 2,8-dioxobicyclo[3.2.1]octane ring. Now, no fewer than four groups 
have achieved total syntheses of zaragozic acids.29-34 This Section is divided into two parts. 
The first part is concerned with approaches to model core systems, and the second part gives 
an overview of the total syntheses.
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1.5.1 Published syntheses of model core systems.
The 2,8-dioxabicyclo[3.2.1]octane ring system had been synthesised prior to the 
discovery of the zaragozic acids. One such example is the synthesis of the 2,8- 
dioxabicyclo[3.2.1]octane ring systems 16 and 17, reported by Heathcock and co-workers35 
as part of the synthesis of the plant alkaloid (-)-secodaphniphylline (Scheme 5). Treatment of 
the acid 18 with Af-methoxy-Af-methylamine, carbonyl diimidazole and then butynyl lithium, 
followed by reduction of the corresponding ketone and subsequent isomerisation of the alkyne 
afforded the alcohol 19. Treatment of 19 with mercuric sulphate and dilute sulfuric acid 






Reagents and conditions: i) MeONHMe, carbonyl diimidazole, CH2 CI2 , 10 min, then butynyl lithium, 
THF, 8 6 %; ii) UAIH4 , Darvon alcohol, -80°C, Et2 0 , 93%; iii) KH, H2 N(CH2 )3NH2, -15°C, 45 min, 87%; 
iv) HgS04, IN H2 S 04, THF, 95%.
The first synthesis of the 2,8-dioxobicyclo[3.2.1]octane ring system directed specifically 
at the zaragozic acids was reported by Aggarwal36 in 1994 (Scheme 6). Identifying the C3-C4 
fragment as an intact tartrate unit, the simple model system 20 was assembled in a two-step 
procedure. Thus, addition of the lithium enolate of the acetonide 21 derived from (S,S)- 
dimethyl tartrate, in the presence of 12-crown-4, to acetonylacetone gave a mixture of isomeric 
adducts. There were at least four isomers present, presumably various diastereoisomers of 22, 
23 and 24, but it was not possible to determine the relative ratios at this stage. Treatment of 
the isomeric mixture with HC1 in methanol under specific conditions effected cyclisation to 
give the bicyclic core 20 as a single diastereoisomer.
14












Reagents and conditions: i) acetonylacetone, LDA, THF, 12-Crown-4, -78°C, 5h, 77%; ii) HCl/MeOH, 
65°C, 90 min, 30%.
Prolonged heating resulted in lower yields of mixtures of cyclised adducts, presumably 
arising from the fact that the diastereomer with the wrong stereochemistry at C5 (from the 
anion addition) is now able to compete in the cyclisation to give less stable core adducts.
This synthesis, though short, suffers from generation of a mixture of isomers. The 
approach clearly has potential applicability to the real system by use of an appropriately 
fimctionalised dicarbonyl compound.
Given the densely oxygenated nature of the bicyclic core, an obvious approach to these 
systems is the use of carbohydrate precursors. At virtually the same time as the Aggarwal 
synthesis, the Roberts’ group reported the synthesis of a fully functionalised bicyclic core 
starting from D-galactose.37 However, their core has the incorrect stereochemistry at C6. 
Roberts’ disconnection of the bicyclic core 25 leads to the hexahydroxyketone 26, which they 
envisaged as cyclising to the bicyclic core on treatment with acid. If 26 is written in its Fischer
15
projection form 27, then their use of a carbohydrate moiety with a four carbon fragment 
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Roberts’ core synthesis is shown in Scheme 8. Thus, Swem oxidation of 28 followed 
by addition of 3-lithiofuran as their chosen four carbon fragment occurred exclusively from the 
a-face. Subsequent manipulations gave the lactol 29 as a single anomer, of which reduction 
followed by esterification and oxidation gave the ketone 30. Treatment of 30 with aqueous 
TFA afforded the furanose 31 as an 8:1 ratio of anomers. Acetonide protection of 31 followed 
by Sharpless dihydroxylation proceeded stereoselectively to give the triol 32 as a single 






























Reagents and conditions: i) Swem oxidation then 3-lithiofuran, THF, -78°C, 93%; ii) NaBH4 , EtOH, 
87%; iii) PivCl, pyridine, DMAP, 72%; iv) Jones reagent, acetone, 91%; v) TFA/H2 O (9:1), 0°C, 89%; vi) 
acetone, anhydrous CUSO4 , CSA, 92%; vii) OSO4 , K3 Fe(CN)6 , hydroquinidine-4-chlorobenzoate, K2 CO3 , 
M eS02NH2, tBuOH/H20  (1:1), RT, 3.5d, 60%; viii) TFA/H2 0/THF (1:1:4), Id, 60%; ix) CSA, anhydrous 
CuS04, CH2 C12, 72h, 41%.
Rizzacasa and co-workers have reported the synthesis of the model core system 34 
starting from D-mannose.38 The key steps involve an Ireland-Claisen rearrangement of the 
allyl ester 35 and a stereoselective epoxidation of the furanoid glycal 36 with 2,2- 
dimethyldioxirane. Thus, seven well precedented steps from D-mannose gave the allyl ester 
35, which underwent an Ireland-Claisen rearrangement to give 36, thereby introducing the C5 
carboxyl function. A series of functional group interconversions gave the dihydrofuran 37, 
which underwent a stereoselective epoxidation (9:1) with 2,2-dimethyldioxirane resulting in 
epoxidation from the opposite face to the benzyl ether. Regioselective opening of the resulting 
epoxide with allyl alcohol, followed by subsequent protection of the C7 hydroxyl as the PMB
17
ether, gave 38. Several steps led to the bicyclic precursor 39, which on treatment with 





















Reagents and conditions: i) LDA, TMSC1, HMPA/THF, -100°C to RT; CH2 N 2 , 71%; ii) 2,2- 
dimethyldioxirane, acetone, CH2 CI2 , 0°C; iii) allyl alcohol, RT, 30 mins; iv) PMBC1, NaH, DMF/THF, 84% 
from 38; v) 50% HF/MeCN (5:95)/H2 0, RT, 2.5h, 89%.
Gurjar and co-workers have reported some interesting findings in their approach to 
model core systems.39 Their work investigated the stereochemical dependence of anhydro-ring 
formation using carbohydrate templates. Up to three ketal isomers are possible in their 
systems: 1) a 1,6-anhydrofuranose 2) a 1,5-anhydrofuranose and 3) a 1,6-anhydropyranose. 
However, their assignments appear to rest purely on lD ^H  NMR shift values and coupling 
constants. Given the complex nature of the ketal isomers possible, it is difficult to 
unambiguously rule out other possible ketal isomers for any of the given model cores without 
full and rigorous 2D-NMR spectroscopy.
18
Starting from 1,2,5,6-di-CMsopropylidene-a-D-glucofuranose derivative 40, six 
precedented steps afforded the olefin 41 which when subjected to catalytic osmylation gave a 
7:3 diastereomeric mixture of diols 42 and 43 respectively. Both diastereomers gave rise to 
the 1,5-anhydrofuranoses 44 and 45 upon acid treatment, instead of the desired 1,6- 
anhydrofuranoses (the latter is the 2,8-dioxabicyclo[3.2.1]octane ring system of the natural 
product) (Scheme 10).
It was thought that generation of the undesired 1,5-anhydrofuranoses could be due to the 
presence of the carboethoxy group having a diminishing effect on the nucleophilicity of the 
adjacent hydroxyl group. To test this notion, the ester was reduced to a protected 
hydroxymethyl group, giving the new cyclisation precursors 46 and 47.
Scheme 10
Reagents and conditions: i) OSO4 , NMO, acetone/water; ii) PTSA (cat.), CHCI3 , A, 100% 44+45.
OBn
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Interestingly, one of the diastereomers 46 did indeed now afford the desired 1,6- 
anhydrofuranose 48 (albeit being the opposite enantiomer with the incorrect stereochemistry at 
C3, C6 and C l  with respect to the natural product system) (Scheme 11). However, the other 


























Reagents and conditions: i) /?-TsOH, CHCI3 , A
In a subsequent communication,40 Gurjar again reported an apparent stereochemical 
dependence for anhydro-ring formation in another model system. The commercially available
2,3,4,6-di-<2-isopropylidene-2-keto-L-gluconic acid 50 was converted into the olefinic 
furanose 51. Catalytic osmylation afforded a 1:1.5 diastereomeric mixture of diols 52 and 53. 
Acid-catalysed cyclisation of diol 52 afforded the 2,6-anhydro ring system 54. However,
20
cyclisation of diol 53 gave the desired core 55 of the zaragozic acids (opposite enantiomer, 
























Reagents and conditions: i) OSO4 , NMO, acetone/water; ii) PTSA (cat.), CHCI3 , A
A final communication from the Gurjar group41 described modification of the previous 
route (Scheme 13) to include functionality at C3. The resultant core 56 (opposite enantiomer 
to the natural product) possesses the incorrect stereochemistry at C4, which arises from 
generation of the undesired diastereomer in the chelation controlled Grignard addition reaction 
to the 5-ulofuranose derivative 57 (Scheme 14). Thus, protection of the primary hydroxyls of 
the diastereomers 52 and 53 (prepared as in Scheme 13) followed by oxidation afforded the 
ketone 57. Addition of vinylmagnesium bromide to 57 resulted in one diastereomerically pure
alcohol 58, (incorrect configuration at C4). Subsequent steps gave the bicyclic precursor 59, 
which on heating in CHCI3 in the presence of tosic acid afforded the bicyclic core 56.
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Reagents and conditions', i) TBSC1, imidazole, CH2 CI2 , RT, 3h; ii) DMSO, (COCl>2 , CH2 CI2 , -78°C, 
Et3N, 1.5b; iii) vinyl magnesium bromide, THF, 0°C to RT, 0.5h; iv) PTSA (cat.), CHCI3 , A.
Heathcock,42 like Roberts, also utilised the 1,6-anhydropyranose moiety in his core 
synthesis in the form of the bis-benzyl protected derivative 60. Oxidation followed by 
Grignard addition allowed for incorporation of functionality suitable to be turned into what 
would become the C5 carboxyl. Acetolysis of the anhydrosugar 61, with concomitant 
acetylation followed by saponification gave an anomeric mixture of triols 62. Selective 
ketalisation followed by oxidation with PDC afforded the corresponding y-lactone 63. Use of 
an organocerium reagent was necessary to incorporate the Cl functionality as use of the more
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basic organolithium reagent led to elimination of the benzyloxy group at C3. Hydrolysis of the 
isopropylidene acetal afforded the 1,4-dialkyl- 1,6-anhydrofuranose 64, representing the 




















R = CH2 CH2 CHCH, Ph, CH2OTBDMS 
Scheme 15
Reagents and conditions: i) DMSO, TFAA, Et3N, CH2 CI2 , -78°C to RT, 87%; ii) RMgBr, THF, -78°C 
to RT, 82-92%; iii) TFA, AC2 O, 65°C; iv) MeONa, MeOH; v) acetone, /?-TsOH; vi) PDC, sieves, CH2 CI2 , 
41-76% from 61; vii) MeCeCl2, THF, -78°C; viii) 2N HC1, THF, reflux, 61-69% from 63.
Heathcock then probed some of the factors influencing the preferential formation of the
1,6-anhydrofuranose derivatives in this model core study.
For the formation of 5-substituted 1,6-anhydrogalactofuranoses, it was found that as the 
electronegativity of the C5 substituent increases, the ratio of 1,6-anhydrofuranose 65 to 1,6- 











Reagents and conditions', i) TFA, AC2 O, 65°C; ii) MeONa, MeOH; iii) p-TsOH, CgHg, 48-79% from 
6 6 .
Table 3: Dependence of 65:66 ratio on the nature of the C5 substituent
R Substrate Ratio 65:66
Me 66a >95:5
Et 66b 8:1
c h 2c h = c h 2 66c 4:1
Ph 66d 1:1
c h 2o t b d p s 66e 1:2
C02Et 66f <5:95
Control experiments showed that the product ratios are kinetic, and not thermodynamic. 
The trend was rationalised as follows. Under acidic conditions, the triols 67 and 68 should be 
under equilibrium via aldehyde 69. Furanose 67 gives rise to the 1,6-anhydrofuranose 65 via 
the oxonium ion 70 and pyranose 68 generates the 1,6-anhydropyranose 66 via the oxonium 
ion 71. Electronegative substituents R at C4 disfavour oxonium ion 70 more than oxonium 
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However, when there was an additional subtituent present at Cl, preferential formation 
of 1,4-dialkyl-1,6-anhydrofuranoses was observed. The desired 1,4-dialkyl-1,6- 
anhydrofuranoses are selectively generated kinetically (kinetic ratios for 72:73 9:1 to >10:1), 
but now slowly equilibrate to the 1,4-dialkyl-1,6-anhydropyranoses. This time, however, the 
equilibrium ratio appears to reflect the steric size of the C5 substituent of the anhydropyranose, 
rather than the electronegativity, since increasing the size of the C5 substituent favours the 
wrong ketal isomer 73 (Table 4).
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R Substrate Time Ratio 72:
c h 2c h = c h 2 72a 3h 2:1
c h 2c h = c h 2 73a 3.5h 2:1
Ph 72b 30 min 1:2
Ph 73b 90 min 1:2
CH2OTBDPS 72c 75 min 1:1
c h 2o t b d p s 73c lh 1:1
Another approach, utilising 1,3-dipolar cycloaddition chemistry followed by an acid- 
catalysed rearrangement of the 6,8-dioxabicyclo[3.2.1]octane to the desired 2,8- 
dioxabicyclo[3.2.1]octane ring system, has very recently been disclosed by the Hodgson 
group.43 The retrosynthetic disconnections are shown below (Scheme 18). It was thought that 
the anhydrofuranose core 74 might be obtained via an acid-catalysed rearrangement of 
anhydropyranose 75, which itself could be obtained via a 1,3-dipolar cycloaddition of the 
carbonyl ylide generated from the diazodiketoester 76, followed by a ketone to hydroxy acid 
conversion.
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Treatment of the diazodiketo ester 77 with methyl glyoxylate in the presence of catalytic 
rhodium acetate afforded the endo cycloadduct 78 as a single isomer (Scheme 19). Addition of 
lithium trimethylsilyl acetylide, (to introduce a masked form of the remaining carboxylate 
unit), occurred exclusively under axial attack to give the lactone 79. Treatment of the derived 
anhydropyranose 80 with acid led to the desired 2,8- rearrangement product 81 which existed 
in a 3:1 equilibrium mixture with the 6,8-dioxabicycle 80.
II-VI













Reagents and conditions: i) methyl glyoxylate, cat. Rh2 (OAc)4, toluene, reflux, 0.5h, 60%; ii) lithium 
trimethylsilylacetylide, THF, -78°C, lh, 80%; iii) K2 CO3 , wet DMF, RT, 3h, 98%; iv) H2  (1 atm.), Pd/C, 
RT, 2h, 100%; v) LiAlH4, Et2 0 , RT, Id, 67%; vi) NaH, BnCl, cat. Nal, DME, 0°C to RT, 52%; vii) 2% 
HC1 in MeOH, RT, 15 min.
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Researchers at Merck had earlier reported a novel approach to the zaragozic acid core 
which also employed 1,3-dipolar cycloaddition chemistry between carbonyl ylides and various 
dipolarophiles.44 This is the only model core synthesis not to rely upon a ketalisation process 
for forming the 2,8-dioxabicyclo[3.2.1]octane ring system. The bicyclic cores are obtained 










In all cases, slow addition of the diazo compound to the dipolarophile, in the presence of 
catalytic rhodium acetate, resulted in a single cyclisation product, of which a few examples are 
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Reagents and conditions: i) Rh2 (OAc)4 , TMSOCH=CH2 , PhH, 70°C, 16%; ii) Rh2 (OAc)4 , 
EtOC^CH, PhH, 70°C, 72%; iii) Rh2 (OAc)4> TMSOCH=CH2, PhH, 70°C, 6 6 %
However, although reactions of the carbocyclic derivatives of the core (i.e. lacking the 
oxygen in the 2 position) generally proceeded smoothly and in good yields, the reactions 
containing the 2 position oxygen all proceeded in very low yields (9%-16%).
Finally, Kraus and co-workers have reported the synthesis of a model core system.45 
Their retrosynthesis involved introduction of the a-hydroxy acid subunit via the keto acid 82 
which in turn would arise from carboxylation of the bridgehead position followed by oxidation 
of the alkene in the bicycle derivative 83. Compound 83 itself was seen to arise from 
oxidation of a compound similar to diol 84 (Scheme 23).








Conversion of hemiacetal 85, (5 precedented steps from D-arabinose), into thioacetal 
86, followed by treatment with mercuric acetate in acetic acid produced the acetate 87 as a 
single diastereomer. Treatment of 87 with the enol silyl ether of 2-butanone afforded the 
ketone 88, which cyclised to afford the bicyclic ketal 89 upon warming in methanol in the 
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Reagents and conditions: i) EtSH, HC1; ii) PhCH(0 Me>2 , p-TsOH, 58% from 85; iii) Hg(0 Ac)2 , AcOH, 
92%; iv) 2-trimethylsilyloxybutene, S11CI4 , -78°C, 65%; v) p-TsOH (cat.), MeOH, 60°C, 69%.
This model core review highlights the fact that the factors affecting the formation of 
either the desired 1,6-anhydrofuranose, the undesired 1,5-anhydrofuranose or 1,6- 
anhydropyranose systems is not straightforward. The Gurjar group have shown there to be a 
stereochemical dependence as to which ketal isomer is formed under their reaction conditions. 
They report of no interconversion between their various ketal isomer systems. Hodgson (and 
Nicolaou, vide infra) on the other hand, reports of a thermodynamic ketal isomerisation, and 
indeed, it was the isomerisation of 1,6-anhydropyranose systems to 1,6-anhydrofuranoses 
that was the impetus for Heathcock's synthesis of the zaragozic acids. The factors influencing 
the formation of the correct ketal isomer are clearly complex, and will be discussed again later 
in Chapter 2.
All of these model core syntheses, impressive though they are, are clearly still a long 
way from the natural product itself. The following section reviews the total syntheses reported 
to date.
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1.5.2 Published total syntheses of the zaragozic acids.
In 1994, Nicolaou reported the first total synthesis of this series of natural products; that 
of zaragozic acid A.31
Four of the six stereogenic centres of the core are constructed by dihydroxylations, the 
first of which employed the Sharpless asymmetric cis- dihydroxylation (AD) of the prochiral 
diene 90 to incorporate the initial chirality. Although the AD of the diene 90, affording diol 91 
in 83% ee, was low yielding, it is interesting to note that it is completely regioselective. 
Moreover, it has been the olefin conjugated to the ester that has been preferentially oxidised. 
This initially appears unlikely, since it is known that OSO4 reacts slowly with electron poor 
olefins. However, to avoid allylic interactions, modelling has predicted that the ester group 
actually lies orthogonal to the plane, and hence overlap of the olefin 7r-system with the ester is 
no longer possible.
In the next key step, the second dihydroxylation of the lactone 92 afforded the triol 93 
via the initially formed triol 94 followed by a spontaneous translactonisation. Subsequent 
manipulations involving stepwise oxidation of two of the hydroxymethyl groups to the 
carboxylic acid level furnished the key aldehyde 95.
Installation of the C 1 sidechain was achieved via addition of the lithiated dithiane 96 
(serving as an acyl anion equivalent) to the aldehyde 95 to give the adduct 97. However, this 
proceeded with poor diastereoselectivity giving approximately a 1:1 mixture of diastereomers, 
for which no conditions could be found to improve the selectivity. Hydrolytic cleavage of the 
desired diastereomer 97 then gave the lactol 98 (Scheme 25).
Nicolaou’s acyl anion equivalent 































Reagents and conditions: i) (DHQD)2 -PHAL, K2 0 s 0 2 (0 H )4, K3Fe(CN)6, K2 C 0 3, M eS02 NH 2, 
lBuOH/H2 0 , 0°C, 30%; ii) 2-methoxypropene, PPTS, 8 8 %; iii) DDQ, CHC13 /H2 0 , 8 6 %; iv) 0 s 0 4, NMO, 
tBuOH/THF/H2 0 , 83%; v) 97, THF, -78°C, 32%; vi) 2% HCl/MeOH, CH2 C12, 99%; vii) Hg(C104)2, 
CaC03, THF/H2 0 , 2.5h, 83%;
Subjection of the lactol 98 to 1.8% HCl-MeOH at reflux effected rearrangement to give 
the zaragozic acid A skeleton 99. (Scheme 26). Incorporation of the C6 sidechain required 
selective esterification of the C6 hydroxyl in the presence of the C7 hydroxyl. However, 
esterification proceeded with a low 3:2 selectivity in favour of the desired C6 ester which after
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subsequent steps gave 100. A series of protecting group manipulations then afforded 
zaragozic acid A in an overall yield of 1%.
zaragozic acid A 
Scheme 26
Reagents and conditions: i) 2% HCl/MeOH, 78°C, 21h, 45%.
At the same time as the disclosure of this work by the Nicolaou group, Carreira 













assembled the core such that the Cl sidechain is incorporated at an early stage in the synthesis, 
and has the tri-carboxylic acid unit at the hydroxymethyl oxidation level. This approach allows 
for the rapid construction of the bicyclic core.
The synthesis began with the condensation of D-erthronic y-lactone 101 with
dimethylamine which after protection afforded the amide 102. Addition of 1- 
ethoxyvinyllithium to 102 yielded an intermediate ketone which underwent a chelate 
stereocontrolled addition with trimethylsilylethynyl magnesium bromide to provide the alcohol 
103 as a 20:1 diastereomeric mixture. Subsequent manipulations led to the alkyne 104 which 
was coupled to the Cl sidechain 105 to afford a mixture of the propargylic alcohols 106 
(Scheme 27).
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Reagents and conditions: i) Me2 NH, MeOH, 0°C, 97%; ii) (MeO^CEt, p-TsOH, 90%; iii) NaH, BnBr, 
THF, 96%; iv) (ethoxyvinyl)lithium, THF, -78°C, v) TMSC=CMgBr, THF, -78°C, 84%; vi) "BuLi, THF, 
-45°C then 105, LiBr, THF, 93%.
Dess-Martin oxidation of 106 afforded the a,[3-unsaturated ynone 107. Stereoselective 
reduction of the ynone 107 to the corresponding trans-enone was accomplished using 
chromium (II) acetate monohydrate dimer, and subsequent removal of the silyl ethers gave
34
enone 108 (Scheme 28). It is interesting to note that dihydroxylation of enone 108 in the 
presence of either Sharpless ligand (DHQ)2-PHAL or (DHQD)2-PHAL afforded the same 
1.7:1 diastereomeric mixture of tetraols in favour of the desired product. The two 
diastereomers isolated could not be separated at this stage. Cyclisation of the mixture with 
0.5% HCl-MeOH afforded the corresponding 2,8-dioxabicyclo[3.2.1]octane cores, which 
were separated following selective protection of both primary hydroxyls as TBS ethers to 





















Reagents and conditions', i) [Cr(0 Ac)2 -H2 0 ]2 , THF/H2 O, 60%; ii) nBu4NF, THF, 93%; iii) OSO4 , 
(DHQD)2-PHAL or (DHQ)2 -PHAL, NMO, acetone/H2 0; iv) 0.5% HCl/MeOH, RT, 2h; v) TBSC1, Et3N, 
DMAP, CH2 C12, 26% from 108.
The next key step was the introduction of a masked form of the C4 carboxylate. This 
was achieved by addition of lithium trimethylsilyl acetylide in the presence of trimethylamine to 
the C4 ketone 110 to give the alkyne 111 as a 6:1 diastereomeric mixture. Oxidation of the 
C3, C4 and C5 positions to the tri-carboxylic acids was achieved via simultaneous oxidation of
35
C3 and C5 hydroxymethyl functionalities to the corresponding di-aldehyde 112. Ozonolysis 
of the double bond in 112 gave the tri-aldehyde 113 which then underwent a triple Pinnick 
oxidation to give the corresponding tri-carboxylic acid 114 (Scheme 29).
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leagents and conditions: i) TMSC=CLi, Et2 0 /M e3 N (1:1), -78°C to -20°C, ii) O3 , CI^CVMeOH, 

















Selective Boc protection of the C7 alcohol of triol 114 using 4-(l-pyrrolidinyl)pyridine 
as the catalytic base allowed for the installation of the C6 sidechain 115 to give 116, complete 


















Reagents and conditions: i) (Boc^O, 4-pyrrolidinopyridine, CH2 CI2 , 82%; ii) 115, DCC, DMAP, 
CH2C12, 78%; iii) TFA, CH2 C12, 100%.
The third total synthesis to be discussed is that of zaragozic acid C by the Evans 
group.33 Evans identified a tartaric acid unit in the C3-C4 portion of the bicyclic core of the 
zaragozic acids. Thus the synthesis commenced with the tartaric acid derivative 117.
37
Enolisation of the ketal 117 with in situ silylation afforded the silyl ketene acetal 118 
which underwent a stereoselective Lewis acid-catalysed aldol addition with aldehyde 119 to 
give adduct 120 as a single isomer (Scheme 31). Oxidation of 120 to the ketone followed by 
a chelation controlled addition of vinylmagnesium bromide introduced the latent C5 carboxyl 
moiety in the form of a vinyl substituent to give 121. Selective dihydroxylation of the phenyl- 
substituted olefin of 121, followed by diol cleavage, lactonisation and subsequent oxidation 
level adjustments afforded the lactone 122. Addition of the Cl sidechain 123 to 122 led to 
the lactol 124. Oxidative cleavage of the C4’ p-methoxybenzyl ether followed by acetylation 
gave the lactol 125. Submitting lactol 125 to the ketalisation / hydrolysis step afforded the 
tris-acid bicyclic core. Re-esterification and hydrogenolysis of the C6 benzyloxy substituent 
afforded the diol 126 which was coupled to the C6 sidechain 115. Deprotection of the C7 
silyl ether and C3, C4, C5 esters provided zaragozic acid C.
The final total synthesis is that of zaragozic acid A by the Heathcock group.34 To date, 
this has only been reported in conference proceedings, and has yet to appear in the literature, 
and hence it will not be discussed here.
Since the first reports of the zaragozic acid/squalestatin family, over 100 papers have 
appeared in the scientific literature ranging from their isolation and characterisation, to their 
complete total syntheses. Much progress has been made in the synthetic area, and new 
problems and challenges have been met during that time, with the boundaries of synthetic 
chemistry being advanced ever forward. It is interesting to note that all three total syntheses not 
to mention numerous model core syntheses presented in this Chapter have employed the 
dihydroxylation reaction, highlighting the power and scope of this synthetic procedure.
This section has given an overview of the total syntheses to date, and in the following 
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zaragozic acid C 
Scheme 31
Reagents and conditions', i) LiHMDS, TMSC1, THF, -78°C to 0°C, 97%; ii) (1PrO)TiCl3 , CH2 CI2 , 2h at 
-78°C then 2.5h at -40°C, 76%; iii) Dess-Martin oxidation, 94%; iv) CH2 =CHMgBr, CH2 C12/THF, -78°C, 
lOh, 76%; v) 1.7 equiv of 123, 3.4 equiv of terf-butyllithium, 1:1 hexane/ether, -78°C, 5 min, then 122, 
-78°C, 15 min, 73%, vi) DDQ, CH2 CI2 /H2 O, lh, vii) AC2 O, DMAP, pyridine, PhH, lh, 90% from 124; viii) 
20:10:1 CH2 CI2 /TFA/H2 O, RT, 14h, ix) 7 equiv N,N’-diisopropyl-0-terf-butylisourea, CH2 CI2 , 52% from 
125; x) H2, 750 psi, 10% Pd/C, AcOH, MeOH, 20h, 96%.
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1.6 Retrosynthetic Analysis of the Zaragozic acids
Retrosynthetically, it becomes immediately apparent that the zaragozic acids can be 
broken down into three distinct fragments: the C6-acyl sidechain, the Cl alkyl sidechain, and 
of course the bicyclic core itself. Any synthetic approach not only has to contend with the 
stereoselective introduction of the numerous stereogenic centres, but also has to take into 
account the high density of oxygen-containing functional groups.
Our convergent approach to the zaragozic acids envisaged late attachment of the C6- 
acyloxy sidechain, and this plan required a suitably protected 2,8-dioxabicyclo[3.2.1]octane 
core. We desired a synthesis that would in principle be flexible enough to allow for the 
synthesis of any of the zaragozic acids. A strategy of this type would no doubt require a 
common intermediate. Also, given that the Merck and Glaxo SAR studies highlighted the 
importance of the C5 carboxylate ,27»28 we planned to include the potential to differentiate the 
C5 acid in our synthesis, should it be required.
A route to the core could be envisaged via epoxide cyclisation routes, the idea of which 
was stimulated by Glaxo’s biosynthetic proposal (see Scheme 4, Section 1.3). This would 
require stereoselective oxidation of a diene. However, this is difficult to achieve as it requires 
reliable asymmetric epoxidation of isolated alkenes and also control in ring size of epoxide 
opening. Therefore, it was thought to be easier to examine asymmetric osmylation reactions of 
dienes.
Our retrosynthetic analysis of the zaragozic acids is shown in Scheme 32. Since it is well 
known that dihydroxylation of alkenes is faster with electron rich double bonds, the carboxylic 
acids have been reduced to the alcohol oxidation level. Disconnection of the C6-acyloxy 
sidechain gave 127, envisaging selective re-acylation at C6. It can be seen that the acyclic 
precursor 128 is just the open chain dihydroxy ketone form of 127. At the start of our work 
there was no precedent for the formation of the desired bicyclic anhydrofiiranose ring system. 
We therefore hoped that acid-catalysed internal ketalisation of the acyclic precursor 128 would 
on thermodynamic grounds lead to the formation of the desired bicyclic ketal core 127 rather 
than the 1,6-anhydropyranose or 1,5-anhydrofuranose structural isomers. The acyclic 
precursor 128 could be obtained by addition of an acyl anion equivalent (serving to
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incorporate the C l sidechain) to aldehyde 129. It would be necessary to carry out this addition 
under chelation control in order to incorporate the C7-hydroxyl with the correct 
stereochemistry. This key disconnection provides an excellent opportunity for late stage 
divergency and, as was our plan, allows for access to any of the zaragozic acids by having the 
appropiately functionalised acyl anion equivalent. Therefore, aldehyde 129 would serve as our 
common intermediate.
Removal of the two adjacent 1,2-diol functionalities of 129 leads to the prochiral 1,3- 
diene 130. In the synthetic direction, it was planned to carry out a double Sharpless 
asymmetric cfy-dihydroxylation46 of the diene 130 to simultaneously control the 
stereochemistry of the four contiguous stereocentres at C3, C4, C5 and C6. The key point to 
note here is that both double bonds of diene 130 require the same chiral ligand for correct 
facial selectivity in the dihydroxylations. Since there would be no mismatch with the ligand, 
we aimed to incorporate all four contiguous stereocentres at once in a one-pot double Sharpless 
AD of diene 130. Synthesis of the 1,3-diene 130 could be realised by way of a palladium 
mediated cross-coupling between the stereodefined vinyl stannane 131 and the vinyl iodide 
132, a transformation commonly known as a Stille-coupling.47 It is worth mentioning that 
both the C3-C4 and C5-C6 relative stereochemical relationships in 129 stem directly from pre­
defining the stereochemistry of the vinyl coupling partners 131 and 132 respectively.
As with many total syntheses, model studies are frequently performed on simplified 
systems prior to focusing attention towards the target molecule itself. Indeed, our initial target 
would be compound 133 where we have replaced the Cl sidechain with a methyl substituent, 





































Scheme 32: Our retrosynthetic analysis of the zaragozic acids
This thesis describes the successful synthesis of the bicyclic core 133 and subsequent 











As outlined in our retrosynthesis, our prochiral 1,3-diene would be constructed using 
Stille coupling methodology between a stereodefined vinyl stannane and vinyl iodide. 
Therefore, these two alkenes became our initial synthetic targets.
2.1 Synthesis of the vinyl stannane
We required our vinyl stannane to have the two carbon substituents in a syn 
arrangement. A very efficient procedure for the stereospecific syn hydrostannylation of 
alkynes had been reported by Guibe and co-workers.48 In the presence of catalytic amounts 
of dichlorobis(triphenylphosphine)palladium or a 7c-allyl molybdenum complex, tributyltin 
hydride was found to undergo a stereospecific ds-addition to a variety of alkynes to give the 
corresponding vinyl stannanes in good to excellent yields.
Following this literature procedure, treatment of but-2-yne-l, 4-diol 134 with nBu3SnH 
under palladium catalysis afforded exclusively the czs-hydrostannylation product 135 in 90% 
yield (Scheme 33).
Benzylation of 135 was first attempted using BnBr / NaH in DMF but these proved not 
to be the conditions of choice since an unidentified, inseparable side-product was formed as 
the reaction progressed. Benzylation using benzyltrichloroacetimidate also proved 
ineffective due to poor solubility of 135 in the. 2:1 cyclohexane/CH2Cl2 solvent system, and 
by-products resulted when a more polar solvent was employed. However, it was found that 
addition of a catalytic amount of BU4NI to the NaH / BnBr / DMF system dramatically 
increased the rate of reaction. This minimised formation of the unwanted side-product and 
hence gave pure 136 in 71% yield. However, it was later found to be more effective to 
initially protect the diol 134 as the bis-benzyl ether 137 and then carry out the cis- 




I =  I
137 
Scheme 33
Reagents and conditions: i) “Bu3SnH, 2 mol% Pd(PPh3 )2 Cl2 , THF, RT, 10 min, 90%; ii) NaH, BnBr, nBii4NI 
(cat.), DMF, 2.5h, 71%; iii) BnBr, nBu4NI (cat.), DMF, 95%; iv) “Bu3 SnH, 2 mol% Pd(PPh3 )2 Cl2, THF, RT, 
2b, 99%.
With one of the Stille coupling fragments now in hand, attention turned to the synthesis 
of the vinyl iodide.
2.2 Synthesis of the vinyl iodide
We required the vinyl iodide to have the two carbon substituents trans to each other. 
Corey has shown50 that hydroalumination of propargylic alcohols with LiAlfLj, is a highly 
stereoselective process giving rise to trans-vinyl alanes which can subsequently be quenched 
at low temperature with an excess of iodine to give either the p- or y-vinyl iodide, depending 
respectively on whether AICI3 or NaOMe is added to the reducing agent. This methodology 




Reagents and conditions', i) UAIH4 , A1C13, THF, reflux, 3h then -78°C, I2 ; ii) LLA.IH4 , NaOMe, THF, reflux, 
3h then -78°C, I2.
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A possible mechanistic rationale is shown in Scheme 35. The vinylaluminium 
intermediate 138 is formed by either a concerted or a stepwise intramolecular frvms-addition 
to the triple bond. Concerted intramolecular cw-addition of an Al-H grouping to an acetylene 
is geometrically very unfavourable,51 although hydroalumination using DIB AL-H does 
involve ds-addition of the aluminium-hydrogen bond to the triple bond.52
When the organoaluminum intermediate 138 is quenched at low temperature with an 
excess of iodine, the y-vinyl iodide 139 is formed in good yield. The reason for the formation 
of the isomeric p-vinyl iodide 140 when AICI3 is employed is due to the fact that this reacts 
with LiAlH4 to generate aluminium hydride (alane) which adds directly to the triple bond in 
a trans fashion rather than through initial coordination with the hydroxyl group.
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Reagents and conditions: i) LiAlH4, NaOMe, THF, reflux, 3h; ii) LiAlH* AIC13, THF, reflux, 3h; iii) -78°C,
I2.
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The Landor group has shown53 that hydroalumination of but-2-yne-l,4-diol with 
UAIH4 followed by quenching with water gave exclusively the trans-isomer of but-2-ene-
1,4-diol 141 in 98% yield (Scheme 36).
OH OH
1 =  1
134
Reagents and conditions: i) UAIH4 , Et2 0 , reflux, 4h
It was therefore envisaged that hydroalumination of 134 with LiAlFLi followed by low 
temperature quench with excess iodine should give rise to the desired E- vinyl iodide 142 
(Scheme 37).
OH OH
1 _  1
134
Initial attempts to synthesise vinyl iodide 142 by heating 134 at reflux in THF with 
LiAlH4 followed by quenching with excess iodine at -78°C resulted in iodide opening of 
THF (presumably through aluminium coordination) to give 4-iodo-butan-l-ol as the major 
product in the crude *H NMR. Reducing the amount of LiAlFL* from 2.5 equivalents to 1.6 
equivalents eliminated this side reaction. However, although the reaction appeared to 
proceed relatively well by TLC (which also indicated that hydroalumination was effected 
completely) the isolated yields of 142 were very disappointing. After addition of I2, the work 
up procedure involved quenching the excess LiAlILj by the successive addition of 
H20/Na0 H/H20 (1:1:3) followed by extraction with ether. It was found that 142 had poor 
solubility in ether and so EtOAc was later used to extract 142, though this caused great 
emulsion problems due to the aluminium salts generated in the quench. However, it was 
found that this could be minimised by quenching the excess LiAlILj with dry EtOAc before
Scheme 37
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quenching the organoaluminium species with I2. Then, after rigorous extraction with 




Reagents and conditions: i) LiAflfy, THF/EtjO, reflux, 1.5h , then 0°C, anhydrous EtOAc, then -78°C, I2 , 
62%.
It was now hoped that good selectivity would be observed for the mono-silylation of 
142 to give the mono-protected vinyl iodide 143 which could then be benzylated to give the 




Unfortunately, silylation of 142 with either TBSC1 or TBDPSC1 under a variety of 
conditions failed to give any reasonable level of selectivity. The best selectivity observed by 
TLC analysis was ca. 2:1 in favour of the desired regioisomer, and the yields were always 
low, at best 32%. This was due to three main reasons: competitive bis-silylation, the low 
levels of conversion used in order to try to reduce bis-silylation, and the difficulty in 
separating the regioisomers by flash column chromatography (FCC) on a synthetic scale.
The proof of the regiochemistry rests on NMR evidence. It was thought likely that 
the J3 coupling of the alkenic proton to the vicinal CH2OH would be larger than that to the 
other allylic methylene. It was also expected that acylation of the primary free hydroxyl 
would cause downfield shift of the adjacent protons, thus identifying them unambiguously.
48
Thus, to that end, the major mono-TBDPS protected regioisomer 145 was acylated to 
give quantitatively 146 (Scheme 40), and the minor mono-TBS protected regioisomer 147 
acylated to afford 148 in quantitative yield (Scheme 41).
In the NMR of 146, the methylene protons next to the acetate group appear at 4.72 
ppm as a broad singlet, and the methylene protons next to the silyl ether at 4.30 ppm as a 
doublet (J = 5.1 Hz) with further fine splitting, confirming the structure of 145.
In the NMR of 148 the methylene protons next to the acetate group appear at 4.69 
ppm as a doublet consistent for a J3 coupling, whilst the methylene protons next to the silyl 
ether at 4.26 ppm appear as a singlet, confirming the structure of 147 and hence by analogy 
the major regioisomer to be 143.





5 4.30 , d , J3=5.1 Hz
Scheme 40




Reagents and conditions: i) AC2 O, pyridine, CH2CI2 , 19h, 100%.
It was clear that an alternative route was required to access the vinyl iodide due to 
these protection problems, and it was decided to investigate mono-protection before 
reduction.
Landor had reported that raono-O-tetrahydropyran-2-yl derivatives of butyne-1,4-diols 
gave rise to a-allenic alcohols when treated with UAIH4.53 The mechanism of the reductive 
elimination step is seen as an intramolecular hydride transfer to C2 with concerted 
elimination of the tetrahydropyranyloxy group (Scheme 42).
Reagents and conditions', i) UAIH4 , Et2 0 , reflux, then H2 O, 73-95%.
Despite this fact we hoped that if the butyne diol 134 was mono-protected as a silyl 
ether, it would still be possible to effect hydroalumination followed by quenching with 
iodine to give a mono-protected vinyl iodide since it was considered that TBDMS ethers are 
poorer leaving groups than THP ethers due to poorer coordination to LiAHfy.
To this end, the mono-TBDMS silyl ether 149 was prepared in 42% yield by treatment 
of 134 with NaH and TBSC1 in DMF. Unfortunately, when 149 was subjected to the LiAlH4 
/ 12 procedure, none of the desired regioisomer 143 was detected. However, 2% of the other 
regioisomer 147 was isolated (Scheme 43) from the complex mixture.
HO OH j TBSO OH OH
Reagents and conditions: i) TBSC1, Imidazole, NaH, DMF, 0°C to RT, 42%; ii) LiAlH4, Et2 0 , reflux, lh , then 
0°C, anhydrous EtOAc, then -78 °C, I2 . 2% of 147.
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Since it was known that Red-Al™ could also effect frans-hydroalumination,54 the 
reaction was attempted several times employing Red-Al™ instead of L1AM 4 . However, 
reactions with Red-Al™ gave rise to a complex mixture of at least eight products (according 
to TLC analysis), none of which were either of the regioisomers 143 or 147. It was therefore 
thought that this methodology with the mono-silyl compound also gave rise to the a-allenic 
alcohol, as the literature suggested, and we turned our attention to a different approach. 
However, since that time, both Rawal55 and Overman56 have successfully carried out this 
transformation on the THP and TIPS mono-ethers 150 and 151 employing Red-Al, though 
very little or no experimental conditions were offered (Schemes 44 and 45).
THPO OH
I —  I - u .
150
Scheme 44
Reagents and conditions: i) Red-Al, Et2 0 , 0°C, then I2 .
TIPSO OH
l _ —  I
151
Scheme 45
Reagents and conditions: i) Red-Al, then I2 , 8 8 %.
OTIPS
OTHP
Ensley and co-workers reported that hydrostannylation of disubstituted acetylenic 
alcohols with nBu3SnH / AIBN gave nearly exclusive formation of the Z-olefin (Scheme 46) 
with control of the regiochemistry for propargylic alcohol derivatives.57
R = M© , C5H11
Scheme 46
Reagents and conditions: i) “BusSnH, AIBN (cat.), 85°C.
51
It was hoped that treatment of the mono-silyl protected acetylene 149 under these 
conditions would provide the regioisomer 152 (or even 153 which would still prove useful) 
which could be converted to the vinyl iodide, since conversion of vinyl stannanes to vinyl 
iodides with iodine in carbon tetrachloride is known to proceed with retention. However, 
treatment of 149 with nBu3SnH / AIBN at either 85°C or 55°C always gave a ca. 1:1 mixture 
of the regioisomers 152 and 153 (as apparent by the 13C NMR) which co-ran on silica gel in 
a wide variety of solvent systems and could not be separated (Scheme 47). The 
stereochemical assignment of 152 and 153 came from conversion to the iodides by treatment 
with iodine in carbon tetrachloride, and comparison of the NMR spectra of the products 
with those of the iodides 143 and 147 whose stereochemistry had previously been 
established on the basis of the mechanism for hydroalumination.
ca. 1 :1  mixture by 13C NMR
143 147
Scheme 47
Reagents and conditions', i) “Bi^SnH, AIBN (cat.), 85°C., lh 20 min, 89%; ii) I2 , CCI4 ,4°C, 100%.
Although treatment of the mixture of 152 and 153 with I2 in CCI4 did quantitatively 
generate the vinyl iodides 143 and 147, we already knew that these could not be effectively 
separated by FCC (see earlier in this section under silylation protection). It was therefore 
evident that this route was not a viable way forward.
In view of the difficulty encountered in differentiating termini at the alcohol oxidation 
level, it was decided to start with two electronically different acetylene substituents, whereby 
one end would be kept at the alcohol oxidation level and the other at the carboxylic acid 
oxidation level. A compound of this type, vinyl stannane 154, had been reported by the Piers
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group (Schem e 4 8 ).58 Thus, addition of the higher order cuprate,
dilithium(trimethylstannyl)(2-thienyl)(cyano)-cuprate, to the a,p-acetylenic ester 155 in THF 
at -78°C, was reported to afford a 95:5 mixture of geometric isomers which after FCC 





Reagents and conditions: i) Me3SnCu(2 -thienyl)(CN)Li2 , THF, -78°C, 65%.
Me3Sn
Since vinyl trimethylstannanes are known to be more reactive than the corresponding 
tributylstannanes in the Stille coupling, it was thought that 154 could be used in the Stille 
coupling if the previously made vinyl stannane 136 was converted to its corresponding vinyl 
iodide. However, this route was not examined since a simpler alternative was discovered. Lu 
and co-workers59 had reported a novel regio- and stereoselective hydrohalogenation reaction 
of 2-propynoic acid and its derivatives (Scheme 49). However, Lu reported that 3- 
substituted-2-alkynoates (R=Pr) afforded poor yields.
R
Z exclusive
X=l; R=H 75%  
X=l; R=nPr 22%
Scheme 49
Reagents and conditions: i) Lil, AcOH, 70°C.
It therefore seemed appealing to see if the conjugate addition of Lil to the alkyne 156 









The alkyne 156 was prepared as shown in Scheme 51. Treatment of propargyl alcohol 
158 with NaH / BnBr in the presence of catalytic B114NI gave the corresponding benzyl ether 
in 91% yield. Subsequent treatment with butyl lithium followed by ethyl chloroformate gave 
the alkynoic ester 156 in 84% yield. To our delight, when 156 was treated with Lil in acetic 
acid at 70°C it gave exclusively the Z-vinyl iodide 157 in virtually quantitative yield after 
just one and a half hours. This should be contrasted with the work of Lu who had found that 
the disubstituted acetylene they had tried needed 24h and only gave product in 22% yield.
158 156 157
Scheme 51
Reagents and conditions', i) BnBr, nBii4 NI (cat.), NaH, DMF, 91%; ii) “BuLi, THF, -78°C, then ClCC^Et, 
-78°C to 0°C, 84%; iii) Lil, AcOH, 7(FC, 1.5h, 95%.
The stereochemistry of 157 was proven by a combination of *H NMR spectroscopy 
and chemical manipulation. A NOESY experiment showed cross peaks for the vinyl proton 
and the methylene protons, and nOe difference experiments showed a 15% enhancement of 
the vinyl methylene protons when the vinyl proton at 6.30 ppm was irradiated. Also the 
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5% nOe
Figure 5: nOe and NOESY experiments for 157.
It was thought that if we had the wrong stereoisomer, then the debenzylated product 
should readily lactonise upon acid treatment to give the butenolide 159. Therefore, 157 was
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debenzylated under the Holmes conditions60 of 7 equivalents BCl3*Me2S to give 160 in 41% 
yield. This was then subjected to reflux conditions in the presence of tosic acid (Scheme 52). 





Reagents and conditions: i) BCl3 *SMe2 , CH2CI2 , 41%; ii) /?-TsOH (cat.), CH2CI2 , reflux, 3h.
With the two stereodefined alkenes now in hand, attention focused on the Stille 
coupling.
2.3 The Stille coupling reaction
To obtain the geometrically pure 1,3-diene, a stereospecific carbon-carbon bond 
forming reaction was required. Carbon-carbon bond formation is one of the most critical 
operations in organic synthesis yet there are relatively few fundamental methods available. It 
has been known for some time that Group VIII transition metals, particularly Ni and Pd, 
effectively catalyse the cross-coupling of organometallic reagents with organic halides and 
related electrophiles (Eq. 1).
M'
RM + R’X ------------------------ ► R-R' + MX
Eq.l
However, many of the organometallic reagents available are sensitive to the 
functionality on the coupling partners and are often difficult to prepare or are air or moisture 
sensitive, and few can be purified and stored.
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Organolithium or Grignard reagents usually give poor conversion and often 
homocoupling of the organic halide is observed. They also have a low tolerance for 
functional groups.
Although coupling of organocopper alkenyl or aryl compounds give higher 
conversions, they suffer from extensive homocoupling. Moreover, the synthetic methods 
available for organocopper reagents tend not to allow the presence of more reactive 
functional groups on the organocopper partner.
Organometallic reagents containing metals of intermediate electropositive character 
such as zinc or mercury generally lead to higher yields of coupled product and fewer side 
reactions since they both tolerate a wide range of functional groups in either of the coupling 
partners. However, methods for their synthesis are somewhat limited.
The structure of the organic portion in organoboranes or aluminiums is also limited by 
the methods of synthesis available, namely hydroboration or hydroalumination.
Organozirconium reagents have the advantage of compatibility with ether or acetal 
groups, along with carbonyl and ester groups (if in the alkenyl halide partner) but suffer from 
low catalytic turnover.
However, organotin reagents must be easily one of the most versatile organometallic 
reagents in Pd-catalysed coupling reactions. They are compatible with a wide variety of 
reactive functional groups, there is a reasonably large number of methods for their 
preparation, and they are not particularly oxygen or moisture sensitive.
In the Pd-catalysed coupling of electrophiles with organotin reagents, only one of the 
groups on the tetravalent tin is transferred. Fortunately, different groups are transferred from 
tin with different rates, the simple alkyl group being slowest:
R— 5  > R C H = C H  > Ar >  R C H = C H C H 2 -  ArCH2 > CH3C O CH 2 > CnH2n+1
[ PdLn ]
RX + R'SnR"3 ----------------------- ► R-R' + X SnR "3
E q .2
Thus, three simple alkyl groups (such as methyl or butyl) are used and the fourth group 
on tin, which undergoes transfer, can be an alkyl, alkenyl, aryl, benzyl, alkynyl or allyl 
group.
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This palladium catalysed cross-coupling reaction of an organotin reagent with organic 
electrophiles (Eq.2) has become commonly known as the Stille coupling, after J. K. Stille.47 
It is a mild, versatile reaction, tolerant of functionality on either coupling partner, and 
moreover it is stereospecific and regioselective, giving product in high yields. This makes it 
ideal for the use in the synthesis of elaborate organic molecules. An impressive recent 















Reagents and conditions: i) 20 mol% Pd(MeCN>2 Cl2 , 'P^EtN, DMF/THF (1:1), RT, 24h, 28%.
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A wide variety of both electrophile and organotin reagents can be coupled. The 
following examples illustrate the scope and versatility of this reaction and highlight the 
compatibility of functional groups.
Substituted vinyl halides undergo direct Pd-catalysed cross-coupling with alkenyltin 
reagents to give good yields of conjugated dienes. The reaction proceeds with retention of 
double-bond configuration in both vinyl partners (Scheme 54).62 Vinyl iodides react readily 
at 25°C-40°C, whilst vinyl bromides require higher temperatures (100°C) for the oxidative 
addition step to take place readily.
BiT + B u a S n ^ ^ ^  BiT v
E, E : Z, E 
94 : 6
Scheme 54
Reagents and conditions: i) Pd(MeCN)2 Cl2 , DMF, RT, 83%.
Vinyl triflates can be made to undergo Pd-catalysed couplings provided that LiCl is 
added to the reaction mixture (Scheme 55).63 The coupling of vinyl triflates is particularly 
valuable due to the ease of their selective synthesis from unsymmetrical ketones by 
generating either the kinetic or thermodynamic enolate.
9 8 : 2
Scheme 55
Reagents and conditions: i) Pd(PPh3 )4 , LiCl, DMF, RT, 90%.
The LiCl is required to form the vinyl palladium chloride complex since palladium 
triflates will not undergo intermolecular transmetallation with vinyl tin compounds (Scheme 






^  Bu3Sn ■Pddjci
Scheme 56
The coupling of allyl bromides or chlorides with alkenyl or aryl tin reagents leads to
1,4-dienes in high yields, such as the example in Scheme 5765, and proceeds with retention 
of double bond geometry in both coupling partners. The allyl halide undergoes regioselective 




Reagents and conditions: i) 3 mol% Pd2 (dba>3 , 6  mol% PPI13, THF, 5CPC, 82%.
The coupling of organotin reagents with acid chlorides allows for the synthesis of 
ketones. The coupling is quite general with respect to both the acid chloride and the 
organotin partners. For example, the Stille coupling has been used in a novel C-C bond 








Reagents and conditions’, i) Pd(PPh3 )2 Cl2 , PhH, reflux, 8-10h.
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The currently accepted mechanism47 for the Stille coupling involves three basic steps 











The oxidative addition of vinyl halides to palladium complexes affords stable c-vinyl 
Pd complexes. The process is stereospecific as the configuration at the trigonal carbon
addition to take place the palladium must be in the zerovalent state, usually stabilised by 
ligands. The oxidative addition process is believed to proceed in one of two ways: either via 
a dissociative mechanism where loss of a ligand may result in a coordinatively unsaturated 
species ML3 which leads to a five-coordinate transition state 161 arising from nucleophilic 
attack of Pd on the carbon halogen bond (Scheme 59), or via a three membered pallada cycle 
162 which rearranges to the c-vinyl Pd complex (Scheme 60).











The next step in the process is the transmetallation. The original ideas on the 
mechanism of this step are shown in Scheme 61.47 The transmetallation was thought to 
proceed to the trans-Pd(II) complex 163 from the coordinatively saturated species 164 via a 
pentacoordinate Pd(II)-7i-stannyl complex species 165, though the exact nature of 165 was 
unknown. Following the transmetallation step, a trans- to ds-isomerisation takes place via a 
five-coordinate transition state such as 166, which undergoes pseudorotation and dissociation 
of a ligand to give the cw-Pd(II) complex 167. For the subsequent 1,1-reductive elimination 
it was discovered that the groups to be coupled must occupy the cis positions. Isolated trans- 
Pd(II) intermediates did not undergo reductive elimination in non-polar solvents. It was 
found that a polar coordinating solvent was necessary for the isomerisation of the trans- 
complex to the cis-complex to take place. For this reason, polar coordinating solvents such 
as DMF, THF and NMP are used in Stille couplings, the most effective being reported to be 







FK ^ - r, + Pdl_2
Scheme 61
It is now generally accepted that the transmetallation is the rate-determining step in 
most cross-couplings of synthetic interest. Though initially not well understood, efforts 
directed at this transmetallation step have led to a greatly increased understanding as to how 
this reaction might be operating and the earlier mechanistic picture described above has been 
modified. This has consequently led to significantly useful modifications of the reaction 
conditions which have now found widespread use in this cross-coupling area (vide infra).
2.3.1 Catalyst systems for the Stille cross-coupling
Different catalysts have been compared,64 and until recently the preferred catalyst for 
Stille couplings was usually Pd(PPh3)4. However, it was observed that excess phosphine 
retarded the coupling and this led to the use of the coordinately unsaturated catalyst 
“Pd(PPh3>2” , usually obtained in situ from a Pd(II) species.
However, the most significant findings of recent years have been from Farina and co- 
workers. They discovered a very substantial ligand effect in a model coupling between 
iodobenzene and vinyltributyltin (Scheme 62) and showed that this kind of effect is general 
for a variety of Stille couplings.68 In general, ligands of low donor capabilities are 
associated with fast rates, whereas strong donor ligands, such as the traditional PPI13, are 
inhibitors of the reaction. After screening a series of ligands, Farina’s studies uncovered two 
new useful ligands for Stille cross-coupling chemistry (Table 5). It was found that by using 
P(2-furyl)3 or Ph3As as the ligand instead of PPI13, a 100 or 1000-fold rate increase was 
observed respectively for the coupling of vinyl stannanes with vinyl / aryl iodides or vinyl 
triflates. It was found that the optimum ratio of Pd : Ligand was 1:2 for P(2-furyl)3 and 1:4 
for AS3P when generated from the weakly coordinated Pd2(dba)3 catalyst.
Scheme 62
Reagents and conditions: i) CH2=CHSnBu3 , Pd2 (dba>3 , Ligand, THF, 50°C
Table 5: Summary of Ligand effects in the Stille reaction





^Inhibition factor of excess ligand
It is thought that these ligands work by accelerating the rate of the transmetallation 
step via ligand dissociation and formation of a Pd-stannane Tt-complex. Prior to Farina’s 
work, it was believed that the fully coordinated species 168 was involved in the 
transmetallation step. Kinetic studies by Farina68 have led to a new model which proposes a
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pre-equilibrium between fully coordinated species 168 and a coordinatively unsaturated 
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Ligands of high donicity (eg. PPh3) inhibit the reaction because they allow only 
minute concentrations of the reactive species 169 at equilibrium. Although substitution 
reactions at square planar Pd(II) complexes usually proceed associatively via 
pentacoordinated intermediates (as in Scheme 61), Farina’s kinetic studies suggest that in 
the case where the nucleophile is an organostannane, the Pd(II) electrophile must be 
coordinatively unsaturated to engage in transmetallation. The low donicity of the (2-furyl)3P 
and AsPh3 ligands facilitate their dissociation from palladium favouring the coordinatively 
unsaturated species at equilibrium and hence leading to increased reactivity.
Another approach to increasing the rate of transmetallation has been the addition of a 
second metal salt. 1,1- and 1,2-Disubstituted alkenyl-2-metallics are reported to react 
unsatisfactorily in Pd-catalysed reactions in the absence of ZnCl2 or CdC^.64, 69 It was 
initially thought that addition of ZnCl2 results in transmetallation from the organotin to 
provide the corresponding organozinc chloride. However, Farina reported that the use of 
anhydrous ZnCl2 in a strictly anhydrous atmosphere offered no rate enhancement of the 
coupling reaction compared to the same reaction without ZnCl2, but that use of ZnCl2
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directly from the bottle gave a 2 to 3-fold rate increase.67 Farina therefore deduced that the 
beneficial effect of adding ZnCl2 to the reaction may be due to its water of hydration or to 
traces of hydrogen chloride.
Another common approach to enhance reactivity and sometimes selectivity in the 
Stille coupling has been the use of co-catalytic copper(I), as first introduced by Liebeskind 
in 1990.70 More recently, Farina, in collaboration with Liebeskind, has begun to study the 
mechanistic basis of this effect.71 Their initial data suggest that Cu(I) acts as a “phosphine 
scavenger” in these couplings. Since ligand dissociation from 168 (Scheme 63) is a key 
event in the transmetallation, any secondary metal ion with an affinity for phosphines may 
help shift this pre-equilibrium toward 169. It is thought that this is how Cul can provide up 
to a 100-fold acceleration when PPI13 is used as a ligand, although addition of Cul in 
conjunction with low donicity ligands such as AsPh3 is essentially ineffective.
Farina and Liebeskind have 119Sn NMR data to suggest that a second effect becomes 
important when, and only when, working in the highly dipolar NMP solvent. Their data 
showed that aryl and alkenyl stannanes react with Cul in NMP in the presence of “soft” 
ligands like AsPh3 to afford an apparent equilibrium which they presumed contained an 





They proposed that the non-polar stannane 171 is cleaved to a trialkyl tin halide, which 
is strongly stabilised in NMP through pentacoordination, and that this might constitute a 
substantial enough thermodynamic contribution to favour the organocopper species.
In addition to kinetic accelerations, the Sn/Cu transmetallation has been reported to 
effect the selectivity of the coupling. Although methyl and butyl groups at tin are usually 
innocent bystanders, several cases have been reported where they can compete with more 





although switching to the AsPh3 ligand greatly reduced the undesired butyl transfer, addition 











Reagents and conditions', i) 2% Pd(PhCN)2 d 2 * LiCl, NMP, 80-100°C, 8 % ligand.
Ligand Temp °C/Time 172:173
(2-furyl)3P 100°/5h 64:36
AsPh3 80°/7h 90:10
AsPh3 + 5% Cul 80°/6h >98:2
Scheme 65: Group transfer selectivity enhancement in the Stille reaction by co-catalytic
copper
The benefit of co-catalytic Cu(I) on the stereoselectivity of the reaction has been 
reported by Gibbs and co-workers.73 Coupling of vinyl triflate 174 with vinyltributyltin 
using Pd(PPh3)4 in THF at reflux afforded a 1:1 mixture of dienic esters 175 and 176. Use 
of “Pd(AsPh3)2” in NMP increased the ratio to 3:1, but addition of 10 mol% Cul 







WITHOUT Cul 3 : 1  56%
~y WITH Cul 16 : 1 69%
Scheme 66
Reagents and conditions', i) Pd(AsPh3>2 , NMP, RT.
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It is clear that the Stille coupling is actually a family of related reactions. In each one, 
the transmetallation proceeds in a fundamentally unique fashion and is subject to unique 
effects by ligands and additives.
2.4 Synthesis of the 1,3-diene
In our synthesis we required the coupling of the vinyl stannane 136 with the 












However, since the differentially protected alkene 144 proved initially elusive it was 
decided preliminarily to subject diol 142 (obtained from the hydroalumination and iodine 
quench procedure) and 136 to the Stille coupling as a test of the methodology, since it was 
known that the Stille coupling tolerated unprotected hydroxyl functionality.
Kocienski74 had reported a Stille coupling employing the bis-TBS ether protected 






Reagents and conditions: i) 8  mol% Pd(PPh3)2 Cl2 , Z11CI2  (2 eq), LiCl (2 eq), dioxane, reflux, 48h, 43%.
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Thus, the vinyl iodide 142 and vinyl stannane 136 were heated under reflux in 1,4- 
dioxane with 2 equivalents of ZnCl2 and LiCl in the presence of Pd (0) (Scheme 69). LiCl 
was added to the reaction, as although there is no vinyl triflate involved, Kocienski had 
suggested it aided catalyst stability.74 However, the main product was 179, resulting from 
protodestannylation of 136 . Other materials recovered were an inseparable complex mixture 
containing the starting vinyl iodide 142 and various catalyst derivatives. The crude *H NMR 
showed only small amounts of coupled product.
Reagents and conditions: i) 8 mol% Pd(PPh3>2Cl2, Z11CI2 (2 eq), LiCl (2 eq), dioxane, reflux.
The next attempt at the coupling was using the vinyl iodide 144 derived from 143. 
However, this time some of the reaction conditions were changed. Since DMF and NMP had 
been reported to be the solvents of choice for Stille cross couplings,62’ 67 the reaction was 
carried out in DMF rather than 1,4-dioxane. It was thought that the protodestannylation of 
136 might be as a result of the elevated temperature of 1,4-dioxane at reflux and/or the 
addition of the ZnCl2, and so the reaction was performed at room temperature with the 
omission of the ZnCl2. The same Pd catalyst was employed, but the reaction was performed 
in the dark since the Pd catalyst is light sensitive. However, these less severe conditions 






Due to the shortage of 144 at this time, the plentiful bis-silyl ether protected vinyl 
iodide 180 became our test substrate for investigating the coupling reaction (Scheme 70). 











Table 6: Results of Stille coupling of 136 and 180
Entry Reagents and conditions: Results
1 Pd(PPh3)2Cl2, DMF, RT, N2, DARK No product
2 Pd(PPh3)2Cl2, DMF, RT, N2, DARK, 
ultrasonication
No product
3 Pd2(dba)3, DMF, RT, N2, DARK No product
4 Pd(MeCN)2, DMF, RT, N2, DARK No product
5 Pd2(dba)3:P(2-furyl)3 (1:4), 
DMF, RT, N2, DARK
No product
6 Pd2(dba)3:P(2-furyl)3 (1:4), 
DMF, 70°C, N2, DARK, 3.5d
8% 181
7 Pd2(dba)3:P(2-furyl)3 (1:2), 2eq ZnCl2, 
degassed DMF, 88°C, N2, DARK, 24h
27% 181 + 29% 179
Our starting point in seeking the optimum conditions were those mentioned above for 
vinyl iodide 144. As entry 1 shows, no coupled product was observed. It was thought that a 
change in catalyst might be beneficial, but again, as entries 2-5 show, no reaction was 
observed with a variety of catalysts at room temperature or when ultrasonication was 
employed. Even the Farina conditions at room temperature failed to give any coupled 
product (entry 5).
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It was not until the reaction was heated that any coupled product was observed (entry 
6). This observation highlighted the reluctance of this reaction to proceed under mild 
conditions, and so in the following attempt not only was the temperature elevated, but also a 
more active catalyst ratio was employed, along with the addition of 2 equivalents of ZnCl2 
(to help effect transmetallation). Additionally, the solvent was degassed prior to use. As 
entry 7 shows, this gave diene 181 in 27% yield, but also 29% of the destannylated alkene 
179 which was probably as a result of the prolonged elevated temperature (as was the case in 
our initial experiment with vinyl iodide 142 employing the same conditions used as 
Kocienski (see Scheme 69)).
By this time we had prepared vinyl iodide 157 and it was submitted to the same 
conditions as entry 7 (Table 6), only with the temperature lowered to 50°C to try to reduce 
the unwanted protodestannylation. To our delight this gave the dienic ester 182 in a 
reasonable 50% yield in the first attempt (Scheme 71). After this pleasing result, a series of 
experiments was run in order to optimise the yield of the reaction, the results of which are 
summarised in Table 7.





Table 7: Stille coupling optimisation of 136 and 157.
Entry tReagents and conditions diene 182 (%)
1 2% Pd2(dba)3, 4% P(2-furyl)3, 2eq ZnCl2, 
DMF, O l ,  50°C, 21h
50%
2 5% Pd2(dba)3, 10% P(2-furyl)3, 10% Cul, 2eq 
ZnCl2, DMF, C=3, 50<>C, 20h
49%
3 2% Pd2(dba)3, 4% P(2-furyl)3, 4% Cul, DMF, 
C=l, 50°C, 4.5d
10%
4 1% Pd2(dba)3, 2% P(2-furyl)3, 2eq ZnCl2, 
DMF, C=l, 50°C, 2.75d
55%
5 2% Pd2(dba)3, 4% P(2-furyl)3, 2eq ZnCl2, 
NMP, C=2, 50°C, 5.5d
57%
6 2% Pd2(dba)3, 8% AsPh3, NMP, C=l, Id at RT 
then 3d at 50°C
68%
7 2% Pd2(dba)3, 8% AsPh3, 2eq ZnCl2, NMP, 
C=l, 3d at RT then 28h at 50°C
17%
8 2% Pd2(dba)3, 8% AsPh3, 8% Cul, NMP, C=l, 
Id at RT then 7d at 50°C, DARK
50%
9 2% Pd2(dba)3, 4% P(2-furyl)3, 2eq ZnCl2, 
DMF, C=l, 50°C, 3.5d
77%
10 2% Pd2(dba)3, 4% P(2-furyl)3, 2eq ZnCl2, 
DMF, C=l, 50°C, 4.5d
86%
11 2% Pd2(dba)3, 4% P(2 -furyl)3, 2eq ZnCfy, 
DMF, C=l, 50°C, 16h
83%
* C=relative concentration, solvents degassed and reactions performed under N2.
In order to improve on entry 1, changes were applied to several variables that were 
thought likely to offer some improvement to the reaction. As mentioned previously, addition 
of co-catalytic amounts of copper(I) had been reported to be beneficial in particularly 
difficult Stille couplings. Therefore, the second attempted reaction (entry 2) was pushed by 
addition of more catalyst and Cul as co-catalyst aswell as increasing the reaction 
concentration three-fold. It initially seemed that the best conditions had been met as judged 
by the rate of consumption of starting materials. All starting materials had been consumed 
within 20h (TLC) but the isolated yield of the diene was only a disappointing 49% (entry 2).
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Although these conditions initially led to a substantial rate enhancement, they would appear 
to suffer from reduced catalyst stability.
The following experiment omitted the ZnCl2 and the reaction yield fell drastically to 
10%, highlighting the beneficial use of added ZnCl2 (entry 3). Entry 4 versus entry 1 shows 
that reduced amounts of catalyst require longer reaction times to obtain the same yields. Use 
of NMP (entry 5) instead of DMF appeared to require considerable lengths of time to 
achieve the same result as entry 1 (albeit the reaction concentration was doubled). By this 
stage the reaction yield was still not satisfactory and so the AsPh3 ligand was employed in 
the next attempt since Farina had reported it to be superior to the P(2-furyl)3 ligand. It had 
been avoided until now due to its obvious toxicity. The AsPh3 ligand did indeed however 
offer a substantial improvement compared to entry 1, now giving diene 182 in 68% yield 
(entry 6). In order to improve on this still further, the reaction was performed as for entry 6 
but with added ZnCl2 (entry 7). This, however, had a deleteous effect on the reaction giving 
diene 182 in only 17%. Comparison of entries 1, 6 and 7 suggested to us that the catalyst 
derived from using the AsPh3 ligand did not seem to tolerate the addition of ZnCl2, but that 
the catalyst derived from P(2-furyl)3 did. This seemed reasonable to us since Farina had 
reported that although a 1:2 ratio of Pd:AsPh3 resulted in a more reactive catalyst than a 1:4 
ratio, the former was considerably less stable.67 However, the P(2-furyl)3 ligand when used 
in a 1:2 ratio does not suffer from such instability, indicating that the catalyst derived from 
AsPh3 is inherently less stable than its P(2-furyl)3 partner. For this reason it has been 
recommended to use 1:2 Pd:P(2-furyl)3 and 1:4 Pd:AsPh3 stoichiometry.
The subsequent reaction employed addition of co-catalytic Cul (entry 8). However, it 
must be said that at the time we were investigating this reaction, there was little 
understanding as to the mechanistic basis for the copper effect. Therefore, we were surprised 
to find that in our hands, addition of co-catalytic amounts of Cul to the same reaction 
conditions employed for entry 6 failed to increase the rate or yield of reaction. On the 
contrary, it seemed to retard the coupling and gave a lower yield (entry 8 vs 6). This 
observation was at first surprising. Since then, however, much insight has been gained into 
the mechanistic basis for the "copper effect" mainly due to the thorough work of Farina. 
Since it is now understood that the rate enhancement due to the copper effect is essentially
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ineffective with the P(2-furyl)3 and AsPh3 ligands, this could be a possible explanation. 
However, the reaction was carried out in NMP, and since it is thought that there is a Sn/Cu 
transmetallation to yield an organocopper species (as discussed earlier), addition of Cul 
could have been beneficial. Presumably the observed negative effect is due in part to 
decreased catalyst stability under those conditions.
It was found that when the initial experiment with the P(2-furyl)3 ligand (entry 1) was 
repeated under the same conditions but heated for longer periods of time (entries 9 and 10) 
increased yields were consistently obtained. The conditions of entry 10 now afforded the 
diene 182 in 86% yield. The final fine-tuning of the reaction conditions now simply required 
optimising the yield of coupled product in a shorter period of time. This was realised by 
increasing the reaction temperature enough to increase the rate of reaction whilst still 
suppressing the protodestannylation side reaction which would occur at still higher 
temperatures. Thus when performed at 65°C under the conditions of entry 6, the reaction 
proceeded in the same high yield, but now just required 16h for completion (entry 11).
This series of experiments highlighted the factors necessary for good yields of product, 
and with this reaction now proceeding in reproducibly high yield, attention was focused on 
the incorporation of the C3-, C4-, C5-, and C6- stereocentres in the asymmetric cis 
dihydroxylation of 182. However, before this could be investigated it was thought prudent to 
perform an experiment which would check for scrambling at one of the alkenes to confirm 
the geometry of the 1,3-diene. It was thought that if the C5-C6 olefin had been scrambled, 
then reduction of the ester and benzylation would afford the symmetrical diene 183, and 











Thus, the dienic ester 182 was reduced to the corresponding dienic alcohol with 
DIBAL-H in 94% yield. Subsequent benzylation with BnBr / NaH in DMF quantitatively 







Reagents and conditions: i) DIBAL-H, CH2 CI2 , -30°C, 93%; ii) BnBr, NaH, DMF, RT, 100%.
The lH NMR of 185 showed two alkenic signals, and the i3C NMR was consistent 
with an unsymmetrical diene. We were therefore confident that the olefin geometries of the 
vinyl iodide and/or the vinyl stannane had been retained in the cross-coupling, though this 
would obviously not confirm whether both olefins had been scrambled at once, as that 
would also result in an unsymmetrical diene. However, this was thought to be unlikely, as it 
would mean that both double bonds would have to be completely isomerised. We were 
therefore confident that the geometry of both olefin coupling partners had been retained in 
the cross-coupling.
2.5 Incorporation of the stereocentres from C3 to C6  via Double Sharpless Asymmetric 
cfr-dihydroxylation (AD).
In the following section, incorporation of the four contiguous stereocentres from C3 to 
C6 using Sharpless AD chemistry will be described. This reaction is the key point of our 
synthesis, and hence it is useful to give a brief historical introduction to the dihydroxylation 




The first cw-dihydroxylation of olefins was first reported by Makowaka in 1908.75 The 
original dihydroxylations required stoichiometric amounts of the expensive, volatile and 
highly toxic osmium tetroxide. Despite the unfriendliness of OSO4, its specificity to react 
exclusively with double bonds was soon recognised as its major attribute. Not only that, but 
OSO4 was found to react with virtually all double bonds, and had no particular substrate 
requirements.
The stoichiometric dihydroxylation was believed to proceed via a [3+2] cycloaddition 
reaction between OSO4 and the olefin to give an osmate (VI) glycolate ester 186 (Scheme 
73).
[3+2] H S o r
J T cvcloaddition O ' O ^ 2 ^ 3  ^ HO OH
;t    M MR R R R
186 187
Scheme 73
The glycolate ester 186 is stable enough to be isolated and characterised. Subsequent 
reduction with H2S or Na2SC>3 affords the diol 187. However, an alternative mechanistic 
proposal by Sharpless will be discussed later.
2.5.2 Catalytic c/s-dihydroxylations.
Although the stoichiometric dihydroxylation of olefins is a reliable reaction, its 
application had remained minimal due to the expense incurred, not to mention the toxicity of 
OSO4. Needless to say, catalytic variants of the reaction which have employed relatively 
inexpensive reagents for the re-oxidation of the Os(VI) have been vigorously pursued.
Inorganic co-oxidants such as the Hofmann reagent76 (0 s04-NaC103/KClC>3) or 
Milas's reagent77 (OSO4-H2O2) were among the first to be introduced, but over-oxidation of
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the substrate was frequently a problem, which resulted in lower yields. Sharpless made 
significant improvements in the catalytic process by employing alkaline rm-butyl 
hydroperoxide (TBHP) as co-oxidant78 which minimised over-oxidation, but the major 
breakthrough came from workers at Upjohn during the synthesis of a prostaglandin. The 
Upjohn process, as it is now commonly referred to, uses AT-methyl-morpholine-A^-oxide 
(NMO) as the stoichiometric co-oxidant79 and requires only small (0.2-1%) amounts of 
OsC>4 in a one-phase acetone-water mixture. Under these conditions over-oxidation is almost 
completely suppressed, and the yields are frequently quantitative. These now experimentally 
simpler conditions have found widespread use in many natural product syntheses.
More recently, Yamamoto demonstrated that use of K3Fe(CN)6 as co-oxidant80 in the 
presence of K2CO3 provided an excellent system for rendering the dihydroxylation process 
catalytic in OSO4. This reagent combination will be returned to later since it has played a 
pivotal role in the development of the Sharpless AD (vide infra).
2.5.3 Asymmetric as-dihydroxylation (AD).
Criegee’s notable discovery of a dramatic rate enhancement in the osmylation reaction 
of alkenes by amines laid the foundation for the AD reaction. Criegee observed that addition 
of amines such as pyridine to the dihydroxylation reaction significantly increased its rate 
through formation of an electron-rich coordination complex with the osmium atom.81 In 
addition, the first catalytic AD was reported by Kokubu and co-workers using Bovine Serum 
Albumin (BSA)-2-phenylpropane-l, 2-diolatodioxo-osmium (VI) complex 82 It was proven 
that osmium tetroxide was bound to BSA through the amine residue (Figure 7). a- 
Methylstyrene gave its product diol with a 68% ee (S-configuration) using lBuOOH as co­
oxidant (Scheme 74).
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Reagents and conditions: i) BSA, OSO4 , ^uOOH, pH 11 carbonate buffer, 25°C, 8 h.
It is not surprising, then, that initial attempts at non-enzymatic asymmetric 
dihydroxylation by Sharpless and Hentges utilised chiral, enantiomerically pure pyridine
low affinity of these ligands for OSO4. Griffith84 had shown that quinuclidine had a much 
higher affinity for OSO4 than pyridines, and hence Sharpless investigated chiral 
quinuclidines derived from the naturally occuring cinchona alkaloid family.83
The first ligands of this series were the acetate and then the chlorobenzoate (CLB) 
esters of dihydroquinidine (DHQD) 188 and dihydroquinine (DHQ) 189, as depicted in 
Figure 8. Note that the DHQD and DHQ derivatives are diastereomers and not enantiomers 
since the C3 is the same configuration in both. They are often referred to as being pseudo- 
enantiomeric since they lead to diols of opposite configuration which have very similar 
enantiomeric excesses.
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R=/>chlorobenzoate, (DHQD)-CLB




Sharpless’s assumption proved correct as these DHQD and DHQ derivatives afforded 
diols with moderate to good enantioselectivities. Initially these ligands were used 
stoichiometrically, but they were later used in catalytic amounts (vide infra).
Other workers in the AD area have investigated the use of chiral C2-symmetric 
diamine ligands. Narasaka85 was the first to report the use of these diamine ligands in 1986, 
and other groups also had considerable success as in most cases the reactions proceeded with 
up to 99% ee  (Figure 9). Although the bidentate ligands generally gave superior 
enantioselectivity to the cinchona alkaloid ligands, they formed very stable chelate 
complexes with the osmium (VI) glycolate products which inhibited the hydrolysis and 
prevented in situ recycling of the osmium and ligand. Thus, AD reactions using these 
bidentate ligands are stoichiometric in both OsC>4 and chiral ligand.
There have been very few reports of other catalytic AD systems. Hirama recently 
reported that use of a monodentate DABCO derivative90 (Figure 10) effected the AD under 
catalytic conditions, but the enantiomeric excesses were only moderate. Murahashi and co­
workers91 enjoyed greater success when they utilised chiral isoxazolidines to effect the 
catalytic AD, giving diols in up to 73% ee (Figure 10).
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Figure 9: Chiral diamine ligands for Stoichiometric AD
A -\ OTBDPS 
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Hirama (1992) Murahashi (1992)
Figure 10: Recent monodentate ligands for catalytic AD
Sharpless realised that the success of the catalytic AD would rely on the reaction being 
funnelled through a pathway involving the chiral catalyst, and introduced the concept of 
ligand accelerated catalysis.46 The principle of the ligand acceleration effect (LAE) for the 








If a chiral ligand can activate a catalyst such that it is only significantly active when 
bound as a catalyst-ligand complex, then asymmetric induction will be maximised. For the 
AD reaction, the original pyridine ligands had too low an affinity for OSO4 and hence the 
LAE was low, giving rise to low asymmetric induction. The bidentate ligands formed a 
catalyst-ligand complex that was so tight that although it accelerated the reaction and hence 
maximised the LAE, it was unable to dissociate at the Os(VI) glycolate stage and hence 
unable to re-enter the catalytic cycle. The cinchona alkaloid ligands are a compromise 
between maximising both the LAE and catalytic turnover. They form a catalyst-ligand 
complex that is tight enough to accelerate the reaction, but not so tight that it would slow 
down subsequent steps in the catalytic cycle, and hence they provide greater turnover.
Sharpless combined the cinchona alkaloid stoichiometric dihydroxylation process with 
the Upjohn NMO procedure and in 1988 reported the first non-enzymatic catalytic AD.92 
However, the enantiomeric excesses of the resulting diols obtained under the catalytic 
procedures were initially lower than those obtained in the stoichiometric reaction. The reason 
for this decrease in ee was found to be due to the presence of a secondary catalytic cycle46 in 
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Scheme 76: Two catalytic cycles exclusive to the NMO system
It was suggested that the initially formed Os(VI) monoglycolate species 190 was 
oxidised by the NMO to the trioxo Os(Vin) glycolate 191. This Os(VIH) glycolate species is 
able to perform a further dihydroxylation, but it now lacks a coordination site for the chiral 
ligand L, and so this dihydroxylation takes place with only low or no enantioselectivity. This 
results in diols with reduced ee’s.
A partial remedy to this problem was slow addition of the alkene, thereby allowing 
hydrolysis of the Os(VI) monoglycolate species 190 before the NMO had a chance to oxidise 
it to the trioxo Os(VIII) glycolate 191.
Sharpless has since made dramatic improvements in the AD reaction. This has been 
due mainly to three key discoveries in his group. It was found that use of K3Fe(CN)6 instead 
of NMO as the stoichiometric re-oxidant under two-phase conditions virtually eliminated the 












2 OH' 2 H20
2 Fe(CN)63' 2  Fe(CN)64'
Scheme 77:Catalytic cycle under the two-phase K3Fe(CN)6 system
Under these conditions, the only oxidant in the organic layer, which is where the 
dihydroxylation occurs, is OSO4, . The co-oxidant K3Fe(CN)6 is now confined to the 
aqueous layer (unlike the NMO case). The resulting Os(VI) monoglycolate ester undergoes 
hydrolysis to give diol and ligand in the organic layer and Os(VI) must return to the aqueous 
layer before its re-oxidation can occur, thereby preventing entry of Os(VI) glycolate into the 
second cycle.
The second key discovery was the so called “sulfonamide effect”. It was found that 
addition of methanesulfonamide considerably accelerated the hydrolysis of the Os(VI) 
glycolate product, and the reaction times were greatly reduced. This allowed high catalytic 
turnover even with sterically hindered olefins and greatly increased the scope of the reaction. 
It also permitted the reaction to be run at 0°C which normally has a beneficial effect on the 
stereoselectivity.
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The third and very important discovery came about as a result of wide screening of 
over 250 different cinchona alkaloid derivatives for the AD process. A new second 
generation of C2-symmetric dimeric ligands employing a phthalazine (PHAL) or 
diphenylpyrimidine (PYR) core emerged. These new ligands were found to greatly out­
perform the first generation monomeric ligands in both the enantioselectivity and scope of 
the reaction (Figure 11).
It was also found that dipotassium osmate dihydrate (K2OSO42H2O) was a suitable 
non-volatile replacement for OSO4, and this allowed for the formulation of a premix 
containing all the required reagents, including the ligand. These AD-mixes are now 
commercially available from Aldrich under the names AD-mix-a or AD-mix-P, depending 
on whether the (DHQ)2-PHAL or (DHQD)2-PHAL ligands are present, respectively. They 
contain 0.2 mol% K2OSO42H2O, 1 mol% ligand, 300 mol% K2CO3 and 300 mol% 
K3Fe(CN)6.
Through a combination of models of the reaction and knowledge of the absolute 
configuration of the diol products and consideration of a vast amount of experimental data, 
an empirical mnemonic device has been proposed for predicting the enantiofacial selectivity 
in the reaction (Figure 12). Use of the device involves placement of the olefin in the plane 
such that the smallest substituent (usually a hydrogen) is in the southeast quadrant. This 
takes precedent over all else since this is by far the major steric barrier. An olefin positioned 
according to this and the other quadrant constraints will be attacked from the top, p-face with 
DHQD derivatives. Conversely, use of DHQ derivatives results in attack from the bottom, a- 
face.
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Figure 12: Empirical mnemonic device for predicting face selectivity
The southeast quadrant, and to a much lesser extent the northwest quadrant of this 
device present steric barriers, whereas the northeast quadrant has been regarded as sterically 
neutral.The southwest quadrant is regarded as being an attractive area, especially suited for 
flat aromatic substituents.
The precise mechanism and origin of the enantioselectivity of the AD has been the 
focus of extensive investigation. Criegee originally proposed a concerted [3+2] cycloaddition 
of OSO4 with an olefin to give directly the Os(VI) glycolate (path A) (Scheme 78), which is 
then hydrolysed either as part of a catalytic cycle or stoichiometrically, to give the 
corresponding diol. However, in 1977 Sharpless suggested a stepwise reaction which is 
initiated by a [2+2]-like addition of the olefin across an Os=0 bond (path B), followed by 
rearrangement of the resulting osmaoxetane intermediate to the glycolate product.46 To date 
no definite conclusions have been made but Sharpless’s recent observations of a non-linear 
Eyring relationship between ee and temperature is inconsistent with Criegee’s one-step [3+2] 
mechanism. These new data, in combination with high level ab initio calculations that 
showed osmaoxetanes to be energetically accessible minima on the potential energy surface, 
suggest that the osmaoxetane pathway may be in operation.
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However, Corey has obtained conflicting kinetic data to provide evidence for the [3+2] 
cycloaddition.93 The precise mechanism is clearly still a long way from being fully 
understood.
Sharpless has also probed the nature of the ligand and gained valuable insight as to the 
origin of the enantioselectivity in the AD reaction. The most striking finding was the 
discovery of an enzyme-like binding pocket present in the dimeric cinchona alkaloid ligands 
such as the phthalazine class. Figure 13 highlights the relationship between ligand structure, 
binding and ceiling rate constants. The rates and enantioselectivities are considerably 
influenced by the nature of the 0-9 substituent, though little effect is observed in the binding 
of the ligand to OSO4 if changes are made here.
Increases the bindir~ 
Small effect on rate
Configuration is crucial 
Only erythro allows high 
rates and binding
Large effect on rate 
Small influence on binding
Oxygenation essential to allow
binding to O s04
Carbon too bulky a substituent
0 Me"^ "N Increases binding 
to O s04 
as well as rates
The presence of a flat aromatic
ring system increases binding and rates;
the nitrogen has no influence
Figure 13
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It is thought that the AD’s face selectivity is chiefly governed by two major factors. 
The first is believed to be due to stabilising stacking interactions between one of the 
substituents on the osmaoxetane (the olefin substituent from the SW quadrant) and the C9 
OR substituent of the ligand. The second factor arises from destabilising repulsive 
interactions between the smallest substituent of the osmaoxetane (the smallest substituent of 
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Best isomer (192), leads to (R)-diol, good ! Steric repulsion destabilizes this isomer
attractive stabilization and minimal ! (193), an (S)-diol precursor
repulsion
Figure 14: The interplay of two crucial interactions, one attractive, the other repulsive, 
provides a simple rationale for the face selectivity in the AD reaction.
2.5.4 The AD of poly-unsaturated substrates
As well as substrates containing a single olefin, polyenes can also serve as substrates 
for the AD. Mono-dihydroxylation can be achieved for polyenes with either isolated or 
conjugated double bonds using the two-phase ferricyanide s y s t e m . 9 4  The regioselectivity of 
mono-dihydroxylation of a polyene will be determined by both steric and electronic effects. 
The osmylation of isolated double bonds will occur preferentially at the more electron rich 
double bond. It has been shown that dihydroxylation of fr<2w.y-l,2-disubstituted and 
trisubstituted olefins proceeds much more readily than with cw-l,2-disubstituted and 











Reagents and conditions: i) AD-mix-P, *BoOH/H2 0 , 0°C, 56%.
For isolated olefins with electronically very similar double bonds, the sterically less 




Reagents and conditions: i) AD-mix-P, *8 0 0 1 1 /1 1 2 0 , 0°C, 84%.
Conjugated polyenes can also be preferentially mono-dihydroxylated under the two- 
phase ferricyanide system.94 The resulting ene-diol is in most cases unable to undergo a 
further dihydroxylation due to the inductively deactivating effect the hydroxyls have on the 
remaining olefin(s). The regioselectivity will again be governed by steric and electronic 
effects. For example, the dienic ester 194 is selectively dihydroxylated at the more electron 







Reagents and conditions: i) AD-mix-j3, MeSC>2NH2 > ^uOH/I^O, 0°C, 78%.
Sharpless has demonstrated that exhaustive dihydroxlation of conjugated dienes with 
Os04 in the presence of NMO in the one-phase system can be achieved, affording polyols.95 
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Scheme 83
Reagents and conditions: i) AD-mix-fi, MeS0 2 NH2 , lBu0 H/H2 0 , 0°C, 84%; ii) OSO4 , NMO, acetone/water, 
RT.
The poly-dihydroxylation in the NMO reaction is thought to result from the 
‘ participation of the second catalytic cycle oxidant, the trioxo Os(VIII) glycolate 191 
(Scheme 76). It was established that l,2-dihydroxy-3-enes were uniquely reactive toward 
further oxidation in the one-phase NMO system. The current hypothesis is that the trioxo 
Os(Vm) glycolate 191 can attain favourable hydrogen bonding interactions in the transition 
state between its oxo ligands and the ene-diol hydroxyls. This hypothesis of stabilising 
hydrogen bonding interactions accounts for the rate enhancement observed for the ene-diols 
as protection of the two hydroxyl groups of the ene-diol results in a considerable decrease in 






dihydroxylation to occur adjacent to the previous site of attack and from the opposite face, 
leading to polyols with a \,2-syn-2$-anti-?>A-syn arrangement down the chain. This is 
consistent with Kishi’s empirical rule96 which suggests that osmylation will occur anti to the 
previous oxygen functionality with the alkene in the conformation shown in Figure 15.
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Figure 15: Kishi’s empirical model
It is important to note that the intrinsic diastereofacial preference described in Scheme 
83 mismatches the selectivity imposed on the system by the DHQD-CLB ligand. However, 
the induction by the ligand is too weak to overcome the strong anti diastereoselectivity 
exhibited by the trioxo Os(VIII) glycolate oxidant and merely results in reducing the ratio 






Reagents and conditions: i) Os04, NMO, acetone/water, RT.
OH OH
OH OH
No ligand present: 16
DHQD-CLB present: 6
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2.6 Application of the AD to our 1,3-diene
If the Sharpless mnemonic is applied to our 1,3-diene 182 it can be seen that the same 
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Figure 16 shows that the only substituent mismatch is that the NW quadrant has the 
largest group, where the mnemonic requires the smallest group there (since the NE comer is 
sterically neutral, the Rm group is less important). Figure 17 shows we have a perfect match
Figure 16
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with the mnemonic. We therefore hoped we could osmylate both double bonds at once to 
give predominantly one diastereomeric tetraol 195 with high enantiomeric purity.
When we initially examined this reaction, we were unaware that exhaustive 
dihydroxylation of conjugated dienes had been reported in the one-phase NMO system. 
However, although dihydroxylation of conjugated dienes had been reported in the two-phase 
ferricyanide system to stop at the ene-diol stage, in some cases it was possible to re-submit 
the resulting ene-diol to the same two-phase ferricyanide system and obtain the 
corresponding tetraol. The following results describe our attempts to dihydroxylate both 
double bonds at once in a one-pot procedure under the two-phase K$Fe(CN)6 system. We 
soon became aware, however, of the need to use the one-phase NMO system to 
dihydroxylate both double bonds at the same time.
The dienic ester 182 was subjected to the AD reaction. Treatment of 182 with AD-mix- 
p at 0°C in lBu0 H:H20 (1:1, v/v) with one equivalent of MeS02NH2 gave no reaction after 
3h. It had been reported that for alkenes which react sluggishly at 0°C, the AD could be 
performed at RT.97 However, after 17h at RT, TLC still indicated mainly starting material, 
and so additional OSO4 and ligand were added. The reaction was very slow, and after 5d still 
ca. 50% starting material was observed. Reductive workup with Na2S03 afforded two 
products as an inseparable mixture in 38% yield. *H NMR analysis of this mixture indicated 
it was a 2:1 ratio of what was thought to be the two isomeric ene-diols 196 and 197, the 
major component being 196 (Scheme 86). The regioisomers were distinguishable based on 
the *H NMR resonance for the olefinic proton in 197 being a singlet, hence allowing 






















Reagents and conditions', i) AD-mix-P, ^uOH/I^O, 1 eq MeS0 2 NH2 , additional OSO4  and (DHQD^PHAL, 
RT, 5d, 38%.
The next attempt employed AD-mix-p supplemented with 4 mol% (DHQD)2PHAL 
and 1 mol% OSO4, running the reaction at RT. After 17h, TLC indicated mainly starting 
material, and after 6d it was necessary to add still more ligand and OSO4. After 12d, the 
reaction was worked up. Although it had initially proved difficult to separate the two 
products, a solvent system was eventually found to achieve their separation effectively. The 
!H NMR of the first eluted compound showed the disappearance of the ester functionality 
and that the C3-C4 double bond had been dihydroxylated. It was thought that after 
dihydroxylation, the ene-diol 197 had lactonised. It was not known whether the five-(198) or 
six-membered butenolide had been formed. However, only the five-membered butenolide 
has an oxidisable secondary hydroxyl. Thus, the butenolide product was subjected to the 
Dess-Martin periodinane reagent.98 This gave a new product, which from the lH and 13C 
NMR suggested to us that benzylic oxidation had taken place but the structure is not 
conclusively known. However, from these limited data the butenolide is tentatively assigned 
to be 198, which was isolated from the AD reaction in 8% yield. The second compound 
eluted was the diol 196, isolated in 18% yield.
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At that time it had very recently been reported by Bitmann and co-workers" that the 
use of K2S2O8 as co-oxidant allowed the use of reduced volumes of solvent, and promoted 
the catalytic reaction. Since it was our aim to obtain the tetraol 195, the diene 182 was 
submitted to the AD reaction, but five times more concentrated with 1 equivalent of K2S2O8 
as co-oxidant. We were delighted to find that after just 2h virtually all of the starting material 
had been consumed (TLC). However, even after 3d, TLC still did not indicate the presence 
of a more polar compound that could be tetraol. The beneficial rate enhancement on adding 
K2S2O8 had been realised, however, and was used in all subsequent two-phase AD reactions. 
A series of experiments was run in order to try to obtain tetraol under forcing conditions. Use 
of several equivalents of both K2S2O8 and CH3SO2NH2, in conjunction with additional 
OSO4 and ligand in concentrated reactions, led to very low yields of what appeared by *H 
NMR to be the two diastereomeric triols 199 and 200 as an inseparable mixture, arising from 

























Reagents and conditions: i) AD-mix-P, tBuOH/H2 0 , 2 eq MeSO^NI^, 2 eq K2 S2 0 8, additional 0 s 0 4  and 
(DHQD)2PHAL, RT.
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It was decided to reduce the ester functionality to a protected alcohol oxidation level 
since it was thought that its presence was a partial cause for the slow rate of reaction by 
making the olefins electron deficient. Reduction would also prevent the lactonisation which 
was complicating matters still further. To this end, reduction of the dienic ester 182 with 











Reagents and conditions: i) DIBAL-H, CH2 CI2 , -30°C, 93%; ii) TBSC1, imidazole, DMF, RT, 19h, 98%.
However, subjection of 201 to what we then regarded as our ‘normal conditions’ of 
using Super AD-mix (which we refer to as SAD-mix!), that is, AD-mix-P, two equivalents of 
CH3SO2NH2, two equivalents of K2S2O8 and a small supplement of both OSO4 and ligand, 
run in the literature reported concentration,97 resulted in very slow rates of reaction. No 















Reagents and conditions: i) AD-mix-(3, tBuOH/H20, 2 eq MeSQ2NH2 , 2 eq K2 S2 O8 , additional OSO4  and 
(DHQD)2 PHAL, RT, 17%.
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It was found that increasing the concentration greatly increased the rate of 
dihydroxylation, and under very forcing conditions (OSO4 and ligand supplements in 
combination with several equivalents of both CH3SO2NH2 and K2S2O8 in considerably 
more concentrated reactions) complete starting material consumption was observed after 
typically 4h. Under these conditions the reactions rapidly led to a ca. 1:1 ratio of 
regioisomeric diols 202 and 203 (3-5h), but after many days, the desired tetraols were now 
observed. However, even after a week the desired tetraol 204 was only obtained in 8% yield.
At that time it was thought that the environment was too 
sterically crowded for the large dimeric (DHQD)2PHAL ligand 
to operate in, and so it was thought advisable to try a change in 
ligand. The DHQD-CLB ligand was tried, since it is monomeric 
and smaller and it was known to still give good 
enantioselectivity for trisubstituted alkenes.46 
The silyl ether 201 was thus submitted to our normal AD 
conditions using DHQD-CLB as ligand. After Id there was ca. 50% starting material left, 
but very good regioselectivity was observed for one of the diols, as seen by the *H NMR 
ratio of ca. 10:1, though it was not possible to determine which of the two olefins had been 
dihydroxylated. After consumption of all the starting material, the crude *H NMR showed 
mainly one diol, but unfortunately very little tetraol, even when left for considerable amounts 
of time.
For the purpose of eventual selective oxidation of the C7 hydroxyl, we required to 
protect the tetraol 204 as the bis-acetonide. With the small amounts of tetraol 204 available
at that time, we found that treatment of 204 with dimethoxypropane (DMP) and catalytic p-
TsOH led to cleavage of the silyl ether.
The low rate in the AD reaction with the silyl protecting group, and its subsequent 
cleavage during the bis-acetonide formation, led us to invesigate the AD on the free hydroxyl 
compound 205. To our delight, when the dienic alcohol 205 was submitted to our normal 
conditions, run at the literature reported concentration, virtually all starting material had been 
consumed within 16h. This was a much increased rate in reaction with respect to both the 









concentrations. However, virtually no regioselectivity was observed, a ca. 1:1 mixture of 
triols 206 and 207 being obtained. The desired pentaol 208 remained elusive until the 
reaction was run at three times the concentration with an additional 10 mol% OsC>4 and 30 
mol% ligand. These conditions yielded the pentaols 208 and 209 in 10% yield as an 
inseparable mixture (Scheme 90). However, what was encouraging was that the 
diastereomeric ratio of 208 to 209 appeared to be better than 8:1. The diastereomeric ratio 
was measured by integration of the peaks in the 13C NMR spectrum of the crude mixture 
with the pulse delay having been set to 10 seconds. This enables meaningful integration of 
the carbon signals as full relaxation is achieved within that time period. All of our future 























208 > 8:1 209
Scheme 90
Reagents and conditions: i) AD-mix-P, tBuOH/H20 (3x lit. concentration), 2 eq MeS02NH2, 2 eq K2 S2O8 , 
additional 10% Os04 and 30% (DHQD)2PHAL, RT.
No mention has been made yet as to the enantioselectivity of these reactions, as 
attention has focused on trying to optimise the reactions to give either tetrols or pentols. This
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has required running the majority of the AD reactions in increased concentrations, and it has 
been suggested that this affects the enantiomeric excesses of the products.46
By this stage we had become aware that it would be easier to perform the reaction in 
the one-phase NMO system in order to obtain directly the tetraols and pentaols. Although 
our initial efforts at a one-pot double AD reaction in the two-phase system never yielded 
much of the desired tetraols or pentaols, much knowledge had been gained from these initial 
experiments which would prove invaluable in the future {vide infra).
2.7 One-phase AD of 1,3-diene
As soon as we were aware that exhaustive dihydroxylation would be easier in the 
homogeneous NMO process, we focused our attention on the one-phase system using the 
dienic alcohol 205 and its derivatives.
Thus, when the dienic alcohol 205 was subjected to 1 mol% OSO4 and 5 mol% 
(DHQD)2-PHAL in the presence of three equivalents of NMO in the homogeneous 
acetone/water system,95 the pentaol 208 was obtained as an 8:1 diastereomeric mixture in 











Reagents and conditions: i) 1% Os04 and 5% (DHQD)2PHAL, 3 eq NMO, acetone/water (5:1), RT, 6d, 74%.
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Unfortunately the enantioselectivity of this one-pot procedure was low, giving pentaol 
208 in only 24% ee. The ee of 208 was measured by 19F NMR analysis of the Moshers’ ester 
derivitive 210 which was prepared according to Scheme 92. *0° Since a prior attempt to 
protect the TBS protected ether 204 as a bis-acetonide derivative resulted in cleavage of the 
silyl ether, we decided to selectively protect the primary alcohol as the pivalate ester 211. 
Thus, treatment of 208 with PivCl, pyridine and catalytic DMAP in CH2CI2 afforded the 
pivaloate ester 211 in 77% yield. Formation of the bis-acetonide with 2-methoxypropene and 
cat. p-TsOH followed by reductive removal of the pivaloate ester with DIBAL-H afforded 
the bw-acetonide alcohol 212. Only at this stage was it possible to separate the traces of the 
minor diastereomer from the dihydroxylation step by FCC. Treatment of 212 with (R)-(+)-a- 
methoxy-a-(trifluoromethyl)phenylacetic acid, DCC and DMAP (cat.) in CH2CI2 afforded 





















Reagents and conditions’, i) PivCl, pyridine, CH2 CI2 , 5 mol% DMAP, 22h, 77%; ii) 2-methoxypropene, p- 
TsOH (cat.), DMF, RT, 17h, 80%; iii) DIBAL-H, CH2 CI2 , -78°C, 91%; iv) (R)-(+)-a-methoxy-a- 
(trifluoromethyl)phenylacetic acid, CH2 CI2 , DCC, DMAP (cat.), RT, 16h, 100%.
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The bis-acetonide alcohol 212 was itself required in the synthesis since selective 
oxidation of the C7 alcohol was required for addition of an acyl anion equivalent to install 
the Cl sidechain. It was thought that the overall yield of the steps involved in going from the 
diene 205 to the bis-acetonide alcohol 212 could be improved if the dienic alcohol 205 was 
protected as the pivaloate ester 213 prior to the AD. It was thought that the resulting tetraol 
would be less water soluble than the corresponding pentaol which would ease the extraction 
process during work-up. This protection of dienic alcohol 205 would also negate the need for 
selective protection, which currently proceeded in only 77% yield. Thus, the pivaloate ester 
213 was prepared in 97% yield by treatment of 205 with PivCl, pyridine and catalytic 
DMAP in CH2CI2 (Scheme 93). However, submitting 205 to the one-phase AD generated an 
interesting result. Not only did the reaction proceed at a greatly reduced rate compared to the 
dienic alcohol 205, resulting in only a 37% yield of tetraol 211, but the diastereomeric ratio 







2 :1  diastereomeric 
mixture
Scheme 93
Reagents and conditions: i) PivCl, pyridine, CH2 CI2 , 5 mol% DMAP, 16h, 97%; ii) 1% OSO4  and 5% 
(DHQD)2 PHAL, 3 eq NMO, acetone/water (5:1), RT, 5.5d, 37% as a 2:1 diastereomeric mixture.
For completeness, the TBS protected derivative 201 was also submitted to the one- 
phase AD. Again, similar results were observed; a greatly reduced rate of reaction, and a 
greatly reduced d.e. These observations, that the nature of the protecting group not only 
affected the rates but also the diastereoselectivity of the process, were surprising since the 
hydroxyl group is expected to lie in the NE quadrant of the Sharpless mnemonic, generally 
regarded as a “sterically neutral” region. As mentioned earlier, the enantioselectivity of the
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one-pot process for the dienic alcohol 205 was low. However, Corey had recently reported 
that protection of allylic alcohols as their /?-methoxybenzoate esters resulted in greatly 
increased enantioselectivity in the two-phase ferricyanide system.101 We therefore hoped 
that protection of the dienic alcohol 205 as its PMB ester 214 would increase the ee in our 
one-phase system. Unfortunately, subjecting PMB ester 214 to the NMO/acetone/water 
system resulted in only a slight increase from 24% ee to 29% ee. The low enantioselectivities 
observed in our one-pot systems are presumably due to the inherent problems associated 
with the second catalytic cycle as discussed previously (Scheme 76). The results of the one- 
pot AD are summarised in Table 8.











2 0 1  R=TBS 
205 R=H
214 R=(4-MeO)C6H4CO






1 213 2 :1 t 37
2 2 0 1 3:1 t 59
3 205 8:1 24 74
4 214 t 29 76
* Conditions: 1 mol % 0 S0 4 , 5 mol % (DHQD)2 -
PHAL, 3 eq. NMO, 5:1 acetone : H2 0 , rt.
3  Estimated by integration of crude 13C NMR with
pulse delay 1 0  s.
^ Measured by NMR analysis of the Mosher’s ester 
derivative of compound 2 1 2 . 
t  not measured.
In order to improve the enantioselectivity we adopted a new modification of the AD 
reaction. Thus, dienic alcohol 205 was subjected to dihydroxylation with Super AD-mix-p 
under the two-phase ^BuOH/water system (Scheme 94). We drew on our valuable knowledge
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gained from our initial attempts to optimise the reaction (see Section 2.10) by addition of 
two equivalents K2S2O8 as additional co-oxidant along with two equivalents MeSC>2NH2 
and 5 mol% (DHQD)2-PHAL and 1 mol% OSO4 . This afforded ca. 1:1 mixture of 
regioisomeric triols 206 and 207 in 78% yield. The second dihydroxylation was now carried 
out in the one-phase system by exposure of the unprotected triols 206 and 207 to 1 mol% 
OSO4 , 5 mol% (DHQD)2-PHAL and two equivalents NMO in acetone/water. This afforded 



























Scheme 94: Revised AD procedure 
Reagents and conditions', i) AD-mix-P, 1 mol% OSO4 , 5 mol% (DHQD)2 PHAL, 2 eq CH3 SO»2NH2, 2 eq 
K2 S2 0 8, 1BuOH/H20  (1:1), 0°C to RT, 4d, 78%; ii) 1 mol% Os04  and 5 mol% (DHQD)2 PHAL, 3 eq NMO, 
acetone/water (5:1), RT, 58%.
We deliberately left the hydroxyl functionalities of 206 and 207 unprotected to exploit 
the rate enhancement obtained due to the favorable hydrogen bonding interactions with the 
trioxo Os(VIII) species. In addition, we had included the (DHQD)2PHAL ligand in the 
second dihydroxylation with the aim to overall amplify the ee at the expense of the de by
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creating a mismatch between the wrong enantiomer from the first dihydroxylation and the 
ligand. However, if all the second dihydroxylation step proceeds through the trioxo Os(VIII) 
species, then the ligand would not be involved, but it is conceivable that the “normal” 
pathway could be operating to some extent in this different solvent system. The idea, as 
applied to our diene 205, is highlighted in Scheme 95. For clarity, only one regioisomeric 
triol is shown, but the argument is identical for both triols. Also, simplification is made by 
assuming the anti- diastereoselectivity for the second step to be complete. The first 
dihydroxylation leads to the two enantiomers 206 and 215. If the second dihydroxylation 
was performed in the absence of the (DHQD)2PHAL ligand, then 206 and 215 would be 
converted into 208 and 216, respectively, and the ee of the product pentaol would be 
identical to the ee of the intermediate triol. In the presence of the (DHQD)2PHAL ligand, 
206 would still be converted into 208. However, for 215, a “mismatch” would exist, and a 
mixture of 216 and the diastereomer 217 would result. Since less of the “wrong” enantiomer 
217 is formed, the ee of the pentaol would be increased. The de, however, would be lowered 










































In order to test this notion, the second step was performed in the absence of the chiral 
(DHQD)2PHAL ligand, using quinuclidine in its place. However, the reactions involving 
quinuclidine were very slow and never proceeded to completion. For this reason, very little 
material was obtained, and since the hypothesis requires the reaction to have proceeded to 
completion to obtain a meaningful comparison, it was not possible to determine the ee of the 
resulting pentaol with this approach.
Nonetheless, we were contented that our new modification gave good yields of the 
desired pentaol with good enantioselectivity. However, although the first two-phase reaction 
was reliable, it was very slow and hence conditions were sought to optimise the reaction still 
further. It was found that use of the more water soluble Na2S20s102 instead of K2S2O8 in 
combination with additional MeSC>2NH2 and OSO4 and ligand dramatically reduced the 
reaction times. Thus, subjecting the dienic alcohol 205 to 5 mol% OSO4, 7 mol% (DHQD)2- 
PHAL, two equivalents Na2S20s and four equivalents MeSC>2NH2 in lBuOH/water at RT 
now afforded the regioisomeric triols 206 and 207 in 70% yield in the greatly reduced time 
of 18h (cf 4d). Treatment of the triols 206 and 207 with now 3 mol% OSO4, 6 mol% 
(DHQD)2-PHAL with three equivalents NMO in acetone/water for 2d afforded the pentaol 
208 in 67% yield. The overall yield for the process of converting the diene 205 to the pentaol 
208 remained the same (45%) but the reaction time had been reduced from 7.5d to 2.5d. 
However, it was noticed that these new conditions led to a slight decrease in ee of the pentaol 
(68% ee).
It is interesting to compare the AD of diene 205 to that of the Nicolaou AD of diene 90 
(Section 1.5.2, Scheme 25) which gave the corresponding diol initially in 78% ee and 20% 
yield, which was later improved to 86% ee and 30% yield. However, our AD does not suffer 
from such poor yields. The use of either Na2S20s or K2S2O8 has clearly made a significant 
difference, as well as the rate enhancement of having a free hydroxyl group in the allylic 
position in the NE quadrant, a result previously unprecedented.103 In addition to this, our 
AD has established that the NE quadrant may present more of a steric barrier than previously 
thought. However, there is no evidence to prove that our diene occupies the mnemonic as we 
might expect. Our assignment of absolute configuration rests on the assumption that, in the 
Sharpless mnemonic, the hydrogen substituent on either double bond of the 1,3-diene would
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be expected to occupy the “south eastern” quadrant, with the (DHQD)2-PHAL ligand then 
attacking from the (3-face. The outcome of a similar asymmetric dihydroxylation in the
Nicolaou synthesis31 (Section 1.5.2, Scheme 25) is in accord with this assumption. Also, 
comparison of the optical rotation of the natural product obtained synthetically from our 
material to that of the isolated natural product itself, would determine the absolute 
stereochemistry of our AD process.
This AD methodology directed at polyol synthesis clearly has immense potential in a 
wide variety of synthetic applications. For example, one could imagine access to a series of 
unnatural sugars via use of the appropriate chiral ligand with the above polyol methodology. 
Normally, several steps are required to manipulate carbohydrates into synthetically useful 
fragments. Here, Stille coupling followed by double AD could give properly 
protected/functionalised pieces directly.
With the double AD now optimised, the remaining steps in the synthesis of the model 
core could be investigated.
2.8 Synthesis of the acyclic precusor of the bicyclic core.
With sufficient quantities of pentaol 208 in hand, the synthesis was once again able to 
move forward.
Oxidation of the bis-acetonide alcohol 212 (prepared according to Scheme 92) to the 
aldehyde 218 initially proved problematic. Attempts using PCC, TPAP or an old batch of the 
Dess-Martin periodinane reagent gave no reaction. Freshly prepared Dess-Martin 
periodinane reagent gave a single non-aldehyde product, the structure of which was initially 
unknown (although it was later thought to be understood what had occurred, vide infra). It 
had recently been reported that o-iodoxybenzoic acid (the intermediate in the Dess-Martin 
periodinane preparation) in anhydrous DMSO was a useful reagent for oxidation of alcohols 
to aldehydes, but this also proved unfruitful. Swem oxidation106 using (COCl)2/DMSO in 
CH2CI2 offered a significant improvement giving aldehyde 218 in 61% yield. However, this 
method suffered from a-epimerisation upon warming the reaction mixture from -78°C after 
addition of triethylamine. This problem was remedied by quenching the reaction at -78°C
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with aqueous NH4CI one hour after addition of triethylamine at -78°C. This procedure 













Reagents and conditions: i) (C0 C1>2 /DMS0 , CH2 CI2 , -78°C then Et3N, -78°C, lh, 83%.
We now needed to install our C l carbon substituent by means of an acyl anion 
equivalent. As can be seen in Scheme 97, the chelation control model106 predicts the desired 
diastereomer 219 if chelation occurred at the C6 oxygen, i.e. a-chelation. However, 
chelation at the C5 oxygen, i.e. P-chelation, would lead to the C7 epimer 220, which would 
result in the bicyclic core possessing the wrong stereochemistry at Cl.
Aldehydes possessing both an a -  and P-chelating group often afford low 
diastereoselectivities when under the chelation control method due to competition at both the 
a-and P-sites. 2,3-O-Isopropylideneglyceraldehyde 221 is one such aldehyde that is 
notorious for frequently returning low diastereoselectivities upon addition of organometallics 



















David and co-workers108 in fact reported that addition of 2-lithio-2-methyl-l,3- 
dithiane occurred with complete stereocontrol to afford the anti product 222 (Scheme 98). 
This is in accord with the Felkin-Ahn model. Incidentally, for addition to our aldehyde 218, 
the non-chelation control Felkin-Ahn model predicted the wrong C7 epimer 220.
O
n  a -
221
Scheme 98




Although the a-chelation control model predicted the desired epimer 220, our initial
usually employed to achieve chelation control.
It had been reported that silyl protected cyanohydrins functioned as acyl anion 
equivalents and could be deprotonated under mild conditions (LDA, -78°C, THF).(Scheme 
99).109 After addition to aldehydes or ketones they underwent a 1,4-silyl transfer followed 
by elimination of cyanide to give the silyl ethers, which on hydrolysis afforded the hydroxy 
ketones.
Reagents and conditions: i) LDA, THF, -78°C, 5 min then R2COR3 ; ii) H3 0 +.
However, we later discovered from the literature that the anion could only be formed if 
the Ri substituent was an electron withdrawing group such as aryl or allyl. This was 
consistent with our observations that treatment of 223 with LDA at -78°C in THF followed 
by addition of aldehyde 218 led only to addition of TMS-cyanide to the aldehyde (Scheme 
100).











Reagents and conditions', i) LDA, THF, -78°C , then 218.
Use of dialkylaminonitriles as acyl anion equivalents had also been reported,110*111 
and aliphatic groups were known to be tolerated. Again, generation of the anion was reported 
to be achieved under mild conditions (LDA, -78°C, THF), but also regeneration of the 
ketone could be effected either by the usual acid hydrolysis or by other mild hydrolytic 
agents such as copper sulfate, iron sulfate, copper acetate or silica gel (Scheme 101).
1,11 ►xMe CN
R=Me 0 =4 ,5 ,6 , 1 2
224 R=Et
Scheme 101
Reagents and conditions: i) LDA, THF, -78°C , 5 min then CH3 (CH2>nCHO; ii) H+.
Thus the diethylaminonitrile 224 was prepared according to the literature procedure.112 
Unfortunately, we had no success in our attempts to add 224 to the aldehyde 218. We 
therefore turned our attention to the anion derived from 2-methyl-1,3-dithiane as our source 
of acyl anion equivalent.113 Thus, addition of 2-lithio-2-methyl-1,3-dithiane to aldehyde 218 
afforded a 1:1.2 mixture of the diastereomeric alcohols 225 and 226 in 97% yield (Scheme 
101). The diastereoselectivity of this reaction was disappointingly low, but the alcohols 225 
and 226 were readily separable by FCC. Efforts to increase the diastereoselectivity by 
addition of chelating metal salts (MgBr2 and ZnBr2) proved unfruitful.
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Scheme 102
Reagents and conditions', i) 2-lithio-2-methyl-1,3-dithiane, THF, -78°C, 97%; ii) HgCClO^, CaCC>3 , 
THF/H20  (5:1), RT, min, 84%; iii) Hg(C104)2, CaCC ,^ THF/H20  (5:1), RT, 30 min, 92%.
The stereochemistry of 225 and 226 was unknown until the correct bicyclic core had 
been made and confirmed (vide infra), and hence the stereochemistry of the addition 
products could be deduced. Removal of the 1,3-dithiane protecting groups with Hg(C104)2 
and CaCC>3 proceeded smoothlyn4 to afford the acyclic precursors 227 and 228, and we 
were now in a position to examine the crucial bicyclic internal ketalisation reaction.
2.9 Cyclisation of the acyclic precursors 227 and 228 to the bicyclic core systems
With the acyclic precursors 227 and 228 in hand, the crucial bicyclic ketalisation was 
investigated. As mentioned previously, at the start of our work there was no precedent for the 
formation of the desired bicyclic 1,6-anhydrofuranose ring system by internal ketalisation. It 
had always been our hope that acid-catalysed treatment of 228 would on thermodynamic 
grounds lead to the formation of the desired 2,8-dioxabicyclo[3.2.1]octane ring system 133 
rather than the 1,6-anhydropyranose or 1,5-anhydrofuranose structural isomers 229 and 230 
(Scheme 103).
Molecular modelling studies115 on minimally substituted cores suggested the 1,6- 
anhydrofuranose isomer (cf. 133) to be the most stable of the three possible ketals. While 
common molecular mechanics force fields are not properly parameterised for these systems, 
they agreed with semi-empirical calculations that the 1,5-anhydrofuranose isomer (cf. 230) 
was much less stable than the other two ketals.
Treatment of the hydroxyketone 228 with 2% HCl/MeOH at 60°C for 18h did indeed 
afford the desired bicyclic anhydrofuranose ketal isomer 133 in 45% yield, but in addition 
generated the undesired 1,6-anhydropyranose ketal isomer 229 in 47% yield (Scheme 103). 




2d, but this resulted in considerably reduced yields (34% of 133) since the reaction had not 
reached completion under these conditions. Leaving the reaction longer merely served to 
increase the amount of 229.
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Reagents and conditions: i) 2% HCl/MeOH, 60°C, 18h, 45% of 133, 47% of 229; ii) CH2 C12 /TFA/H20  
(20:10:1), RT, 16h, 38% of 133, 38% of 229.
Employing the cyclisation conditions used by Evans in his zaragozic acid C 
synthesis,33 i.e, CH2Cl2:TFA:H20 (20:10:1), resulted in the same 1:1 ratio of 133 to 229 but 
in slightly lower yields (Scheme 103). Use of 6M HC1 in EtOH at RT led to a much more 
rapid reaction, (tic indicated mainly just the two cores 133 and 229 after just 5h), but 
strongly favoured the 1,6-anhydropyranose 229.
The structure and stereochemistry of 133 were proven by extensive NMR experiments 
on the derived 6,7-bis-acetate 231 (Figure 18). The !H NMR spectrum identified two 
doublets at 6.01 and 5.11 ppm, corresponding to H6 and H7. The observed J H6-H7 value of
2.8 Hz was characteristic of the desired ring system and of the correct 6R, 7R relative 
stereochemistry.il6 The i35DEPT experiment identified three CH signals at 81.8, 77.7 and 
73.1 ppm. The lH-13C correlation experiment identified the CH signals at 81.8 and 77.7 ppm 
as the acetylated hydroxyls, and hence allowed assignment of the remaining CH signal at 
73.1ppm as C3. This then allowed assignment of H3 at 4.43 ppm. Important cross-peaks in 
the NOESY spectrum were observed between the Cl-methyl group and H7, and between H6 
and H3. In addition, *H NMR difference nOe experiments observed a 14% enhancement of 










J values nOe NOESY
H6-H7; 2 .8  Hz 14% H6-H3 H7-C1 Me
H6-H3
Figure 18
The isomeric ketal structure 229 was assigned based on its NMR. The relative 6R, 
7R stereochemistry resulting from the dithiane addition was established by analogy to the 
correct core 133 since it was generated from the same hydroxy ketone. The observed J H6- 
H7 value of 7.8 Hz was characteristic of fraws-diaxial coupling in a six-membered ring, and 
was consistent with the reported J H6-H7 coupling constant of 8.0 Hz for the 










J values J values
H6-H7; 7 .8  Hz H6-H7; 8 .0  Hz
Figure 19
We were satisfied as to which ketal isomer was which based on the *H NMR J values 
and 2D-NMR spectroscopic data, but 3-bond HMBC studies would be required for full 
confirmation.
In investigating the cyclisation of the C l epimer, a somewhat different result was 
obtained. To our surprise, treatment of the C7 epi alcohol 227 with 2% HCl/MeOH at either
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RT or with heating always led exclusively to what appeared to be the undesired 1,6- 
anhydropyranose ketal isomer 233 (Scheme 105). Cyclisation of 227 under the Evans 
conditions33 also gave the same result.
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Reagents and conditions: i) 2% HCl/MeOH, 60°C, 18h, 75%; ii) CH2 Cl2 /TFA/H2 0  (20:10:1), RT, 16h, 69%.
The structure of the 1,6-anhydropyranose 233, resulting from the C7 epimer of the 
dithiane addition, was tentatively assigned from the J H6-H7 coupling constants. It had been 
reported that the 6R, 7S stereochemistry of the natural product had a J H6-H7 value of 6.5 
Hz.116 This was also in accordance with the Nicolaou 6R, 7S model core 234 having a J H6- 
H7 value of 6.3 Hz.31d However, the observed J H6-H7 in both 233 and the derived 6,7-bis- 
acetate 235 of 4.4 Hz indicated we had the anhydropyranose isomer 233 rather than the 
isomeric 1,6-anhydrofuranose 236 (Figure 20), though again 3-bond HMBC studies would 
be required for full confirmation.
233 R=H 
235 R=Ac
J va lu es  
H6-H7; 4.4 Hz
J values  
H6-H7; 6.3 Hz
Expected J va lues  
H6-H7; ca. 6.5 Hz
Figure 20
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It was thought that the exclusive formation of the anhydropyranose ring system 233 
might be as a result of developing hydrogen bonding interactions of the C5-C6-C7 triol 
functionality. It seemed interesting to test this notion by protecting the C7-hydroxyl prior to 
the cyclisation thereby reducing the hydrogen bonding interactions and see if this would 
generate any of the 1,6-anhydrofuranose isomer 237 (Scheme 106).
However, silylation of 225 with as many as 9 equivalents of TBDPSC1 and 12 
equivalents of imidazole in DMF at 70°C for several days gave no reaction, as did the use of 
TBDMSOTf and 2,6-lutidine in CH2CI2. Similarly, treatment of 225 with NaH and Mel in 
THF gave none of the corresponding methyl ether, returning only starting material. It was 
thought that the dithiane group was causing severe steric hindrance of the C7 hydroxyl, and 
that removal of the dithiane to give the keto-alcohol 227 prior to protection might alleviate 
the problem. Again though, attempted silylation of 227 with either TBDPSCl/imidazole in 
DMF at 70°C, or TBDPSC1, Et3N and cat. DMAP in CH2CI2 failed to give any reaction. Use 
of TBDMSOTf and 2,6-lutidine in CH2CI2 gave a mixture of products. The *H nmr of one of 









not conclusively known, it was tentatively assigned as 238. Nonetheless it was submitted to 
the Evans cyclisation conditions.33 Tic analysis showed a polar product that co-ran with the 
known core 234, and hence suggested that if the TBS ether had been made, it in any case 
underwent cleavage in the cyclisation reaction (Scheme 106).
Reagents and conditions', i) TBSOTf, 2,6-lutidine, CH2CI2 ; ii) CH2 CI2 /TFA/H2O (20:10:1), RT, 4h.
Returning to the correct C7 core, we initially thought that the cyclisation would be 
under thermodynamic control. To test this notion, the isolated cores were resubmitted to the 
reaction conditions. Thus, separate treatment of 133 and 233 with 2% HCl/MeOH at 70°C 
showed no change by tic after 4h. Likewise, treatment of 229 with 2% HCl/MeOH at 70°C 
for 2h, then RT for 3d indicated none of the other core system at any stage by tic. Thus, the 
cyclisation would appear to be kinetically controlled. This would appear contrary to 
Nicolaou’s cyclisation of the incorrect C7 epimer 239, since re-submission of the 
anhydropyranose 239 (isolated if the reaction was not allowed to proceed to completion) to 
the reaction conditions resulted in further rearrangement to the 1,6-anhydrofuranose 240 
(Scheme 108).31d However, none of the analogous anhydropyranose with the correct C7 
stereochemistry was isolated to establish if this rearrangement also occurred for the correct 
C7 system.
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Reagents and conditions: i) 2% HCl/MeOH, 6 8 °C, 9h, 59%.
Leading on from our cyclisation studies, it was obviously desirable to increase the ratio 
of the 1,6-anhydrofuranose isomer 133 over the 1,6-anhydropyranose isomer 229. We 
wondered what factors might be governing the observed ratio, and what could be done to 
improve it. Our control experiments had established that the cores did not equilibrate and 
hence suggested our cyclisation to be under kinetic control (cf. Evans).118 The factors 
influencing the cyclisation are clearly complex, and since the intermediates cannot be 
characterised, ideas are difficult to prove. It is not known whether the acetonide cleavage or 
cyclisation itself is the rate determining step. However, it is conceivable that the relative rate 
of acetonide removal could influence the cyclisation in so far as if the C3-C4 acetonide was 
removed first, then the cyclisation might occur to give the undesired anhydropyranose 229 
via the oxonium ion 241 (Scheme 109). Conversely, if the C5-C6 acetonide was removed 


























Therefore, we sought to remove this additional factor, so that only the intrinsic relative 
tendency of the hydroxyls to cyclise is operating, by deprotecting the dithiane after the 


















In the event, both acetonides of 226 proved to be extremely robust towards acid 
hydrolysis, but with one of the acetonides very much more so than the other. Treatment of 
226 with 50% aqueous TFA in THF did not effect the hydrolysis. Use of Pd(MeCN>2Cl2 in 
acetone as developed by Lipshutz119 gave mainly starting material after 3d, and as ever 
increasing amounts of Pd were added, tic indicated a multi-component mixture. Use of the 
Evans cyclisation conditions proved more effective, although very slow (Scheme 112). After 
16h, all the starting material had been consumed, and two new products were observed by 
tic. As time progressed the less polar component was converted into the more polar 
compound. The reaction was left until all the less polar compound had been converted into 
the more polar of the two spots (2d), by which time a small amount of an even more polar 
component was observed. At this stage the reaction was worked up and the two components 
were isolated. The NMR was consistent with the major product being the desired pentaol 
243, isolated in 35% yield. The second isolated product was the bicyclic core 133, isolated in 
31% yield.
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BnO 226 BnO 243
Scheme 112
Reagents and conditions: i) CH2CI2 /TFA/H2O (20:10:1), RT, 2.75d, 35% 243, 31% 133.
Interestingly, none of the other isomeric core 229 was detected. It would seem that 
under the extended duration of the reaction, once at the pentaol 243, the dithiane had also 
been hydrolysed liberating the ketone for cyclisation. It was encouraging to find that only the 
desired core 133 was observed, and these preliminary results would seem to support our 
hypothesis. The very small amounts of 243 were subjected to Hg(C104>2 and CaCC>3. A 
single product was obtained, but the iH NMR of the crude product indicated no presence of 
the characteristic methyl group at ca. 2ppm, indicating the loss of the ketone functionality. It 
appeared that either the C5 or C6 hydroxyl had cyclised onto the ketone. Unfortunately there 
were insufficient amounts of material to obtain proper characterisation and this deprotection 
approach may be the subject of future investigation.
2.10 Efforts aimed at improving stereocontrol of the C7-hydroxyI: the triene approach.
In light of the poor diastereoselectivity observed in the dithiane addition reaction, it 
was envisaged that the C7 hydroxyl could be installed by AD methodology at the same time 





























BnO 205 BnO 247
Scheme 113
The same (DHQD)2PHAL ligand would be required to achieve the correct face 
selectivity for all three olefins. This route is extremely attractive since not only would it 
incorporate all 5 stereocentres from C3 to C7, it would also negate the need for acetonide 
protecting groups and hence makes for an extremely efficient synthesis of the bicyclic core 
133. While this has yet to be achieved, some preliminary investigations were performed and 
these are described here.
It was thought that synthesis of the triene 244 could be achieved using Wittig 
methodology by addition of the known120 phosphine oxide 246 to the aldehyde 247. 
Aldehyde 247 itself could arise either from reduction of the dienic ester 182, or by oxidation 
of the alcohol 205.
Initial attempts at reduction of the dienic ester 182 with DIBAL-H at -78°C in CH2CI2 
always progressed directly to the alcohol 205 without ever any indication of the aldehyde 
247 by tic. Reduction of esters with LiAlIfy in the presence of Et2NH had been reported to 
stop at the aldehyde level without further reduction to the alcohol,121 but these conditions 
also reduced 182 directly to the alcohol 205. We therefore investigated the oxidation of 
alcohol 205.
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Oxidation of 205 with TPAP, Dess-Martin periodinane, TEMPO,122 PCC and Collins 
reagent all gave the same results. In all cases, tic indicated two new products, which when 
individually isolated and purified by FCC appeared as a mixture in the ^  NMR as two 
aldehydes and another unidentifiable product. Immediate tic analysis of the NMR samples 
indicated that what was once a single spot now appeared as the same two spots. It became 
apparent that some kind of interconversion process was taking place, and this led us to 
approach the synthesis of aldehyde 247 in a different manner.
We opted for an approach based on a Stille coupling with a vinyl iodide fragment that 








The vinyl iodide 248 was prepared according to Scheme 115. DIBAL-H reduction of 
157 at -78°C gave the aldehyde 249 along with what was presumed to be the isomerised 
aldehyde 250 (tic) since aldehydes of this nature had been reported to be unstable and prone 
to isomerisation.123 For this reason, the aldehyde 249 was not purified but submitted directly 
into the next step. Thus, treatment of the crude reaction mixture with trimethyl orthoformate 
in the presence of catalytic PPTS in MeOH gave the corresponding hemi-acetal 248 as the 
major product in an overall yield of 69%, along with the readily separable 251 as the minor 

















Reagents and conditions: i) DIBAL-H, CH2 CI2 , -78°C, 15 mins; ii) CH(0 Me)3 , MeOH, 10 mol% PPTS, 69% 
248 overall.
The stereochemistry of 248 was proven by an nOe difference experiment which 







A co-worker49 later found that the isomerisation during the DIBAL-H reduction could 
be avoided, enabling 248 to be obtained cleanly and in high yield. The same co-worker 
found that the NMR of the crude reaction mixture resulting from coupling of 248 with the 
vinyl stannane 137 used in our core synthesis, under our optimised Stille conditions, was 
identical to that obtained from oxidation of the dienic alcohol 205. It was later found49 that 
there was possibly an equilibrium between the aldehyde 247 and the enol isomer 252, though 








It seemed logical that during the Stille coupling, the acetal functionality had probably 
been hydrolysed due to the presence of the added ZnCl2, liberating the aldehyde 
functionality (either before or after the coupling had taken place), which would account for 
the observations.
By this stage, we had decide to focus our efforts towards a total synthesis of the 
zaragozic acids, and these preliminary results directed at the novel triene route may be the 
subject of future investigations.
CHAPTER 3 
Toward Zaragozic Acid D
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3.1 Expansion of the route toward the zaragozic adds.
Initially, it seemed appealing to expand our core synthesis so as to incorporate a Cl 
substituent with appropriate functionality to allow access to any of the zaragozic acids. Our 
initial objective was to obtain the core 253 which we envisaged would arise by using the 
dithiane 254 instead of 2-methyl-1,3-dithiane (Scheme 117).
Thus, 254 was prepared according to Scheme 118. Treatment of 2,3-dihydrofuran with 
1,3-propanedithiol in the presence of BF3.0 Et2 according to the literature procedure124 
afforded the 2-(3-hydroxypropyl)-1,3-dithiane, which following protection as the TBDPS 




Reagents and conditions', i) 1,3-propanedithiol, BF3 .0 Et2  (cat), PhH, reflux, 3h, 51%; ii) TBDPSC1, imidazole, 








However, attempts to couple 254 with aldehyde 218 or even simply to anisaldehyde, 
under the same conditions as used earlier for 2-methyl-1,3-dithiane, resulted in no reaction. It 
was observed that treatment of 254 with nBuli rapidly led to the solution turning black. At 
that time this observation was not pursued, but it later became significant (vide infra).
By this time, we had decided to make zaragozic acid D our target for total synthesis, 
and hence immediately started work on a fully functionalised sidechain.
3.2 Retrosynthetic analysis of zaragozic acid D
Our approach to the total synthesis of zaragozic acid D involved the use of a 2- 
substituted 1,3-dithiane which would contain all the functionality of the natural product C l- 
sidechain. However, the stereochemistry of the C4’ and C5’ substituents in the C l sidechain 
of zaragozic acid D are unknown.8 Despite this, we thought it would be reasonable to assume 
they had the same relative configuration as all the other zaragozic acids with a C4’ and C5’ 
substituent. We would therefore require the dithiane 255 as our fully functionalised acyl 
anion equivalent (Scheme 119).
Model studies from our earlier work with simplified dithianes of type 254 (section 3.1, 
Scheme 117) indicated that the C4’ substituent would require protection as the more robust 
TBDPS ether rather than the TBS ether in order for the protection to survive the Evans 
cyclisation conditions. We planned to use the Evans cyclisation conditions for construction 
of the bicyclic core since Nicolaou had reported the cleavage of the TBDPS group of his Cl 
sidechain under his 2%HCl/MeOH cyclisation conditions.3 ld Dithiane 255 would itself arise 
from dissolving metal reduction of the alkyne 256 which would allow simultaneous 
incorporation of the E-double bond and removal of the benzyl ether. The alkyne 256 could 






















3.3 Synthesis of the C l sidechain
Camera had reported the synthesis of the alcohol 258 during his synthesis of the Cl 
sidechain of zaragozic acid C,32 via Evans aldol methodology (Scheme 120). We hoped that 






Reagents and conditions: i) 9-BBNOTf, ‘P^NEt, CH2 CI2 , -78°C then 5-(benzyloxy)pentanal, -78°C to RT 
over 12h, then H202/Me0H, 84%.
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The synthesis of tosylate 257 is shown in Scheme 121. Thus, treatment of 1,5-pentane- 
diol 259 with NaH, benzyl bromide and catalytic B114NI in DMF afforded the mono-benzyl 
protected alcohol in 45% yield, oxidation of which with PCC afforded aldehyde 260 (82%). 
Treatment of the Evans chiral auxiliary 261 with nBuLi followed by quenching with 
propionyl chloride afforded the oxazolidinone 262 in 91% yield. The subsequent aldol 
reaction giving alcohol 258 was modified not only in the conditions but also differring in the 
borane and base used to the procedure reported by Camera.32 Thus, addition of dibutylboron 
triflate (freshly prepared from tributyl borane and triflic acid) and triethylamine to 
oxazolidinone 262 at -78°C followed by addition of aldehyde 260 afforded the alcohol 258 
in 81% yield as a single diastereoisomer, the data for which were identical to those reported 
by Camera.33 Our route from 258 now diverges from Carreira. Protection of 258 with 
TBDPSC1 and imidazole in DMF, removal of the chiral auxiliary with LiBH* and MeOH in 
THF and then reaction of the resultant primary alcohol with /7-toluenesulfonyl chloride in 










Reagents and conditions: i) NaH, BnBr, nBu4 NI (cat), 0°C to RT, 2h, 45%; ii) PCC, CH2 CI2 , 0.5h, 82%; iii) 
“BuLi, THF, -78°C, then propionyl chloride , -78°C to RT, 0.5h, 91%; iv) “Bu2 BOTf, Et3N, CH2 C12, -78°C 
then 0°C 45 mins, then 260, -78°C to RT over 13h, then H2 0 2 /Me0H, (PC 0.5h then RT lh, 81%; v) 
TBDPSC1, imidazole, DMF, Id, 89%; vi) UBH4 , MeOH, THF, 0°C to RT, 1.5h, 84%; vii) p-toluenesulfonyl 
chloride, pyridine, CH2CI2 , Id, 89%.
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Unfortunately, attempts to displace the tosylate 257 with lithium phenylacetylide 
(freshly prepared from phenylacetylene and nBuLi) in THF at either RT or at reflux failed to 
give any reaction. For this reason, the iodide 263 was prepared (85% yield) by treatment of 
the alcohol 264 with triphenylphosphine, iodine and imidazole in toluene.125 Again, no 
reaction was observed on heating 263 at reflux in THF with lithium phenylacetylide, even 














Reagents and conditions: i) lithium phenyl acetylide, THF, reflux; ii) PPI13, 12, imidazole, toluene, 14h, 85%; 
iii) lithium phenylacetylide, THF, DMPU or LiCl, reflux.
It was apparent that this approach did not offer a way forward, so it was decided to 






This approach would require a one carbon homologation of the sidechain to provide 
the required aldehyde 265, and Wittig methodology was also chosen for the homologation 
step since addition of methoxymethyl phosphoranes to aldehydes followed by hydrolysis of 
the resultant enol ether had been reported to be an efficient procedure for aldehyde 
homologation.126 The preparation of 265 is shown in Scheme 124. Oxidation of alcohol 264
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with the Dess-Martin periodinane reagent afforded aldehyde 266 in 99% yield. The 
homologation of 266 to 265, however, required some attention in order for the reaction to 
proceed reliably.
Initially, methoxymethyltriphenylphosphonium chloride was treated with PhLi 
followed by addition of 266 to the resulting suspension maintained at -50°C. The mixture 
was stirred at -30°C for 2h, then brought to RT and stirred for 5h. Addition of 60% 
perchloric acid then effected hydrolysis of the resultant enol ether 267 (Figure 22) in situ. 
After work-up and chromatography, several components were isolated. The -^H and 13C 
NMR of the product homologated aldehyde 265 also indicated the presence of the acetal 268 
(Figure 22). This had presumably formed during the hydrolysis of 267 by reaction of the 
liberated aldehyde with MeOH in the presence of the perchloric acid. Compounds 265 and 
268 co-ran on silica gel and could not be separated. The third component, (which by tic 
appeared in the reaction before the addition of HCIO4), was identified as enal 269 (Figure 




Reagents and conditions: i) Dess-Martin periodinane reagent, CH2 CI2 , 20 mins, 99%; ii) 





Figure 22: Intermediates and by-products obtained from aldehyde homologation
It was found that formation of the enal side-product 269, (presumably arising from the 
Wittig reagent acting on 266 as a base, forming an anion a  to the carbonyl, which then 
underwent elimination of the silyloxy group), could be completely avoided by simply pre­
cooling the aldehyde 266 to -78°C prior to its addition to the Wittig reagent, also maintained 
at -78°C. When the reaction was left at -78°C, however, although tic indicated the complete 
consumption of the starting aldehyde 266 after just 30 mins, work-up by quenching with 
water at -78°C, followed by addition of HCIO4, resulted in very low yields of 265. Instead, 
an intractable oil which was insoluble in a wide range of organic solvents, was isolated. It 
was found that the isolated oil was the phosphonium salt 270 (Figure 22), a result of the 
elimination being suppressed at -78°C. However, simply treating isolated 270 with 
NaHMDS in benzene at RT effected the elimination to give quantitatively the enol ether 267 
as a 1:1 stereoisomeric mixture (as observed by NMR of the crude reaction).
In addressing the undesired acetal formation during the HCIO4 hydrolysis step it was 
found that treatment of the crude isolated mixture of 265 and 268 with aqueous TFA in THF 
for 30 mins was sufficient to hydrolyse the majority of 268 to the aldehyde 265, although it 
was never possible to obtain pure aldehyde from this reaction. Use of acetone and tosic acid 
to effect transketalisation gave inferior results leading to a 2:1 aldehyde 265:ketal 268 ratio. 
The overall optimised conditions for the homologation are shown in Scheme 125. Thus, after 
the Dess-Martin oxidation, the aldehyde 266 was added to the Wittig reagent at -78°C (to 
avoid generation of the enal 269), and once tic indicated consumption of all the starting 
aldehyde 266, the reaction mixture was allowed to warm to RT to effect completely the
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elimination. Addition of perchloric acid followed by treatment of the crude isolated mixture 
of aldehyde 265 and ketal 268 with aqueous TFA in THF for 30 mins afforded the 
homologated aldehyde 265 in good overall yield (ca. 75%). No exact yield is quoted since it 
was never possible to fully hydrolyse the ketal 268, and hence the near pure aldehyde 265 
was used directly in subsequent steps.
Reagents and conditions: i) Dess-Martin periodinane reagent, CH2 CI2 , 20 mins, 99%; ii) 
methoxymethyltriphenylphosphonium chloride, PhLi, E t20,15 mins, then 266 -78°C, 35 mins then RT, 0.5h, 
then HCIO4 ; iii) THF/H2 0/TFA (20:5:1), 0.5h, ca. 75%.
With the desired homologated aldehyde 265 in hand, we could now turn our attention 
to the incorporation of the E-double bond. This was initially investigated with 
benzyltriphenylphosphonium bromide, as although an E/Z mixture was expected with this 
Wittig reagent, it was envisaged that subsequent isomerisation to the thermodynamically 
favoured E-isomer could be readily effected.
Thus, when aldehyde 265 was added to a suspension of the lithium salt of 
benzyltriphenylphosphonium bromide, the corresponding olefins 271 and 272 were obtained 
as an inseparable 1.6:1 mixture of the E:Z isomers (as determined by analysis of the crude 
NMR) (Scheme 126). Unfortunately, all attempts to isomerise the Z-to the E-double bond 
with catalytic iodine and/or hi) failed.








In light of the failure to isomerise the Z- to the E-olefin, a more selective olefination 
approach was required. Julia olefination methodology offered one such approach since it is is 
highly E-selective. Thus, treatment of 265 with the anion derived from benzylphenyl sulfone 
followed by in situ quenching with acetyl chloride afforded the crude (3-acetoxy sulfones 273
as a mixture of diastereoisomers. However, better yields were realised by acylation of the 
isolated p-hydroxy sulfones with acetic anhydride in pyridine. Reductive elimination was 
effected by use of the recently reported system127 employing Mg powder in the presence of 
catalytic amounts of HgCl2 in EtOH to afford the olefins 271 and 272 as a 2.6:1 E:Z mixture 
of isomers in an overall yield of 56% (Scheme 127). This ratio was disappointingly low 
since Julia olefination methodology is usually reliable in terms of the reactions high E- 
selectivity.
271 E-isomer: 272 Z-isomer 
2.6 : 1
Scheme 127
Reagents and conditions', i) benzylphenyl sulfone, “BuLi, THF, 0.5h, RT, then 265; ii) acetic anhydride, 
pyridine; iii) Mg powder, HgCl2  (cat), EtOH, 56% overall.
The stereoselective synthesis of the E-olefin 271 was ultimately achieved by means of 
a recently reported129 modification of the Wadsworth-Emmons olefination, employing 
crown ethers. Thus, addition of a mixture of aldehyde 265 and diethylbenzylphosphonate to 
a slurry of NaH in THF containing catalytic amounts of 15-crown-5 exclusively afforded the 










Reagents and conditions: i) diethylbenzylphosphonate, NaH, 15-Crown-5 (cat), THF, 0°C to RT, 1.5h, 70%.
With 271 now in hand, the remaining steps of the sidechain synthesis were completed, 
according to Scheme 129.
Attempted debenzylation of 271 (in the presence of the double bond) with Na in liquid 
ammonia and EtOH at -78°C failed to give any of the alcohol, but gratifyingly, use of 
BCl3.SMe2 in CH2CI2 afforded alcohol 274 in 95% yield.60 Oxidation of 274 to the 
aldehyde 275 with the Dess-Martin periodinane reagent, under the Schreiber modification130 
(addition of up to one equivalent of water to the reaction, vide infra), followed by protection 






Reagents and conditions: i) BCl3 -SMe2 , CH2CI2 , RT, 1.5h, 95%; ii) Dess-Martin periodinane reagent, CH2 CI2 , 
then H2O (1 eq), 15 mins, 94%; iii) 1,3-propanedithiol, 20 mol% BF3 *OEt2 , CH2CI2 ,12h, 100%.
With the 1,3-dithiane 255 now serving as our fully functionalised O  sidechain, we 
now required the aldehyde 218 in order to investigate the coupling to 255.
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While earlier we had obtained aldehyde 218 via Swem oxidation, during the synthesis 
of the C l sidechain, a new batch of the Dess-Martin periodinane (DMP) reagent had been 
prepared.129’ 131 In light of the findings by Schreiber and co-workers that addition of up to 
one equivalent of water had a greatly beneficial effect on the oxidation of alcohols, we re­
investigated the use of the DMP reagent for the oxidation of the bis-acetonide alcohol 212 to 
the corresponding aldehyde 218. This modification now gave the desired aldehyde 218, but 
the yields varied considerably (60%-90%) due to the impracticability of adding the same 
precise amount of water each time for the scale these oxidations were carried out.
Nonetheless, the greater convenience of this procedure over the previously employed 
Swem oxidation made these the conditions of choice for obtaining aldehyde 218.
3.4 Attempted coupling of the C l sidechain 255 to aldehyde 218.
With the dithiane 255 in hand, the final C-C bond forming reaction could be 
investigated which would install the entire carbon backbone of zaragozic acid D.
The standard conditions for anion formation of 2-substituted 1,3-dithianes require 
treatment of the dithiane with nBuLi at -40°C which is then held at -25°C for 1.5h to 
complete deprotonation.113a The solutions remain colourless unless the 2-substituent is an 
aryl group.
However, treatment of dithiane 255 with nBuLi at -40°C resulted in a deep red solution 
on warming to -25°C. After 1.75h at -25°C, the mixture was cooled to -78°C prior to 
addition of aldehyde 218. However, on cooling 255 to -78°C, the solution turned pale yellow 
and it was noticed that the stirrer bar had turned black, much in the same way as it would for 
a dissolving metal reduction in liquid ammonia, possibly indicating that electron transfer 
processes were in operation. Addition of the aldehyde to the mixture resulted in no reaction 











Reagents and conditions: i) “BuLi, THF, -40°C to -25°C, 1.75h, then -78°C, 218.
Many repeats of the reaction always gave the same result, and some interesting 
observations were made when temperature changes were made during the anion formation.
Thus, addition of nBuLi at -78°C resulted in a very pale yellow solution, which turned 
deep orange on warming through the temperature range of -30°C to -24°C. Re-cooling the 
solution to -37°C resulted in a yellow solution, which on warming again to -30°C did not 
turn back to the deep orange colour, but on the contrary, turned an even paler yellow. As 
always, the stirrer bar had turned black. Although the sidechain was usually recovered in 
high yield, the NMR of the recovered sidechain indicated the presence of a small amount 
of another compound. It was not known if a dianion of some description was being formed, 
which might involve deprotonation of a phenyl ring as well as the dithiane. It was also 
speculated that the nBuLi might have been adding to the styrene double-bond, which might 
account for the small amounts of suspected benzylic signals observed in the *H NMR of 
recovered 255.
To this end, a deuterium incorporation study was undertaken. The dithiane 255 was 
treated with nBuLi at -40°C and then held at -25°C for 1.5h. The resultant red solution was 
quenched at -50°C with D2O. It was found that use of a substantial excess of nBuLi (ca. 4
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equivalents) was required to fully incorporate deuterium at the 2-position of the dithiane.
However, due to poor resolution of the nmr spectrum, it was not possible to acertain 
whether deuterium had been incorporated elsewhere in the molecule.
Since direct deprotonation seemed problematic, it was thought that an approach aimed 
at lithiation of a 2-halo- or 2-stannyl-1,3-dithiane might alleviate the problem. Indeed, it was 
reported132 that 2-trimethylstannyl-l,3-dithianes undergo spontaneous transmetallation on 
addition of nBuLi at -100°C (Scheme 131).
Scheme 131
Reagents and conditions: i) “BuLi, THF, -100°C, 5 secs.
We knew we could get complete deuterium incorporation on D2O quenching if a large 
excess of nBuLi was employed, and we therefore hoped that quenching with Me3SnCl under 
the same conditions would generate the 2-trimethylstannyl-1,3-dithiane 276 (Scheme 132).
SnMe;
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Reagents and conditions: i) “BuLi (ca. 4 eq), THF, -40°C to -25°C, 1.5h, then -50°C, D2O.
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Unfortunately, the trimethylstannyl group could not be incorporated using this 
approach.
Given the inherant problems encountered in generating 2-lithio-l,3-dithianes, we 
thought at this stage it would be prudent to investigate the use of a different acyl anion 
equivalent which could be generated under milder conditions.
3.5 Use of protected cyanohydrins as our acyl anion equivalent
Due to the metallation problems with our 1,3-dithiane 255 we had decided to employ a 
different acyl anion equivalent which might prove somewhat easier to metallate. Stork 
reported ethoxyethyl protected cyanohydrins to be useful acyl anion equivalents.133 The 
ethoxyethyl protecting group served to stabilise the resultant a-cyano carbanion, thus 
allowing for the use of aliphatic aldehydes as well as aromatic ones as cyanohydrin 
precursors. The deprotonation was reported to be effected under the mild conditions of LDA 
in THF/HMPA at -78°C after 5 mins. The ketone could be regenerated by hydrolysis of the 
ethoxyethyl protecting group with 5% H2SO4 followed by treatment of the resultant 
cyanohydrin with base (Scheme 133).
Scheme 133
Reagents and conditions', i) LDA, THF/HMPA, -78°C, 5 min, then RiX; ii) 5% H2 S0 4 /Me0 H, iii) NaOH or 
Et3N/acetone.
However, an additional problem in using the ethoxyethyl cyanohydrin would be the 
generation of several other diastereoisomers arising from an additional two chiral centres. 
Therefore, in the hope of reducing by half the number of diastereoisomers that the addition 
reaction would inevitably generate, (a new chiral centre is generated at C7 in the addition 
process), the 1-methyl-1-methoxyethyl protected cyanohydrin 277 was prepared as well as 
the ethoxyethyl protected cyanohydrin 278 (Scheme 134). Thus, treatment of the previously
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obtained aldehyde 275 with TMS-cyanide in CH2CI2 in the presence of cat. Znl2,134 
followed by addition of THF, TFA and H2O afforded the cyanohydrins 279 as a 1:1 
diastereoisomeric mixture. Treatment of 279 with 2-methoxypropene and catalytic p-TsOH 
afforded the 1-methyl-1-methoxyethyl protected cyanohydrins 277 as a 1:1 mixture of 
diastereoisomers.
Treatment of 279 with ethyl vinyl ether and catalytic p-TsOH resulted in a multi- 
component mixture. It was found that ethyl vinyl ether and p-TsOH reacted together 
exothermically giving rise to a brown polymeric mixture. Use of PPTS in place of p-TsOH 
remedied this to afford the ethoxyethyl protected cyanohydrins 278 as a 1:1:1:1 mixture of 
diastereoisomers.
OTBDPS




277 1:1 diastereomeric 
mixture
OTBDPS
278 1:1:1:1 diastereomeric 
mixture
Scheme 134
Reagents and conditions: i) TMSCN, Z11I2 (cat), CH2 CI2 , 0°C to RT, 0.5h, then TFA/THF/H2 O (1:1:1), 
10 mins, 8 8 %; ii) 2-methoxypropene, p-TsOH (cat), 5 mins, 82%; iii) ethyl vinyl ether, PPTS (cat), CH2 CI2 , 
RT, 15h, 84%.
Attempted coupling of either 277 or 278 under the Stork conditions,133 (except with 
the omission of HMPA), to aldehyde 218 resulted in no reacton. When HMPA was 
employed in the coupling of 278 to 218 aldehyde, small amounts of what is believed to be
coupled product 280 (-10%) were isolated (Scheme 135). The NMR of the purified 
components indicated a grossly indistinguishable diastereomeric mixture, but the presence of 
the characteristic olefinic protons and the butyl signal of the TBDPS group of the sidechain, 
and the acetonides from the aldehyde fragment, suggested that the observed products were a 
result of the coupling. The unreacted sidechain was recovered. However, aldehyde 218 had 
disappeared and an inseparable by-product, that appeared by TLC and *H NMR to be the 
bis-acetonide alcohol 212 contaminated with a very similar compound, (thought to be the 
epimer 281), was formed. A likely explanation for this observation is that the LDA had not 
deprotonated 278 to any significant extent and had acted as a hydride transfer agent.
TBDPSO EEO CN OH OH
BnO BnO
Scheme 135
Reagents and conditions: i) LDA, THF/HMPA, -78°C, 5 mins, then 218, lh.
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It was thought that use of the more bulky NaHMDS base might alleviate reduction of 
218 since it is unable to act as a hydride transfer agent. Use of NaHMDS did indeed 
eliminate the hydride transfer process, but offered no improvement in the yield of coupled 
products. Again, the Cl sidechain was recovered intact.
Unfortunately, no conditions could be found to effect the coupling with these protected 
cyanohydrins to ever produce more than 10% of coupled products. The small amounts of 
coupled products, though gross diastereomeric mixtures, were nonetheless converted to the 
ketone 282 (Scheme 136), but no full characterisation was possible and the structures are 
only supported by *H NMR, IR (confirming the presence of the ketone) and Mass Spec.









Reagents and conditions: i) 5% H2 S0 4 /Me0 H, RT, lh; ii) Et3 N/acetone, RT, 4.5h.
The lack of success with the protected cyanohydrin 278 as acyl anion equivalents was 
disappointing and it was unclear why the reaction was always so low yielding. It was not 
clear what the way forward would be with this approach since there seemed little scope for 
modification of the conditions. However, for the previously tried 1,3-dithiane 255, it was 
thought side-reactions, due to the double bond in conjugation with the phenyl group present
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in 255, might in some way be responsible for the failure of the reaction to couple to the 
aldehyde. It was therefore decided to reinvestigate the use of dithianes as the acyl anion 
equivalent, but without the double-bond functionality, with a view to incorporating it at a 
later stage in the synthesis.
3.6 The 1,3-dithiane: revisited.
As mentioned above, we thought that if the double bond was responsible for the 
difficulties encountered in the metallation of dithiane 255, then replacement with a group 
that could allow for its later incorporation should permit continuation of the synthesis 
without too much deviation from our original synthetic plan. We decided that a protected 
alcohol functionality at the terminus of the chain would be suitable to carry out the same 
synthetic procedures once the addition product had been cyclised to the desired 2,8- 







The primary alcohol protecting group was chosen on the basis of: 1) compatibility with 
dithiane metallation conditions, 2) being robust enough to withstand the ketalisation
conditions, and 3) to allow for its selective removal in the presence of the TBDPS- and 
benzyl ethers. This somewhat limited the choice, but the p-methoxybenzyl ether fulfilled all 
three requirements. For this reason, the dithiane 283 was chosen and prepared according to 
Scheme 138.
Thus, homologation of aldehyde 266 as previously detailed (Scheme 125), followed by 
reduction with NaBH4 in MeOH to the corressponding alcohol and subsequent protection 
with acetic anhydride in pyridine/CH2Cl2 gave the acetate 284. Debenzylation of 284 with 
BCl3.SMe2 in CH2CI2, Dess-Martin periodinane oxidation followed by protection with 1,3- 
propanedithiol and catalytic BF3-OEt2 afforded the dithiane 285. Removal of the acetate 
protecting group with K2CO3 in MeOH gave the alcohol 286 in 98% yield. However, 
treatment of 286 with PMBC1, NaH and catalytic BU4NI in DMF led to a mixture of products 
including a meagre 10% 283 which we were unable to isolate in pure form along with 16% 
recovered starting material. It was found that one of the main products formed was alcohol 
287 where the TBDPS group had been removed. Omitting the catalytic BU4NI resulted in 
almost exclusive formation of 287. It was later discovered that it had already been reported 
that use of NaH in HMPA was an extremely efficient method for the deprotection of TBDPS 
ethers,!35 and this would appear to account for the formation of 287. Attempts to protect the 
primary hydroxyl of 286 with p-methoxybenzyltrichloroacetimidate using 0.3 mol% TfOH 
generated a mixture of products. The p-methoxybenzyltrichloroacetimidate reagent had been 
reported as being extremely sensitive to the amount of TfOH employed.136 10 mol% TfOH 
was reported to be sufficient to cause its rapid and complete destruction. It had been 
suggested that use of catalytic CSA instead of TfOH, in CH2CI2, although giving very slow 
reaction rates, proved a superior system.136 Protection of 286 under these conditions was 
indeed slow, and also generated a mixture of components. Again, a low yield of 283 was 


















Reagents and conditions: i) methoxymethyltriphenylphosphonium chloride, PhLi, Et2 0 , 15 mins, then 266 
-78°C, 35 mins then RT, 0.5h, then HCIO4 ; ii) THF/H2 0/TFA (20:5:1), 0.5h, ca. 75%.iii) NaBH4 , MeOH, RT, 
lh, %; iv) acetic anhydride, pyridine, CH2CI2 ,15h, 97%; v) BCl3 -SMe2 , CH2CI2 , RT, 20 mins, 92%; vi) Dess- 
Martin periodinane reagent, CH2 CI2 , then H20  (1 eq), 35 mins, 92%; vii) 1,3-propanedithiol, 20 mol% 
BF3 OEt2, CH2 C12, 16h, 87%; viii) K2 C03, MeOH, RT, lh, 98%; ix) PMBC1, NaH, nBu4 NI (cat), DMF, RT, 
10% 283.
Despite this, the coupling reaction of 283 to aldehyde 219 was investigated under the 
standard anion formation conditions of nBuLi at -25°C for 1.5h. However, no reaction was 
observed, even in the presence of added HMPA (Scheme 139). The bis-silyl ether 288 
(prepared by silylation of 286 with TBDMSC1 and imidazole in DMF) also failed to couple 
in similar conditions.
OTBDPS
2 8 3  P=PMB 
288  P=TBS
Scheme 139
Reagents and conditions: i) “BuLi, THF, -40°C to -25°C, 1.5h, then -78°C, 218.
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However, by this stage we felt there was enough experimental evidence to hypothesise 
that the TBDPS group was a culprit in these attempted metallation reactions. In the 
attempted coupling of the simple dithiane 254 (see 3.1) the reaction turned black under the 
metallation conditions, and failed to give any product. The protection of 286 with NaH and 
PMBC1 led to the removal of the TBDPS group, and indeed was a reported procedure for its 
deprotection, indicating a possible incompatibility of this group towards anions/bases. 
During the Nicolaou synthesis of zaragozic acid A, several sidechains such as ours were 
employed.3ld All added in reasonable yield with just little over one equivalent of the 
sidechain being required. However, when R=TBDPS, a significant excess of the sidechain 
was necessary with respect to the aldehyde fragment, but when R=DTBMS, 1.1 equivalents 
were sufficient, again possibly indicating a problem specific to the TBDPS group (Figure 
23).
It would seem the phenyl groups on silicon might be the cause of the problem. A 
literature survey highlighted several problematic metallations of dithianes containing the
TBDPS group, although no comment ever suggested the 
TBDPS group might be to blame. Lipshutz reported137 that 
the problems of these metallations could be overcome by 
use of NaOlBu and nBuLi which after lh at -78°C, gave 
greatly increased yields of product (Scheme 140).
The rationale behind this combination of reagents were 
several fold. Firstly, the intrinsically stronger base expected from NaOlBu and nBuLi might 
be of a lower aggregation state. Also, although dithianes lithiate with a strong preference for 
the equatorial site, the sodio analogue might have different stereoelectronic/steric demands, 
which might in turn lead to differing reactivity. Once metalated, the sodio analogue should 
exhibit greater reactivity over the lithiated dithiane, due in part to less favourable driving 
forces for oxygen-sodium chelation.
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Therefore the coupling of our original fully functionalised Cl sidechain dithiane 255 to 
aldehyde 218 was re-investigated under the Lipshutz conditions as follows: A suspension of 
NaOlBu and nBuLi were stirred in hexanes at 0°C for lh, then at RT for lh, then pre-cooled 
to -78°C. The dithiane 255 was then added. This mixture was stirred for a further hour at 
-78°C before the addition of aldehyde 218 (Scheme 141). Unfortunately, no coupled product 
was observed, and the dithiane 255 was recovered fully intact. However, none of aldehyde 
218 was recovered. Instead, the epimerised aldehyde 289 and a mixture of products which 










Reagents and conditions: i) nBuLi/NaOtBu, THF, -78°C, lh, then 218.
This last reaction marks the present state of affairs with this route toward zaragozic 
acid D. The synthesis of zaragozic acid D has so far been thwarted by our inability to couple 
the C l sidechain to the key aldehyde 218. Many months of frustrated effort have been 
directed solely at achieving this coupling. Although it has been very disappointing not to 
have achieved the total synthesis, it is hoped that the following section might offer some 
possible way forward for future workers.
3.7 Conclusions and further work.
The novel and challenging structure of the zaragozic acids, along with their potent 
biological activity, have made these compounds a major target for the international 
community of synthetic organic chemists. Our efforts in this field have led us to report138 the 
concise synthesis of the model core 133, via the key aldehyde 218 (Scheme 142). A Stille 
cross-coupling between the stereodefined alkenes 136 and 157 afforded the stereochemically 
pure 1,3-diene 182 in excellent yield. A novel variation of the Sharpless asymmetric 
dihydroxylation (AD) was used to control stereochemistry at four contiguous stereocentres
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of the core to give the pentaol 208 (78% ee, diastereomeric ratio >9:1). This is one of the 
first examples of enantioselective exhaustive dihydroxylation of a 1,3-diene. This use of 
Stille coupling methodology in conjunction with the Sharpless AD provides a powerful new 
approach to polyol synthesis. Addition of 2-lithio-2-methyl-l,3-dithiane to 218 to introduce 
the Cl-side chain, followed by deprotection and ketalisation afforded the model bicyclic core 
133.
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Scheme 142: Summary of our model core synthesis
To illustrate our approach beyond the synthesis of a model core, we chose zaragozic 
acid D as our target for total synthesis. We have accomplished the synthesis of the C l side 
chain 255 of zaragozic acid D in enantiomerically pure form, with absolute and relative 
stereochemistry being controlled by Evans aldol methodology. Efforts to couple this 
sidechain, and several other sidechain derivatives, to the key aldehyde 218, have failed as a 
result of metallation problems.
However, a large range of options are still available. For example, Danishefsky139 
reported that a mixture of KO ^u and nBuLi (the so-called LICKOR base) at -78°C required 
only 20 minutes to completely effect the metallation of a complex 2-substituted-l,3-dithiane 
containing silyl ether groups. In addition, the literature shows that metallation of dithianes 
containing the TBDPS protecting group can, for the majority cases, be effected by use of 
tert-butyl lithium. Therefore, it is thought that employing either of these conditions should
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lead to the coupling of 255 to aldehyde 218, and a proposed route for the completion of the 
synthesis of zaragozic acid D is shown in Scheme 143.
Addition of dithiane 255 under one of the above sets of conditions, is expected to 
generate a mixture of stereoisomers at C7, as was the case in our model study. It is hoped 
that the desired diastereomer will again be readily separable. Following removal of the 
dithiane group, acid-promoted ketalisation will afford the desired 2,8- 
dioxabicyclo[3.2.1]octane core 290 now containing the fully functionalised C l sidechain. 
Acetylation of the C6 and C7 hydroxyls of 290 and simultaneous removal of the three 
benzyloxy protecting groups will set the stage for an unprecedented triple oxidation of the 
triol 291 to the triacid 293 via the trialdehyde 292. A possible problem inherent in the 
oxidation of any 1,4-diol is cyclisation of an intermediate hydroxy aldehyde to the lactol and 
subsequent oxidation to the lactone, effectively preventing complete oxidation of one of the 
original alcohols. However, use of the Swem oxidation ((C0C1)2 / DMSO) should overcome 
this problem since the aldehyde is only generated after addition of triethylamine. Since all 
three alcohols would be activated prior to this, an in situ protection of the alcohols would be 
effected, thereby inhibiting potential cyclisation to a lactol. Indeed, there is precedent for use 
of the Swem oxidation to convert 1,4-diols to the corresponding dialdehydes,140 and it is 
hoped that this transformation can be applied to our more complex triple oxidation of triol 
291. Carreira has recently shown that a trialdehyde similar to 292 (prepared by sequential 
oxidations) can be oxidised to the acid with buffered NaClC>2 and converted to the 
corresponding tris rm-butyl ester.32 It is therefore hoped that application of these steps to 
our trialdehyde 292 should give the corresponding tris rm-butyl ester 294.
All subsequent remaining steps of the synthesis will follow recent precedent by 
Carreira. Selective Boc protection of the C7-OH will leave the C6-OH free to allow 
esterification at the C6 hydroxyl.32 Fluoride-mediated removal of the TBDPS group, 
acetylation of the side-chain hydroxyl, and simultaneous removal of the Boc- and lBu esters 











v j j f  291 X= CH2OH 
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294Z ara g o z ic  ac id  D
Scheme 143
Reagents and conditions: i) metallated 255; ii) Hg(C1 0 4 >2 , CaC0 3 , THF:H2 0 ; iii) H+; iv) AC2 O; v) 
Debenzylation; vi) Swem oxidation; vii) NaC102; viii) lBu esterification; ix) Acetate removal (K2 CO3 , 






and 13C NMR spectra were recorded in CDCI3 on either Jeol GX-270, Jeol EX-400, Jeol 
FX-270, Bruker AM 250, Bruker AM 400, or Bruker DRX 500 machines or an Hitachi 
Perkin-Elmer R-24B 60 MHz NMR spectrometer, using residual protic solvent (CHCI3, 
8h = 7.26 ppm) or CDCI3 (8c=77.0 ppm, t) as internal reference. Coupling constants are 
measured in Hertz and have been read directly from the peak printout, and hence are quoted 
uncorrected. The multiplicities in 13C spectra were determined by DEPT experiments. Infra­
red spectra were run on a Perkin-Elmer 1605 FT-IR machine and were run from 4000-600 
cm-1. Mass spectra were recorded under conditions stated for that particular compound, 
using a VG-7070B, VG Micromass 70E, VG Biotech Quattro II, VG ZAB-E or VG 
Autospec; Microanalyses were performed at either the microanalytical laboratories of the 
University of Bath or Nottingham. Optical rotations were measured using a JASCO DIP- 
370 digital polarimeter. Column chromatography was performed on Merck Kieselgel 60 
(230-400 mesh) unless otherwise stated. Diethyl ether and tetrahydrofuran solvents were 
distilled from sodium-benzophenone ketyl; toluene from sodium and dimethylformamide, 
dichloromethane and N-methylpyrollidinone from calcium hydride. Petrol refers to 
petroleum ether b.p. 60-80°C which was distilled prior to use. Other solvents and reagents 
were purified by standard procedures as necessary. 141 Analytical thin layer chromatography 
was performed using pre-coated glass-backed plates (Merck Kieselgel 60 F254) and 
visualised by ultra-violet light and/or acidic eerie ammonium molybdate, polyphosphoric 






To a stirred solution of 2-but-2-yne-l,4-diol 134 (4.30 g, 50 mmol) in dry THF (150 ml) 
containing Pd(PPh3)2Cl2 (700 mg, 1 mmol, 2 mol%) was added tributyltin hydride (14.6 ml, 
55 mmol) dropwise over 6 mins. After 5 mins, more tributyltin hydride (1.3 ml, 5 mmol) 
was added in one portion. The reaction immediately darkened and was concentrated in 
vacuo. The residual brown oil was purified by FCC (20%-100% EtOAc/Petrol) to give the 
title compound 135 (16.90g, 90%) as a yellow oil. The data obtained were consistent with 
the literature;142 8h  (270 MHz, CDCI3) 5.80 (1H, tt, J  6 Hz, 2 Hz, 37SnH 68Hz), 4.40 (2H, s, 
3/SnH 36 Hz), 4.21 (2H, d, J  6 Hz), 1.70 (2H, bs), 1.60-1.20 (18H, m), 0.90 (9H, t, J 7 Hz).
Preparation of (Z?>l,4-Bis-(benzyIoxy)-2-(tri-n-butylstannyl)-2-butene 136
To a stirred solution of diol 135 (3.04 g, 8.05 mmol) in dry DMF (30 ml) under N2 was 
added NaH (445 mg, 18.53 mmol) followed by tetrabutylammonium iodide (152 mg, 0.40 
mmol, 5 mol%) and benzyl bromide (2.10 ml, 17.70 mmol). The reaction was stirred in the 
dark for 2.5h, then filtered (fluorosil) washing through with Et2 0 . The Et20 layer was 
separated, and the DMF extracted with Et20 (x3). The ethereal layers were combined, dried 
(MgS04), filtered and evaporated under reduced pressure. The residual yellow liquid was 
purified by FCC (0-6% Et20/petrol) to give the title compound 136 (3.2g, 71%) as a clear 
oil, Vmax(film)3030, 2954, 2923, 2852, 1496, 1454, 1358, 1091, 1028, 735, and 697 cm’1; 
5H (270 MHz, CDCI3) 7.31-7.17 (10H, m, Ph), 5.71-5.66 (1H, m, CH=), 4.42 (2H, s, 
PhCi/2), 4.40 (2H, s, PhCtf2), 4.09 (2H, d, J  1.3 Hz, CH2), 3.96 (2H, d, 7 5.7 Hz, CH2), 




m/z (El) 501 (M+-C4H9), 451 (M+-PhCH20), 291 (120Sn(C4H9)3), 91 (PhClfe); found: C, 
64.9; H, 8.37. C30H46O2S11 requires C, 64.7; H, 8.32%.
Preparation of (Z)-2-Iodo-2-butene-l,4-diol 142
HO OH
l _ = _ l
134
To a stirred slurry of LiAlH4 (3.10 g, 81.6 mmol) in dry ether (100 ml) under N2 was added 
2-butyne-l,4-diol 134 (4.30 g, 50 mmol) in dry THF (170 ml+ 30 ml washing) dropwise 
over 25 mins via cannula. The mixture was heated at reflux for lh 20 mins and then the 
excess LiAlH4 was quenched with dry EtOAc (50 ml) at 0°C. The reaction was cooled to 
-78°C and quenched with iodine (48.5 g, 200 mmol) in dry THF (150 ml) and ether (100 ml) 
via cannula over 8 mins. The mixture was stirred at -78°C for 25 mins, then diluted with 
EtOAc (100 ml) and poured onto basic saturated aqueous sodium thiosulfate solution (200 
ml). The aqueous phase was saturated with solid NaCl, and the organic layer was separated. 
The aqueous layer was extracted with EtOAc (4 x 100 ml), the organics combined, then 
washed with saturated aqueous sodium thiosulfate (3 x 100 ml), dried (MgS04), filtered and 
evaporated under reduced pressure. The residual orange oil was pre-adsorbed onto silica gel 
(silica-methanol) prior to purification by FCC (40-80% EtOAc/petrol) to give the title 
compound 142 (6.63 g, 62%) as a yellow oil, vmax(filni) 3303, 3183, 1648, 1233, 1079, 
1033, 978, and 959 cm-l; 5h (400 MHz, CDCI3) 6.31-6.20 (1H, m, CH=), 4.36-4.20 (4H, m, 
CH2), 2.50 (1H, br, OH)\ 8C(100 MHz, CDCI3) 133.5, 107.6, 71.2 , 66.7 ; m/z (El) 214 
(M+), 196,183, 168, 127; observed: M+, 213.9489. C4H7IO2 requires M+ 213.9491.
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Preparation of 4-(terf-butyldimethyIsiloxy)-2-butyn-l-ol 149
HO OH TBSO OH
134 149
To a cooled (0°C), stirred solution of 2-butyne-l,4-diol 134 (0.50 g, 5.81 mmol) in dry 
DMF (15 ml) under N2 was added NaH (153 mg, 6.10 mmol). The mixture was stirred at 
RT for lh and then TBDMSC1 (0.92 g, 6.10 mmol) was added at 0°C. The reaction was 
stirred at 0°C for 3.5h, then at RT for 16h before the addition of saturated aqueous NH4CI 
(10 ml). The mixture was extracted with Et20 (3 x 30ml) and the extracts combined and 
washed with saturated aqueous NH4CI (3 x 20ml) and saturated aqueous brine (3 x 20ml), 
then dried (MgSCU), filtered and evaporated under reduced pressure. The residue was 
purified by FCC (5-30% Et20/petrol) to give the title compound 149 (497 mg, 42%) as a 
colourless liquid; the data obtained were consistent with the literature;142 8h (400 MHz, 
CDCI3) 4.34 (2H, t, J  1.8 Hz, CH2O), 4.28 (2H, t, J  1.8 Hz, CH2O), 2.20 (1H, bs, OH), 0.90 
(9H, s, tBu), 0.11 (6 H, s, Me2Si).
Preparation of 3-(BenzyIoxy)propyne 295
To a cooled (0°C), stirred solution of propargyl alcohol 158 (10 ml, 171 mmol) in dry DMF 
(100 ml) was added NaH (4.93 g, 205 mmol) portionwise, followed by tetrabutylammonium 
iodide (3.17 g, 8.58 mmol) and benzyl bromide (22.4 ml, 188 mmol). The reaction was 
allowed to warm to RT and stirred in the dark for 24h before the addtion of saturated 
aqueous NH4CI. The mixture was extracted with Et20 (x3). The ethereal layers were 
combined and washed with 2M NaOH (x2), water (x2), and saturated aqueous brine (x2), 
then dried (MgSC>4), filtered and evaporated under reduced pressure. The residual orange oil 




yellow liquid; the data obtained were consistent with reported literature;143 vmax(film) 3292, 
3064, 3031, 2856, 2116, 1724, 1496, 1454, 1355, 1075, 1028, 936, 741 and 698 cm-l; 5H 
(60 MHz, CDCI3) 7.4-7.2 (5H, m, Ph), 4.6-4.4 (2H, m, PhCtf2OCH2), 4.2-4.0 (2H, m, 
PhCH2OCi/2), 2.5-2.3 (1H, m, O C tf).
Preparation of Ethyl 4-(benzyIoxy)-2-butynoate 156
BnO
I---- = = —  COgEt
156
To a cooled (-78°C), stirred solution of 295 (11.57g, 79.2 mmol) in dry THF (400 ml) was 
added nbutyl lithium (36.4 ml, 2.5 M solution in hexanes, 91.10 mmol) over 25 mins under 
N2. After lh, ethyl chloroformate (15.13 ml, 158.4 mmol) was added dropwise over 12 
mins. The temperature was raised to 0°C and the mixture stirred for 50 mins before 
quenching with saturated aqueous NaHCC>3 (250 ml). The mixture was allowed to warm to 
RT and stirred for a further 50 mins before partitioning between water (150 ml) and CH2C12 
(200 ml). The aqueous layer was extracted with CH2C12 (2 x 100ml) and the organics 
combined then dried (MgSC>4), filtered and evaporated under reduced pressure. The residue 
was purified by FCC (10% Et20/petrol) to give the title compound 156 (14.5 g, 84%) as a 
yellow liquid; the data obtained were consistent with the literature;144 §h(60 MHz, CDCI3) 
7.35-7.2 (5H, m, Ph), 4.5 (2H, m, PhCtf2OCH2), 4.12 (2H, m, PhCH2OCJ/2), 4.11 (2H, q, J  
7.0 Hz, C 0 2C //2CH3), 1.16 (3H, t, J1.0  Hz, C 02CH2CH3).
Preparation of (Z)-Ethyl 4-(benzyloxy)-3-iodo-2-butenoate 157
BnO
I £ = ■ C02Et
156
To a stirred solution of 156 (9.22 g, 42.30 mmol) in glacial acetic acid (40 ml) was added 




to RT. The mixture was evaporated in vacuo (azeotroping with toluene) and the residue was 
taken up in Et20 and filtered to remove the inorganics. Additional Et2<D was added and 
washed with saturated aqueous NaHCC>3 (x5). The aqueous layers were combined and back 
extracted with Et20 (x3), and the ethereal layers combined and washed with saturated 
aqueous sodium thiosulfate (x3), then water (x2) and saturated aqueous brine (x3). The 
organics were dried (MgSC>4), filtered and evaporated under reduced pressure. The residue 
was purified by FCC (10% Et20/petrol) to give the title compound 157 (14.67 g, 100%) as a 
pale yellow liquid, vmax(film) 3030, 2980, 2865,1726,1632, 1496,1454,1365,1286,1177, 
1106, 1051, 857, 738 and 698 cm"1; 8H(400 MHz, CDC13) 7.30-7.16 (5H, m, Ph), 6.73 (1H, 
t, J  1.8 Hz, CH=), 4.48 (2H, s, PhC/72OCH2), 4.16 (2H, d, J  2.1 Hz, PhCH2OC^2), 4.15 
(2H, q, J  7.0 Hz, C 02C//2CH3), 1.22 (3H, t, J  7.0 Hz, C 02CH2C ^ 3); 8c(100 MHz, CDCI3)
164.3, 137.0, 128.4, 127.9, 127.6, 123.7, 115.8, 78.9, 72.4, 60.6, 14.1; m/z (El) 346 (M+), 
301, 254, 240, 226, 209, 198,189, 143,127, 113, 91,77; found: C, 45.5; H, 4.6. C13H15IO3 
requires C, 45.1; H, 4.4%).












Vinyl iodide 180 (80 mg, 0.18 mmol) was dissolved in dry DMF (1 ml). The solution was 
degassed with N2 for 10 mins prior to the addition of ZnCl2 (49 mg, 0.36 mmol) followed 
by fri-(2-furyl)-phosphine (1.7 mg, 0.07 pmol) and Pd2(dba)3 (1.6 mg, 0.04 jimol Pd). The 
solution was stirred for 10 mins until the purple colour had discharged before the addition of 
the vinyl stannane 136 (110 mg, 0.20 mmol) neat, rinsing in with DMF. The mixture was 
heated at 88°C for 24h and then allowed to cool to RT before the addition of 10% NH4OH
157
(1 ml). After 5 mins the mixture was extracted with Et20 (x3) and the extracts were 
combined and washed with water (x2), saturated aqueous brine (x2), then dried (MgS04), 
filtered and evaporated under reduced pressure. The residue was purified by FCC (0-15% 
Et20/petrol) to give the title compound 181 (28 mg, 27%) as a clear oil, vmax(film) 3055, 
3029, 2953, 2929, 2885, 2857, 1496, 1471, 1386, 1362, 1254, 1070, 1004, 939, 836, 780, 
736, 697 and 670 cm-1; 5H(270 MHz, CDC13) 7.33-7.17 (10H, m, Ph), 5.65 (1H, t, J  6.4 Hz 
with finer coupling, CH=), 5.55 (1H, t, J  6.6 Hz with finer coupling, CH=) 4.43 (2H, s, 
PhC//2OCH2), 4.35 (2H, s, PI1C//2OCH2) 4.21 (2H, d, J  6.4 Hz with finer coupling, 
PhCH2OCtf2CH=), 4.12 (2H, d, J  1.3 Hz, PhCH2OCtf2C=CH), 4.08 (2H, d, J  6.4 Hz, 
SiOCi/2CH=) 3.96 (2H, s, SiOCtf2C=CH), 0.82 (9H, s, tBu), 0.81 (9H, s, tBu), -0.03 (12H, 
2s, 2x Me2Si); 5c(100 MHz, CDCI3) 141.5,136.8,130.8,128.4, 128.3, 127.7,127.6,126.3,
72.4, 72.1, 67.2, 66.0, 65.7, 60.6, 26.0, 25.9, -5.0, -5.3; m/z (Cl, iso-butane) 582 (M+), 475, 
451, 417, 391, 367, 327, 237, 211, 181, 133, 107, 91; found: C, 70.2; H, 9.4. C34Hs404Si2 
requires C, 70.1; H, 9.3%.
Preparation of (Z^)-E thyl 6-benzyloxy-(3,4-ftis-(benzyIoxymethyl))-2,4-hexadienoate 
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Vinyl iodide 157 (16.50 g, 47.69 mmol) was dissolved in dry DMF (170 ml). The solution 
was degassed by ultrasonication under argon flow before the addition of ZnCl2 (13.00 g, 
95.37 mmol), P(2-furyl)3 (332 mg, 1.91 mmol) and Pd2(dba)3 (665 mg, 0.95 mmol). The 
solution was stirred under argon for 25 mins before the addition of the vinyl stannane 136 
(31.93 g, 57.22 mmol) neat via cannula, rinsing in with DMF (10 ml). The mixture was 
heated at 65°C for 20h and then allowed to cool to RT. The mixture was then poured into a
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separating funnel containing saturated aqueous NH4CI (150 ml) and Et20 (200 ml). The 
ethereal layer was separated and the aqueous layer extracted with Et20 (4 x 150 ml). The 
organics were combined and washed with saturated aqueous sodium thiosulfate (2 x 100 
ml), H2O (1 x 100 ml) and saturated brine (3 x 100 ml), then dried (MgSC>4), filtered and 
evaporated under reduced pressure. The residue was purified by FCC (15% EtOAc/petrol) to 
give the title compound 182 (19.93 g, 86%) as a pale yellow oil, vmax(film) 3063, 3030, 
2978, 2858, 1716, 1636, 1496, 1454, 1377, 1362, 1332, 1212,1162, 1096,1074, 1028, 872, 
737 and 698 cm’1; 5H(270 MHz, CDCI3) 7.25-7.17 (15H, m, Ph), 6.00 (1H, d, J  1.8 Hz, 
E t02CCtf=), 5.56(1H, t, J  6.4 Hz, BnOCH2Ctf=) 4.48 (2H, s, PhCtf2OCH2), 4.43 (2H, s, 
PhCtf2OCH2) 4.37 (2H, s, PhCtf2OCH2), 4.15 (2H, s, CH2O), 4.10-3.99 (6H, m, includes
4.08 (2H, d, J  6.4 Hz, BnOCtf2CH=), 4.04 (2H, q, 77.0 Hz, CO2CH2CH3)), 1.16 (3H, t, J
7.0 Hz, C 02CH2Ctf3); 8C(100 MHz, CDCI3) 165.8 (s), 156.6 (s), 138.1 (s), 137.8 (s), 128.9 
(d), 128.4 (d), 128.3 (d), 127.9 (d), 127.7 (d), 127.64 (d), 127.59 (d), 115.4 (d), 73.2 (t), 72.6 
(t), 72.2 (t), 68.0 (t), 65.9 (t), 59.9 (t), 14.2 (q); m/z (Cl, iso-butane) 487 (M+), 441, 421, 
395, 379, 365, 289, 273, 181, 107, 91; found: C, 76.4; H, 7.2. C31H34O5 requires C, 76.5; 
H, 7.0%.







To a cooled (-40°C), stirred solution of dienic ester 182 (32.44 g, 66.75 mmol) in dry 
CH2CI2 (150 ml) was added DIBAL-H (140 ml, 1.0 M solution in CH2CI2, 140 mmol) 
dropwise under argon over 30 mins. The temperature was raised to -20°C and maintained 
for lh, then quenched at -10°C by careful addition of dry MeOH (10 ml). The mixture was
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then stirred at 0°C and then a solution of Rochelle's salt (33 ml of saturated solution in 200 
ml H2O) was cautiously added in 4 portions. The mixture was then allowed to warm to RT 
and stirred for 30 mins. The organic phase was separated and the aqueous phase was 
acidified with 2M HC1 until all the aluminium salts had dissolved, then extracted with 
CH2CI2 (4 x 150 ml). The organics were combined, then washed with 2M HC1 (2 x 100 ml), 
H2O (1 x 100 ml), saturated aqueous brine (2 x 100 ml), then dried (MgSC>4), filtered and 
evaporated under reduced pressure. The residual yellow oil was purified by FCC (50-70% 
Et20/petrol) to give the title compound 205 (27.86 g, 94%) as a clear oil, vmax(film) 3421, 
3062, 3029, 2856, 1496, 1453, 1362, 1093, 1071, 1027, 737 and 698 cm '1; 8h (270 MHz, 
CDCI3) 7.35-7.24 (15H, m, Ph), 5.90 (1H, t, J  7.1 Hz, CH=), 5.64 (1H, t, J  6.4 Hz, CH=), 
4.48 (2H, s, PhCtf20), 4.45 (2H, s, PhCff20), 4.43 (2H, s, PhCff20), 4.20-4.09 (4H, m, 
PhCH20 CH2 and =CHC//2OH), 4.05 (4H, s, 2x PhCH2OC/J2), 2.04 (1H, t, J  6.4 Hz, OH)\ 
5C(100 MHz, CDCI3) 140.9, 138.1, 138.0, 137.5, 136.6, 130.7, 129.1, 128.5, 128.4, 128.3, 
127.9, 127.8, 127.7, 127.6, 73.0, 72.8, 72.2, 71.8, 66.1, 65.6, 59.1; m/z (+FAB) 467 
(M+Na), 445 (M+H), 427, 391, 369, 351, 337, 321, 307, 289, 273, 259, 245, 229, 215; 
found: C, 78.7; H, 7.4. C29H32O4 requires C, 78.4; H, 7.3%.









To a stirred solution of dienic alcohol 205 (0.88 g, 1.98 mmol) in dry DMF (1.5 ml) under 
argon was added imidazole (336 mg, 4.94 mmol) followed by TBDMSC1 (357 mg, 2.371 
mmol). The mixture was stirred for 16.5h before quenching with saturated aqueous NH4CI. 
The mixture was then extracted with Et20 (x3). The ethereal layers were combined then
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washed with water (x3) and saturated aqueous brine (x3), then dried (MgSCU), filtered and 
evaporated under reduced pressure. The residual yellow liquid was purified by FCC (15% 
Et20/petrol) to give the title compound 201 (0.96 g, 87%) as a clear liquid, vmax(film) 3065, 
3030, 2955, 2929, 2885, 2857, 1496, 1471, 1388, 1361, 1254, 1071, 1004, 939, 836, 780, 
735, 697 and 670 cm-1; 5h (270 MHz, CDCI3) 7.30-7.20 (15H, m, Ph), 5.72 (1H, t, J  6.2 
Hz, CH=\ 5.62 (1H, t, J  6.4 Hz, CH=), 4.46 (2H, s, PhCtf20),4.42 (2H, s, PhCtf20), 4.36 
(2H, s, PhCtf20 ), 4.31 (2H, d, J  6.2 Hz, PhCH2OCtf2), 4.13 (2H, d, /  6.2 Hz, 
PhCH2OCtf2), 4.06 (2H, s, PhCH2OCff2), 4.05 (2H, s, PhCH2OCff2); 8C(100 MHz, 
CDCI3) 138.8, 138.3, 138.2, 138.1, 136.9, 131.0, 130.9, 128.4, 128.3, 128.1, 128.0, 127.8, 
127.7, 127.6, 127.5, 73.0, 72.3, 72.0, 71.6, 66.4, 65.8, 60.5, 25.9, 18.3; m/z (+FAB) 531, 
513, 489, 475, 461, 441, 423, 409, 379, 363, 351, 327, 283, 268, 253, 231, 221, 211, 195, 
181, 147, 133, 113, 105, 91; found: C, 74.8; H, 8.4. C35H4604Si requires C, 75.2; H, 8.3%.









To a stirred solution of dienic alcohol 205 (255 mg, 0.57 mmol) in CH2C12 (1.0 ml) was 
added p-anisoyl chloride (118 mg, 0.69 mmol) followed by DMAP (cat) and Et3N (120 |il, 
0.86 mmol). After 3h, the mixture was partitioned between saturated aqueous NH4CI and 
CH2C12, and the organic layer separated. The aqueous layer was extracted with CH2C12 (3 x 
5 ml) and the combined organics were washed with 2M HC1 (1 x 10 ml), H20  (1 x 10 ml) 
and saturated aqueous brine (3 x 10 ml), then dried (MgSC>4), filtered and evaporated under 
reduced pressure. The residual yellow oil was purified by FCC (30% Et20/petrol) to give
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the title compound 215 (0.96 g, 87%) as a clear liquid, vmax(film) 3062, 3030, 2922, 2854, 
1711, 1606, 1581, 1511, 1496, 1454, 1360, 1316, 1257, 1168, 1100, 1073, 1028, 848, 771, 
738 and 698 cm-*; 5h (270 MHz, CDC13) ; m/z (+FAB) 601 (M+Na), 579 (M+H), 229,181,
165,135,123, 107; observed: M+H, 579.2769. C37H39O6 requires M+H, 579.2747.
Preparation of (2R, 3R, 4Zs)-2,3-dihydroxy-6-benzyloxy-(3,4-Zus-(benzyIoxymethyl))-4- 
hexen-l-ol 206 and (45, 55 ,2Z)-4,5-dihydroxy-6-benzyIoxy-(3,4-£w- 
(benzy!oxymethyI))-2-hexen-l-ol 207 and (2R, 35,4R, 55)-2 ,3 ,4 ,5-tetrahydroxy-6- 
















To a vigorously stirred, cooled (0°C) solution of dienic alcohol 205 (600 mg, 1.35 mmol) in 
lBuOH (2.2 ml) and H2O (2.2 ml) was added AD-mix-P (1.89 g) followed by K2S2O8 (729 
mg, 2.7 mmol), (DHQD)2-PHAL (105 mg, 0.13 mmol), OSO4 (14 mg, 0.05 mmol) and 
CH3SO2NH2 (256 mg, 2.70 mmol). The reaction was then allowed to warm to RT, and after 
4d additional (DHQD)2-PHAL (210 mg, 0.27 mmol) was added. After a further 5d, solid 
Na2S(>3 (1.5 g) and EtOAc were added and the mixture stirred for 3h, then filtered and the 
solid residues re-extracted with EtOAc (x4). The filtrate and EtOAc extracts were combined 
and dried (MgS0 4 ), filtered and evaporated under reduced pressure. The residue was 
purified by FCC (80-100% Et20/petrol then 100% EtOAc) to give a mixture of the two 
triols 206 and 207 (504 mg) and the pentaol 208 as an 8:1 diastereomeric mixture (71 mg, 
10%) all as clear oils; full data of pentaol as given in new AD procedure below; 5h (270 
MHz, CDCI3) 7.38-7.21 (15H, m, Ph), 4.57-3.40 (18H, m), 2.67 (1H, bs, OH), 1.27-1.07 
(2H, m); 8C(100 MHz, CDCI3) 137.6, 136.9, 136.2, 128.9, 128.8, 128.7, 128.6, 128.5,
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128.4, 128.3, 128.2, 128.13, 128.05, 128.0, 127.9, 78.7, 77.7, 74.1, 73.9, 73.5, 73.2, 71.5,
71.4,70.5, 70.4, 63.2,.
Typical one-phase AD:
To a stirred solution of dienic alcohol 205 (440 mg, 1.00 mmol) in acetone (2.0 ml) was 
added NMO (585 ml, 5.12 M solution in H20, 3.00 mmol) followed by (DHQD)2PHAL (39 
mg, 0.05 mmol) and OSO4 (2.5 mg, 0.01 mmol). After a total of 6d, solid sodium 
metabisulfite and CH2CI2 was added and the mixture stirred for lh, then dried (MgSC>4), 
filtered and evaporated under reduced pressure. The residual brown oil was purified by FCC 
(75-100% EtOAc/petrol) to give the pentaol 208 (380 mg, 74%) as a clear oil, data as given 
in new AD procedure below.147











A 1L 3-necked flask was charged with lBuOH (130 ml) and H2O (160 ml). To this was 
added AD-mix-P (44 g) followed by (DHQD)2PHAL (1.23 g, 1.58 mmol), OSO4 (80 mg, 
0.32 mmol), K2S2O8 (17.05 g, 63.06 mmol), and CH3SO2NH2 (5.99 g, 63.06 mmol). This 
mixture was stirred well for 20 min, then cooled to 0°C before dropwise addition of dienic 
alcohol 205 (14.00 g, 31.53 mmol) in lBuOH (30 ml). The reaction came to RT after a few 
hours and stirring was continued for an additional 4 d at RT, after which time solid Na2SC>3 
(45 g) and EtOAc (300 ml) were added and the mixture stirred for lh. The organic layer was 
separated and the aqueous layer extracted with EtOAc (3 x 150 ml). The combined organics
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were washed sequentially with 2M KOH (3 x 100 ml), H2O (2 x 100 ml) and brine (3 x 100 
ml), then dried (MgSC>4), filtered and evaporated under reduced pressure. The residue was 
purified by FCC (80% Et20/petrol) to give the triols 206 and 207 (11.75 g, 78%). To a 
stirred solution of the triols 206 and 207 (11.75 g, 24.58 mmol) in acetone (47 ml) and H2O 
(9 ml) was added (DHQD)2PHAL (957 mg, 1.23 mmol) and OSO4 (63 mg, 0.25 mmol) 
followed by NMO (5.76 g, 49.16 mmol). After 3.5d solid Na2S20s was added, followed by 
CH2CI2 (100 ml). After a further lh, the mixture was filtered, evaporated under reduced 
pressure, and azeotroped with benzene. The residual black oil was purified by FCC (75- 
100% EtOAc/petrol) to give the title compound 208 as a >9:1 diastereomeric mixture (7.30 
g, 58%) as a clear oil, [a]o +4.5 (c 1.0 in CHCI3) @ ca. 76% ee; vmax(film) 3423, 3013, 
2928, 2872, 1494, 1453, 1366, 1214, 1078 and 754 cm-*; 5h (270 MHz, CDCI3) 7.38-7.21 
(15 H, m, Ph), 4.57-3.40 (18 H, m), 2.67 (1 H, bs, OH), 1.27-1.07 (2 H, m); 5C(100 MHz, 
CDCI3) 137.6, 136.9, 136.2, 128.9, 128.8, 128.7, 128.6, 128.5, 128.4, 128.3, 128.2, 128.13,
128.05, 128.0,127.9, 78.7,77.7, 74.1, 73.9, 73.5, 73.2, 71.5, 71.4, 70.5,70.4, 63.2; m/z (Cl, 
iso-butane) 513 (M+H), 391, 369, 309, 279, 257, 229, 181,154,123, 107,91, 69; found: C, 
67.6; H, 7.1. C29H36O8 requires C, 68.0; H, 7.1%.
Preparation of (2R, 3R, 4R, 5S)-6-benzyIoxy-(3,4-£is-(benzyloxymethyl))-l- 











To a cooled (0°C) stirred solution of pentaol 208 (14.58g, 28.48 mmol) in CH2CI2 (100 ml) 
was added pivaloyl chloride (4.14 ml, 34.17 mmol) followed by DMAP (173 mg, 1.42 
mmol) and pyridine (3.46 ml, 42.7 mmol). The reaction was then allowed to come to RT 
and stirred for 16h, then quenched by addition of saturated aqueous NH4CI (50 ml). The
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organic layer was separated and the aqueous extracted with CH2CI2 (4 x 50 ml). The 
organics were combined then washed with 2M HC1 (3 x 50 ml), H2O (2 x 50 ml), saturated 
aqueous NaHCC>3 (2 x 50 ml), H2O (1 x 50 ml), saturated aqueous brine (2 x 50 ml), then 
dried (MgSC>4), filtered and evaporated under reduced pressure. The residue was purified by 
FCC (60% Et20/petrol) to give the title compound 211 (13.07 g, 77%) as a pale yellow oil, 
[«]d +7.4 (c 1.0 in CHCI3), vmax(film) 3442, 3030, 2929, 2870, 1724, 1454, 1366, 1285,
1164, 1098, 911, 740 and 698 cm-1; 8H(400 MHz, CDCI3) 7.37-7.17 (15H, m,Ph), 4.53- 
4.18 (10H, m, includes 4.52 (1H, d, /11 .2  Hz), 4.50(4H, s, OCtf2Ph), 4.40 (2H, dd, J  19.3 
Hz and 6.5 Hz), 4.35 (1H, d, J  8.8 Hz), 4.32 (1H, d, J  11.7 Hz), 4.24 (1H, d, J  11.2 Hz)),
4.17 (1H, s, 3° OH), 4.07 (1H, s, 3° OH), 3.78 (2H, dd, J  16.6 Hz and 10.3 Hz), 3.66-3.63 
(3H, m, includes 3.64 (1H, d, J  8.8 Hz)), 3.54 (1H, bs, 2° OH), 3.45 (1H, d, J  10.3 Hz), 
1.20 (9H, s, Wu); 8C(100 MHz, CDCI3) 178.9 (s), 137.6 (s), 136.9 (s), 136.3 (s), 128.6 (d),
128.5 (d), 128.5 (d), 128.3 (d), 128.2 (d), 128.0 (d), 127.9 (d), 127.7 (d), 78.2 (s), 77.1 (s),
74.0 (t), 73.8 (t), 73.5 (t), 72.7 (d), 71.6 (d), 71.2 (t), 70.7 (t), 70.4 (t), 66.2 (t), 38.7 (s), 27.2 
(q), 27.2 (q), 27.2 (q); found: C, 68.5; H, 7.6. C34H44O9 requires C, 68.4; H, 7.4%.









To a stirred solution of tetraol 211 (13.00 g, 21.81 mmol) in DMF (125 ml) containing p- 
TsOH (400 mg, catalytic amount) was added dropwise 2-methoxypropene (7.84 ml, 87.25 
mmol). After 13h the reaction was quenched by addition of saturated aqueous NaHCC>3 (100 
ml), then extracted with Et20 (4 x 100 ml). The organics were combined and washed with
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saturated aqueous NaHC03 (1 x 100 ml), H2O (1 x 100 ml), saturated aqueous brine (2 x 
100 ml), then dried (MgSCU), filtered and evaporated under reduced pressure. The residue 
was purified by FCC (30% Et20/petrol) to give the title compound 296 (13.07 g, 77%) as a 
pale orange oil, [a]$ -5.1 (c 1.0 in CHCI3), vmax(film) 3029, 2977, 2930, 2860,1730,1455,
1372,1248,1211, 1155,1086,732 and 696 cm-*; 6h(270 MHz, CDCI3) 7.40-7.20 (15H, m, 
Ph), 4.72-4.34 (10H, m, includes PhC/f2OCH2 and PivOCH 2), 3.86-3.68 (4H, m, 
PhCH2OCtf 2), 3.62 (1H, d, J  10.8 Hz, PhCH20 CH2), 3.54 (1H, d, J  10.8 Hz, 
PhCH2OCtf2), 1.42 (3H, s, CH3), 1.35 (6H, s, 2 x CH3), 1.32 (3H, s, C //3), 1.21 (9H, s, 
tBu); mJz (+FAB) 677 (M+H), 662, 619 (M-tBu), 569, 555, 527, 497, 469, 453, 377, 363, 
319, 255, 243,211; found: C, 71.0; H, 7.8.C40H52O9 requires C, 71.0; H, 7.7%.









To a cooled (-78°C), stirred solution of pivaloate ester 296 (10.68 g, 15.79 mmol) in dry 
CH2CI2 (85 ml) was added DIBAL-H (39.5 ml, 1.0 M solution in CH2CI2, 39.5 mmol) 
dropwise under argon over 20 mins. After 45 mins the reaction was quenched by careful 
addition of dry MeOH (5 ml). The mixture was allowed to warm to 0°C and stirred at this 
temperature for 10 mins before careful addition of a solution of Rochelle's salt (33 ml of a 
saturated solution in 200 ml H2O) in 3 portions. The mixture was then allowed to warm to 
RT and stirred for 30 mins. The organic phase was separated and the aqueous phase was 
acidified with 2M HC1 until all the aluminium salts had dissolved, then extracted with 
CH2CI2 (4 x 100 ml). The organics were combined, then washed with 2M HC1 (1 x 100 ml), 
H2O (1 x 100 ml), brine (2 x 100 ml), then dried (MgSC>4), filtered and evaporated under
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reduced pressure. The residual yellow oil was purified by FCC (50% Et20/petrol) to give 
the title compound 212 (8.51 g, 91%) as a clear oil, [a]™ -9.1° (c 1.0 in CHCI3) @ ca. 76%
ee; Vmax (film) 3491, 3063, 3029, 2984, 2937, 2865, 1496, 1454, 1379, 1248, 1212, 1170, 
1078, 1028, 1000, 911, 848, 737 and 698 cm-*; 5H (500 MHz, CDCI3) 7.37-7.20 (15H, m, 
Ph), 4.68 (1H, dd, J  8.0 Hz and 2.6 Hz), 4.61 (1H, d, J  12.3 Hz), 4.58-4.47 (5H, m, includes
4.50 (1H, d, J  12.6 Hz)), 4.39 (1H, d, J  11.9 Hz), 4.03-3.96 (1H, m), 3.92-3.84 (1H, m), 
3.83-3.72 (5H, m, includes 3.81 (1H, d, /19 .6  Hz) and 3.75 (1H, d, /19 .6  Hz)), 3.50 (1H, d, 
J  11.0 Hz), 2.55 (1H, dd, J  7.7 Hz and 6.0 Hz, OH), 1.46 (3H, s, CH3), 1.37 (3H, s, Ctf3),
1.35 (3H, s, C i/3), 1.34 (3H, s, Ci/3); 5C (100 MHz, CDCI3) 138.2 (s), 137.8 (s), 137.6 (s),
128.4 (d), 128.3 (d), 128.3 (d), 127.8 (d), 127.6 (d), 127.5 (d), 110.5 (s), 108.7 (s), 86.2 (s),
85.0 (s), 81.0 (d), 79.9 (d), 73.9 (t), 73.6 (t), 73.2 (t), 71.6 (t), 70.6 (t), 69.4 (t), 60.7 (t), 27.9 
(q), 27.1 (q), 26.1 (q), 25.9 (q); m/z (FAB) 615 (M+Na), 593 (M+H), 573, 535, 413, 341,
251,171,149, 123; observed: M+Na, 615.2936. C35H44Na08 requires M+Na, 615.2934.
Preparation of Moshers ester 210
To a stirred solution of alcohol 212 (11 mg, 0.02 mmol) in CH2CI2 (0.3 ml) was added DCC 
(6 mg, 0.03 mmol) followed by DMAP (catalytic) and (R)-(+)-a-methoxy-a- 
(trifluoromethyl)phenyl acetic acid (6 mg, 0.03 mmol). After 19h the mixture was diluted 
with CH2CI2 (10 ml) and washed with 2M HC1 (x2), H2O (xl), saturated aqueous NaHCC>3 
(x3), H2O (xl), saturated aqueous brine (x2), then dried (MgSC>4), filtered and evaporated 
under reduced pressure. The residual oil was purified by FCC (30% Et20/petrol) to give the 
Moshers ester derivative 210 (16 mg, 100%) as a clear oil. The enantiomeric excesses were 
determined by 19F NMR analysis; the fluorine peaks are observed at -72.3 (major) and -72.2 
ppm.
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To a cooled (-78°C), stirred solution of oxalyl chloride (67pl, 0.76 mmol in dry CH2CI2 (1.7 
ml) was added a solution of anhydrous DMSO (107 pi, 1.52 mmol) in CH2CI2 (1.5 ml) 
dropwise via cannula over 4 mins. After 14 mins a solution of alcohol 212 (300 mg, 0.51 
mmol) in CH2CI2 (1.4 ml) was added dropwise over 5 mins and stirred at -78°C for 25 
mins. Then Et3N (354 pi, 2.53 mmol) was added over 4 mins. After lh, the reaction was 
quenched at -78°C by addition of saturated aqueous NH4CI (0.8 ml) and the mixture was 
then allowed to warm to RT. The organics were separated and the aqueous layer extracted 
with CH2CI2 ( 3 x 5  ml). The organics were combined and washed with saturated aqueous 
NH4CI (2x5  ml), H2O ( 1x 5  ml), saturated aqueous brine ( 1x5  ml), then dried (MgSC>4), 
filtered and evaporated under reduced pressure. The residual yellow oil was purified by FCC 
(30% Et20/petrol) to give the title compound 218 (248 mg, 83%) as a clear oil, [oc]q -15.1
(c 0.94 in CHCI3) @68% ee, Dmax(film) 3087, 3062, 3029, 2982, 2934, 2858, 1729, 1496, 
1454, 1380, 1247, 1215, 1172, 1096, 1028, 932, 910, 859,737 and 698 c u t^ S r  (500 MHz, 
CDCI3) 9.70 (1H, s, CHO), 7.36-7.23 (15H, m, Ph), 4.61 (1H, d, 7 12.3 Hz), 4.55 (1H, d, 7
11.9 Hz), 4.51 (1H, d, 7 11.9 Hz), 4.46-4.41 (3H, m), 4.31 (1H, d, 7 12.1 Hz), 3.90 (1H, d, 7
10.5 Hz), 3.85 (1H, d, 7 10.5 Hz), 3.71 (1H, dd, 7 10.5 Hz and 1.8 Hz), 3.60 (1H, dd, 7 10.5 
Hz and 8.3 Hz), 3.52 (1H, d, 79.9 Hz), 3.48 (1H, d, 79.9 Hz), 1.41 (3H, s, CH3), 1.39 (3H, 
s, Ci/3), 1.37 (3H, s, CH3), 1.35 (3H, s, C//3); 8c (125 MHz, CDCI3) 195.5, 138.0, 137.5,
128.4, 128.3, 127.9, 127.8, 127.8, 127.7, 127.6, 110.1, 109.9, 86.9, 85.2, 83.5, 79.5, 73.8,
73.3, 73.1, 70.6, 69.4, 68.9, 28.6, 27.0, 26.4, 26.0; m/z (+FAB) 614, 592, 335, 277, 257,
168
243, 227, 213, 197, 191, 181, 165, 157, 149, i41, 131, 123, 109; found C, 71.3; H, 7.2. 
C35H42O8 requires C, 71.2; H, 7.2%.
Method B (Dess -Martin Oxidation)
To a stirred solution of alcohol 212 (250 mg, 0.42 mmol) in CH2CI2 (5 ml) was added a 
solution of Dess-Martin periodinane reagent (233 mg, 0.55 mmol) in anhydrous CH2CI2 (7 
ml) via cannula. After 10 mins “wet” CH2CI2 (6.5 ml of a l | L t i  H2O/I ml CH2CI2 solution) 
was added in portions over a 45 mins time period. The reaction was then concentrated in 
vacuo before the addition of a 1:1 solution of saturated aqueous NaHCC>3 / 1M Na2S2C>3 (25 
ml) and Et20 (25 ml). The mixture was stirred for 25 mins, then the organics were separated 
and the aqueous layer extracted with Et20 (3 x 20 ml). The organics were combined and 
washed with H2O (1 x 25 ml), saturated brine (3 x 25 ml), then dried (MgSC>4), filtered and 
evaporated under reduced pressure. The residual yellow oil was purified by FCC (20% 
Et20/petrol) to give the title compound 218 (225mg, 91%) as a clear oil, data as above.
Preparation of (l'S, 27?, 37?, 4'S, 5'S)-2-[(2', 3', 4’, 5'-Ws-(di-0-isopropyIidene))-6'- 
benzyloxy-3l,4'-ftw-(benzyloxymethyl))-l'-hydroxy-hexyl]-2-methyl-l,3-dithiane 225 
and ( l1/?, 27?, 37?, 4'S, 5'S)-2-[(2f, 3', 4', 5'^is-(di-0-isopropylidene))-6'-benzyloxy- 
3',4'-^w-(benzyIoxymethyI))-l'-hydroxy-hexyl]-2-methyl-l,3-dithiane 226.
To a cooled (-50°C), stirred solution of 2-methyl-1,3-dithiane (87 pi, 0.79 mmol) in THF 
(1.5 ml, malting 0.5 M solution) was added nBuLi (332 pi, 2.5 M solution in hexanes, 0.83 
mmol) dropwise over 3 mins. Then mixture was then allowed to warm to -20°C and
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maintained at this temperature for 1.5h. The contents of the flask was then cooled to -78°C 
before the dropwise addition of aldehyde 218 (186 mg, 0.31 mmol) in THF (1.4 ml) via 
cannula over 2 mins. After 20 mins the reaction was quenched at -78°C by addition of H2O 
(5 ml) and CH2CI2 (10 ml), then allowed to warm to RT and poured into a separating funnel 
containing 2M KOH (2 ml). The organics were separated and the aqueous extracted with 
CH2CI2 ( 5 x 5  ml). The organics were combined, washed with 2M KOH (1 x 10 ml), H2O 
(1 x 10 ml), sat. brine (2 x 10 ml), then dried (MgS04), filtered and evaporated under 
reduced pressure. The residual yellow oil was purified by FCC (30% Et20/petrol) to give 
the title compound 225 (114 mg, 44%) and 226 both as clear glassy solids.
Less polar 225, [a]» -11.2 (c 2.1 in CHCI3) @ ca. 76% ee; vmax(film) 3432, 3026, 
2979, 2925, 2861, 1453, 1370, 1247, 1214, 1171, 1076, 909, 852, 736 and 698 cm' 1 ; 8H 
(500 MHz, CDCI3) 7.39-7.24 (15H, m, Ph), 4.95 (1H, d, 7 9.0 Hz), 4.73 (1H, dd, 7 7.4 Hz 
and 2.7 Hz), 4.66-4.61 (3H, m), 4.53 (1H, d, J 4.4 Hz), 4.50 (1H, d, 74.0 Hz), 4.48 (1H, d, 7
4.4 Hz), 4.45 (1H, s), 4.35 (1H, dd, J  8.9 Hz and 3.5 Hz), 4.24 (1H, d, J  3.5 Hz), 3.97 (1H, 
d, J  10.6 Hz), 3.84-3.78 (4H, m), 3.56 (1H, d, J  10.8 Hz), 3.35 (1H, ddd, J  13.6 Hz, 10.6 Hz 
and 3.1 Hz), 3.14 (1H, ddd, J  13.6 Hz, 10.5 and 3.0 Hz), 2.69 (1H, ddd, 79.6 Hz, 6.2 Hz and 
3.1 Hz), 3.14 (1H, ddd, J  13.6 Hz, 10.5 Hz and 3.0 Hz), 2.69 (1H, ddd, J  9.6 Hz, 6.2 Hz and
3.4 Hz), 2.58 (1H, ddd, 79.4 Hz, 6.2 Hz and 3.1 Hz), 2.07-1.96 (1H, m), 1.93-1.82 (1H, m),
1.50 (3H, s), 1.49 (3H, s), 1.37 (3H, s), 1.36 (3H, s), 1.24 (3H, s); 8c (125 MHz, CDCI3)
138.2 (s), 138.0 (s), 137.5 (s), 128.4 (d), 128.2 (d), 128.0 (d), 127.8 (d), 127.8 (d), 127.7 (dO, 
127.6 (d), 127.5 (d), 127.5 (dO, 110.9 (s), 108.3 (s), 86.0 (s), 85.4 (s), 80.6 (d), 79.8 (d), 78.9 
(d), 74.0 (t), 73.5 (t), 73.2 (t), 70.7 (t), 70.2 (t), 69.0 (t), 52.5 (s), 28.4 (t), 27.7 (q), 27.0 (q),
27.0 (t), 26.1 (q), 25.7 (q), 25.6 (q), 24.8 (t); m/z (+FAB) 747 (M+Na), 725 (M+H), 667, 
591, 469, 335, 271, 243, 227, 213, 197, 181, 165, 149, 123; found: C, 66.6; H, 7.5.
C40H52O8S2 requires C, 66.3; H, 7.2%.
More polar 226, [a]?  -8.3 (c 0.85 in CHCI3), a)max(film) 3468, 3029, 2983, 2925,
2853, 1496, 1454, 1377, 1247, 1211, 1171, 1089, 910, 734 and 698 cm"1; 8H (500 MHz,
CDCI3) 7.37-7.20 (15H, m, Ph), 4.91 (1H, s), 4.77 (1H, d, J  7.3 Hz), 4.66 (1H, d, J  12.5
Hz), 4.57 (1H, d, 711.9 Hz), 4.54 (2H, s), 4.53 (1H, d, 7 12.5 Hz), 4.43 (2H, d, 7 11.9 Hz),
4.16 (1H, d, 7 10.9 Hz), 3.91 (1H, d, 7 10.2 Hz), 3.87 (1H, d, 77.3 Hz), 3.78 (2H, d, 7 10.2
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Hz), 3.60 (1H, d, J  10.9 Hz), 3.03 (1H, bs), 2.84-2.71 (2H, m), 2.57-2.54 (1H, m), 2.32-2.30 
(1H, m), 1.90-1.70 (2H, m), 1.48 (3H, s), 1.42 (3H, s), 1.38 (3H, s), 1.37 (3H, s), 1.35 (3H, 
s); 5C (125 MHz, CDCI3) 138.7, 138.1, 137.9, 128.6, 128.4, 128.3, 128.2, 128.1, 128.0,
54.1, 28.3, 27.3, 26.2, 26.1, 25.9, 24.3, 22.2; m/z (+FAB) 747 (M+Na), 725 (M+H), 667, 
591, 559, 469, 341, 335, 271, 243, 227, 213, 197, 181, 165, 149, 123; observed: M+H,
725.3206. C40H53O8S2 requires M+H, 725.3182.
Preparation of (3R, 4R, 5R, 65, 75)-(4,5 ,6, 7-£is-(di-0-isopropyIidene))-8-benzyIoxy-5, 
6-&tf-(benzyloxymethyI))-3-hydroxy-octan-2-one 228
To a stirred solution of dithiane 226 (150 mg, 0.21 mmol) in THF (0.75 ml) was added H2O 
(150 pi) followed by CaCC>3 (49 mg, 0.54 mmol), then a solution of Hg(ClC>4)2 (115 pi, 4M 
solution in H2O, 0.50 mmol) was added dropwise. After 30 mins saturated aqueous 
NaHCC>3 (2 ml) and Et20 (5 ml) were added and the mixture stirred for 10 mins. The 
organics were then separated and the aqueous layer extracted with Et20 ( 3 x 5  ml). The 
organics were combined and washed with H2O ( 3 x 5  ml), saturated aqueous brine ( 3 x 5  
ml), then dried (MgSC>4), filtered and evaporated under reduced pressure. The residual 
yellow oil was purified by FCC (30% Et20/petrol containing 1% Et3N, then eluted with 
30% Et20/petrol) to give the title compound 228 (120 mg, 92%) as a clear oil, [a]™ -3.7 (c
0.64 in CHCI3) @ ca. 76% ee; vmax(film) 3461, 3067, 3029, 3983, 2926, 2855,1722,1496, 
1454, 1372, 1248, 1211, 1170, 1074, 1028, 1000, 896, 852, 737, 698 and 665 cm-l;5H (500 
MHz, CDCI3) 7.35-7.21 (15H, m, Ph), 4.71-4.66 (2H, m), 4.63 (1H, d, /12 .4  Hz), 4.56-4.46
OH
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(4H, m), 4.67 (1H, d, J  11.6 Hz), 4.32 (1H, dd, J  5.4 Hz and 2.1 Hz), 3.97 (1H, d, J  10.8 
Hz), 3.94 (1H, d, J  10.1 Hz), 3.81-3.72 (2H, m), 3.68-3.61 (2H, m), 3.55 (1H, d, J  10.8 Hz),
2.18 (3H, s, COCH3), 1.45 (3H, s, C //3), 1.44 (3H, s, CH3), 1.36 (3H, s, CH3), 1.34 (3H, s, 
C//3); 5c (125 MHz, CDCI3) 207.8 (s), 138.5 (s), 137.9 (s), 137.7 (s), 128.4 (d), 128.3 (d),
128.0 (d), 127.9 (d), 127.8 (d), 127.6 (d), 127.5 (d), 110.3 (s), 108.6 (s), 87.1 (s), 85.2 (s),
80.2 (d), 79.7 (d), 74.7 (d), 73.7 (t), 73.6 (t), 73.1 (t), 72.8 (t), 71.0 (t), 69.2 (t), 28.2 (q), 26.9 
(q), 26.3 (q), 26.0 (q), 25.8 (q); m/z (+FAB) 657 (M+Na), 635 (M+H), 341, 293, 213, 197,
181,149, 123; Found: C, 70.1; H, 7.3. C37H46O9 requires C, 70.1; H, 7.2%.









To a stirred solution of dithiane 225 (120 mg, 0.17 mmol) in THF (0.75 ml) was added H2O 
(150 | l U )  followed by CaCC>3 (39 mg, 0.43 mmol), then a solution of Hg(C104)2 (92 pi, 4M 
solution in H2O, 0.40 mmol) was added dropwise. After 30 mins saturated aqueous 
NaHCC>3 (2 ml) and Et20 (5 ml) were added and the mixture stirred for 10 mins. The 
organics were then separated and the aqueous layer extracted with Et20 ( 3 x 5  ml). The 
organics were combined and washed with H2O ( 3 x 5  ml), saturated brine ( 3 x 5  ml), then 
dried (MgSC>4), filtered and evaporated under reduced pressure. The residual yellow oil was 
purified by FCC (30% Et20/petrol containing 1% Et3N, then eluted with 30% Et20/petrol) 
to give the title compound 227 (90 mg, 84%) as a clear oil, [oc]  ^ +4.3 (c 1.2 in CHCI3) @
ca. 76% ee; v ^ f i l m )  3458, 3063, 3029, 2937, 2861,1716,1496,1454,1369,1249,1213, 
1170, 1077, 1028, 998, 910, 852, 737 and 698 cm-1; 8H (400 MHz, CDCI3) 7.35-7.25 (15H,
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m, Ph), 4.78-4.71 (2H, m), 4.65-4.50 (6H, m), 4.30 (1H, d, 7 9.3 Hz), 3.87-3.72 (6H, m), 
3.61 (1H, d, 7 10.7 Hz), 2.07 (3H, s, C(0)Cff3), 1-49 (3H, s, C/f3), 1.38 (3H, s, Ctf3), 1-37 
(3H, s, Ctf3), 1.33 (3H, s, Cff3); 6c (125 MHz, CDC13) 208.1 (s), 138.1 (s), 137.7 (s), 137.6
(s), 128.4 (d), 128.3 (d), 127.9 (d), 127.8 (d), 127.7 (d), 127.6 (d), 110.5 (s), 109.0 (s), 86.3 
(s), 86.2 (s), 79.8 (d), 79.2 (d), 73.9 (t), 73.6 (d+t), 73.3 (t), 70.9 (t), 70.2 (t), 69.1 (t), 28.1 
(q), 27.4 (q), 27.0 (q), 26.1 (q), 25.8 (q); m/z 657 (M+Na), 181,154, 133,109,91; found: C,
70.1; H, 7.5. C37H46O9 requires C, 70.1; H, 7.2%.
Preparation of (IS, 3R, 4S, 5R, 6R, 7R)-4,6,7-trihydroxy-3,4,5-tri-(benzyloxymethyI)-l- 
methyl-2,8-dioxabicyclo[3.2.1]octane 133 and (IS, 2R, 3R, 4R, 5S, 6R)-2,3,4- 
trihydroxy-4,5 ,6-tri-(benzyIoxymethyl)-l-methyl-7,8-dioxabicycIo[3.2.1]octane 229
Nicolaou conditions
Hydroxy ketone 228 (80 mg, 0.126 mmol) was treated with 2% HCl/MeOH (0.5 ml) and 
heated at 60°C for 18h. The mixture was then allowed to cool to RT and quenched by 
addition of saturated aqueous NaHC03 (2 ml) and diluted with CH2CI2 (10 ml). The 
organics were separated and the aqueous layer extracted with CH2CI2 ( 3 x 5  ml). The 
organics were combined, then dried (MgSC>4), filtered and evaporated under reduced 
pressure. The residual brown oil was purified by FCC (50-100% EtOAc/petrol) to give the 
title compound 133 (30 mg, 45%) as a white solid and 229 (32 mg, 47%) as a clear oil.
Less polar 133, [ a #  -1.5 (c 0.3 in CHC13) @ ca. 76% ee; vmax(film) 3444, 3020,
2918, 2868, 1445, 1386, 1353, 1205, 1170, 1093, 1023, 900, 730, 696 and 666 cm -l;6H 
(400 MHz, CDC13) 7.36-7.24 (13H, m, Ph), 7.17-7.15 (2H, m, Ph), 4.79 (1H, t J  2.9 Hz, 
H6), 4.53 (2H, dd, J  18.6 Hz and 12.2 Hz, CH2OCtf2OPh), 4.47 (2H, dd, J  16.4 Hz and
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11.2 Hz, CH2OCtf2OPh), 4.39 (1H, dd, J  5.4 Hz and 3.4 Hz, H3), 4.31 (2H, s, 
CH2OCtf2OPh), 4.00 (1H, bs, H7), 3.92 (1H, d, J  9.8 Hz, one of Ctf2OCH2OPh @C4 or 
C5), 3.78 (1H, dd, J  11.2 Hz and 3.4 Hz, one of Ctf2OCH2OPh @C3), 3.64-3.57 (3H, m, 
one of Ctf2OCH2OPh @C3 and C7/2OCH2OPh @C4 or C5), 3.52-3.43 (3H, m, includes 
3.44 (1H, s, 4-0H), one of Ctf2OCH2OPh @C4 or C5 and 7-0H), 2.47 (1H, d, J  5.4 Hz, 6- 
OH), 1.50 (3H, s, Ctf3); 8C (100MHz, CDCI3) 138.0 (s), 137.6 (s), 128.6 (d), 128.3 (d),
128.2 (d), 128.0 (d), 127.7 (d), 127.7 (d), 127.6 (d), 127.6 (d), 127.5 (d), 104.1 (s), 86.7 (s),
84.7 (d), 79.3 (t), 73.9 (t), 73.5 (t), 73.2 (t), 72.9 (d), 70.8 (s), 69.5 (t), 69.3 (t), 68.4 (t), 22.2 
(q); m/z (+FAB) 559 (M+Na), 537 (M+H), 509, 413, 391, 259, 181, 149, 109; observed: 
M+Na, 559.2288. C3iH36Na08 requires M+Na, 559.2308.
More polar 229, [ a £  +44.0 (c 1.0 in CHCI3) @ ca. 76% ee; vmax(film) 3440, 3062,
3029, 2921, 2855, 1496,1454,1382,1271, 1256, 1207, 1095, 1027, 904, 834, 738, 698 and 
666 cm-1; 8h (400 MHz, CDCI3) 7.29-7.10 (15H, m, Ph), 4.58-4.44 (5H, ra, includes 4.46 
(1H, s, 5-OH), three of PhCtf20  and H3), 4.34 (1H, d, J  12.2 Hz, one of PhCtf20), 4.26 
(1H, d, /  11.7 Hz, one of PhO /20), 4.21 (1H, d, J  11.7 Hz, one of PhCtf20), 3.88 (1H, d, J
10.7 Hz, one of PhCH2OCtf2), 3.70 (1H, d, J  10.7 Hz, one of PhCH20 CH2), 3.68 (1H, d, J
9.8 Hz, one of PhCH2OCi/2), 3.63 ( 1H, t, 79.8 Hz, becomes d, 77.8 Hz on D20  shake, H6 
or H7), 3.53 (1H, t, 7 8.3 Hz, becomes d, 77.8 Hz on D20  shake, H6 or H7), 3.42-3.24 (3H, 
m, PhCH2OCtf2), 2.41 (1H, d, 7 9.8 Hz, 6-0H or 7-0H), 2.01 (1H, d, 7 8.3 Hz, 6-0H  or 7- 
OH), 1.47 (3H, s, C //3); m/z (+FAB) 559 (M+Na), 537 (M+H), 391, 181, 167, 149, 131, 
123,109; found: C, 69.7; H, 7.0. C31H36O8 requires C, 69.4; H, 6.8%.
Evans conditions
Hydroxy ketone 228 (22 mg, 0.04 mmol) was stirred in CH2C12 (200 |il) : TFA (100 |il) : 
H20  (10 (0.1) at RT for 16h. The mixture was then quenched by addition of saturated aqueous 
NaHC03 (2 ml) and diluted with CH2C12 (10 ml). The organics were separated and the 
aqueous layer extracted with CH2C12 ( 4x5  ml). The organics were combined, washed with 
saturated aqueous brine (1 x 10 ml), then dried (MgSC>4), filtered and evaporated under 
reduced pressure. The residual orange oil was purified by FCC (50-100% EtOAc/petrol) to
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give the title compound 133 (7 mg, 38%) as a white solid and 229 (7 mg, 38%) as a clear 
oil. The data obtained were identical to those given above.






Hydroxy ketone 227 (34 mg, 0.05 mmol) was treated with 2% HCl/MeOH (0.4 ml) and 
stirred at RT for 13h, then heated at 50°C for 5h. The mixture was then allowed to cool to 
RT and quenched by addition of saturated aqueous NaHCC>3 (2 ml) followed by dilution 
with CH2CI2 (10 ml). The organics were separated and the aqueous extracted with CH2CI2 
( 3 x 5  ml). The organics were combined and washed with saturated brine (1 x 10 ml), then 
dried (MgSC>4), filtered and evaporated under reduced pressure. The residual brown oil was 
purified by FCC (50% EtOAc/petrol) to give the title compound 233 (20 mg, 70%) as a 
clear oil, [a ]”  +29.2 (c 1.1 in CHCI3) @ ca. 76% ee; v,nax(film) 3420, 3033, 2922, 2864,
1496, 1453, 1382, 1205, 1096, 1028, 870, 737, 698 and 667 cm-^Sn (400 MHz, CDCI3) 
7.39-7.20 (13H, m, Ph), 7.19-7.14 (2H, m, Ph), 4.80 (1H, d, 7 1.5 Hz, 5-0H), 4.55-4.43 (4H, 
m, H3 and PhC7/2OCH2), 4.41 (1H, d, 7 11.7 Hz, PhCff2OCH2), 4.29 (1H, d, 7 11.7 Hz, 
PhCH2OCH2), 4.23 (1H, d, 711.7 Hz, PhCf/2OCH2), 3.97 (2H, d, 710.7 Hz, on D20  shake 
becomes 3.97 (1H, d, 7 10.3 Hz, PhCH2OCH2), 3.96 (1H, d, 74.4 Hz , H6 or H7)), 3.82 
(1H, d, 79.8 Hz, PhCH2OCH2), 3.75 (1H, d, 710.7 Hz, PhCH2OCH2), 3.57 (1H, dd, 711.7 
Hz and 4.4 Hz, on D2O shake becomes 3.56 (1H, d, J 4.4 Hz, H6 or H7), 3.42-3.27 (4H, m, 
three of PhCH2OCi/ 2 and 6-0 H or 7-0H), 2.85 (1H, d, J  10.7 Hz, 6-0 H  or 1 -OH), 1.56
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(3H, s, CH3); 8c  (100MHz, CDCI3) 137.7 (s), 137.5 (s), 136.2 (s), 128.6 (d), 128.4 (d),
128.4 (d), 128.3 (d), 128.2 (d), 128.1 (d), 127.8 (d), 127.8 (d), 127.7 (d), 108.2 (s), 84.4 (s),
77.2 (s), 76.0 (d), 74.3 (t), 74.1 (d), 73.8 (t), 73.3 (t), 70.6 (t), 69.7 (t), 69.1 (t), 64.9 (d), 21.1 
(q); m/z (+FAB) 559 (M+Na), 537 (M+H), 341, 327, 281, 267, 221, 207, 193, 181, 165,
147,131,123, 111; observed: M+H, 537.2496. C3iH370 8 requires M+H, 537.2488.
Evans conditions
Hydroxy ketone 228 (26 mg, 0.041 mmol) was stirred in CH2CI2 (200 |i l ) : TFA (100 pi) : 
H2O (10 pi) at RT for 23h, then concentrated in vacuo. The residual orange oil was purified 
by FCC (50% EtOAc/petrol) to give the title compound 234 (15 mg, 69%), data as above.
Preparation of (2’S, 3 'R, 45)-4-benzyl-3-(3'-hydroxy-2f-methyl-l'-oxaheptyl)-2- 
oxazolidinone 258




To a cooled (-78°C), stirred solution of (S)-3-(l-oxapropyl)-4-(phenylmethyl)-2- 
oxazolidinone 262 (20.00 g, 0.10 mol) in CH2CI2 (360 ml) was added dibutylboron triflate 
(26.5 ml, 105 mmol) dropwise over 15 mins, followed by Et3N (15.9 ml, 115 mmol) 
dropwise over 10 mins. The reaction was brought to 0°C and stirred at this temperature for 
45 mins. After recooling the contents to -78°C, a pre-cooled (-78°C) solution of 5- 
(benzyloxy)-pentanal (18.21 g, 107 mmol) in CH2Cl2(70 ml) was added dropwise via 
cannula over 50 mins. The reaction was allowed to come to RT overnight, and after a total 
reaction time of 13h, quenched at 0°C by addition of pH7 phosphate buffer (100 ml) and 
MeOH (270 ml). Then a 2:1 mixture of MeOH/ 30% H2O2 (270 ml) was cautiously added 
and the resultant milky white suspension was stirred at 0°C for l/2h then at RT for lh. The
Bn
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mixture was then poured into a separating funnel containing H2O (350 ml) and the organics 
separated. The aqueous layer was extracted with CH2CI2 (4 x 200 ml). The organics were 
combined then dried (MgSCU), filtered and evaporated under reduced pressure. The residual 
pale orange oil was purified by FCC (50% EtOAc/petrol) to give the title compound 258 
(34.43 g, 81%) as a clear oil. The data obtained were consistent with the literature ;32b [a]^
+101.9 (c 0.41 in CH2C12); vmax(film) 3512, 2938, 2861, 1779, 1695, 1496, 1454, 1385, 
1210, 1109 and 738 cn r1; §h (500 MHz, CDCI3) 7.35-7.33 (6H, m, Ph), 7.30-7.26 (2H, m, 
Ph), 7.20 (2H, d, J 1 2  Hz, Ph), 4.72-4.68 (1H, m, OCH2CH(N)Bn), 4.50 (2H, s, 
CH2O C tf2Ph), 4.24-4.18 (2H, m, O Ctf2CH(N)Bn), 3.96-3.95 (1H, m, 
CH2CH(OH)C7/(CH3)C(0)), 3.76 (1H, ddd, J  14.1 Hz, 7.0 Hz and 2.6 Hz, 
CH2Ci/(OH)CH(CH3)C(0 )), 3.48 (2H, t, 76.5 Hz, CH2OCH2Ph), 3.25 (1H, dd, J  13.4 Hz 
and 3.3 Hz, one of OCH2CH(N)CH2Ph), 2.89 (1H, d, J  3.0 Hz, OH), 2.79 (1H, dd, J  13.4 
Hz and 9.5 Hz, OCH2CH(N)Ctf2Ph), 1.68-1.55 (4H, m), 1.47-1.41 (2H, m), 1.25 (3H, d, J
7.0 Hz, CH(OH)CH(Ctf3)); 8c  (125MHz, CDCI3) 177.5, 153.0, 138.6, 135.0, 129.4, 129.0, 
128.3,127.6, 127.4, 127.4, 72.9, 71.4, 70.2, 66.2, 55.1,42.1, 37.8, 33.6, 29.6, 22.7,10.4.










To a stirred solution of alcohol 258 (34.00 g, 80.0 mmol) in DMF (50 ml) was added 
imidazole (16.31 g, 240.0 mmol), followed by te/t-butyldiphenylsilyl chloride (35.26 ml,
135.5 mmol). After 1 d, the mixture was partitioned between saturated aqueous NH4CI (100 
ml) and Et20 (50 ml). The organics were separated and the aqueous layer extracted with 
Et20 (3 x 100 ml). The organics were combined and washed with 2M HC1 (1 x 100 ml), 
H2O (3 x 200 ml), saturated brine (3 x 200 ml), then dried (MgSC>4), filtered and evaporated 
under reduced pressure. The residual yellow oil was purified by FCC (10-20% Et20/petrol)
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to give the title compound 297 (47.20 g, 89%) as a clear oil, [a]o +38.3 (c 0.98 in CHCI3); 
VmaxCfihn) 2931, 2857, 1780, 1703, 1475, 1454, 1427, 1381,1351, 1209, 1110,1046, 1016, 
822, 739 and 702 cnr*; SH (400 MHz, CDCI3) 7.69-7.65 (4H, m, SiPh), 7.47-7.22 (16H, m, 
Ph), 4.45 (2H, s, CH2OCtf2Ph), 4.39-4.33 (1H, m, CH2C7/(OSi)CH(CH3)) 4.21-4.16 (1H, 
m), 4.06 (1H, dd, J  8.8 Hz and 2.0 Hz), 3.90-3.83 (2H, m), 3.36-3.28 (3H, m, Ctf2OCH2Ph 
and one of OCH2CH(N)CT2Ph), 2.73 (1H, dd, J  13.2 Hz and 9.8 Hz, one of 
OCH2CH(N)Ci/2Ph), 1.64-1.12 (9H, m, includes 1.33 (3H, d, 7 6.8 H z,), 1.10 (9H, s, lBu); 
8C (100MHz, CDCI3) 174.9 (s), 153.0 (s), 138.6 (s), 136.0 (d), 135.9 (d), 135.5 (s), 134.5 
(s), 133.8 (s), 129.7 (d), 129.6 (d), 129.4 (d), 128.9 (d), 128.3 (d), 127.6 (d), 127.5 (d), 127.4 
(d), 127.4 (d), 127.3 (d), 73.7 (d), 72.8 (t), 70.1 (t), 65.9 (t), 55.7 (d), 42.4 (d), 37.5 (t), 35.0 
(t), 29.5 (t), 27.0 (q), 21.5 (t), 19.4 (s), 10.1 (q); m/z (+FAB) 664 (M+H), 606 (M-lBu), 586, 
408, 323, 199, 183, 135, 117, 91; found: C, 74.3; H, 7.7. C4iH49NC>5Si requires C, 74.2; H, 
7.4%





To a cooled (0°C), stirred solution of imide 258 (8.13 g, 12.84 mmol) in THF (40 ml) was 
added anhydrous MeOH (1.50 ml, 38.52 mmol) followed by LiBH^ (18.35 ml, 2M solution 
in THF, 38.52 mmol) dropwise over 6 mins. The reaction was then brought to RT. After 
1.5h the reaction was poured into a separating funnel containing a saturated solution of 
Rochelle’s salt (50 ml) and then 2M HC1 was cautiously added until all the salts had 
dissolved. The mixture was then extracted with Et20  (3 x 50 ml), the organics were 
combined and washed with H20  (1 x 50 ml), saturated aqueous brine (3 x 50 ml), then dried 
(MgS04), filtered and evaporated under reduced pressure. The residual yellow oil was 
purified by FCC (30% Et20/petrol) to give the title compound 298 (5.28 g, 84%) as a clear 
oil, [a]“  -27.5 (c 0.69 in CHCI3); v m a x ( f i h n )  3443,3069,3048, 2931,2857,1589,1472,
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1454, 1427, 1389, 1361, 1110, 1028, 939, 821, 740, 702 and 613 cm -l;8H (270 MHz, 
CDC13) 7.72-7.65 (4H, m, SiPh), 7.45-7.25 (11H, m, Ph), 4.39 (2H, s, CH2OCtf2Ph), 3.85- 
3.79 (1H, m, CH2Ctf(OSi)CH(CH3)) 3.65 (1H, t, J  9.2 Hz, OH), 3.43-3.56 (1H, m), 3.30-
3.17 (2H, m), 1.95-1.82 (2H, m), 1.60-1.07 (15H, m, includes 1.05 (9H, s, lBu)), 0.83 (3H, 
d, J  6.9 Hz, CH(OSi)CH(Ctf3)); 5C (100MHz, CDC13) 138.6 (s), 136.0 (d), 134.3 (s), 133.7 
(s), 129.8 (d), 129.6 (d), 128.3 (d), 127.7 (d), 127.6 (d), 127.5 (d), 77.2 (d), 75.2 (d), 72.8 (t),
70.1 (t), 65.8 (t), 33.1 (t), 29.5 (t), 27.1 (q), 22.5 (t), 19.4 (s), 11.0 (q); m/z (+FAB) 491 
(M+H), 433 (M-tBu), 325, 235, 217, 199, 91; observed: M+H, 491.2985. C3iH430 3Si 
requires M+H, 491.2981.







To a stirred solution of alcohol 264 (68 mg, 0.14 mmol) in CH2C12 (0.3 ml) was added p- 
toluenesulfonyl chloride (40 mg, 0.21 mmol), followed by pyridine (34 pi, 0.42 mmol). 
After 1 d, the mixture was partitioned between 2M HC1 (1 ml) and CH2C12 (5 ml). The 
organics were separated and the aqueous layer extracted with CH2C12 ( 3 x 5  ml). The 
organics were combined and washed with 30% aqueous Q 1SO4 solution (1 x 10 ml), H20  (3 
x 10 ml), saturated brine (3 x 10 ml), then dried (MgS04), filtered and evaporated under 
reduced pressure. The residual yellow oil was purified by FCC (30% Et20/petrol) to give 
the title compound 257 (80 mg, 89%) as a clear oil, [a]n -5.6 (c 0.93 in CHC13);
vmax(film) 3068, 2931, 2857, 1598, 1495, 1455, 1428, 1363, 1189, 1177, 1110, 1044, 968, 
816, 741, 703 and 666 cm-1; 8H (400 MHz, CDC13) 7.66 (2H, d, J  8.3 Hz, Ar), 7.53-7.50 
(4H, m, Ar), 7.39-7.17 (13H, m, Ar), 4.30 (2H, s, CH2OCtf2Ph), 3.98 (1H, dd, J  9.3 Hz and
6.4 Hz), 3.90-3.84 (1H, m), 3.62-3.58 (1H, m, CH2Ctf(OSi)CH(CH3)), 3.16-3.08 (2H, m),
2.36 (3H, s, S02ArCtf3), 1.88-1.81 (1H, m, CH2CH(OSi)Ctf(CH3)), 1.40-0.84 (15H, m,
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includes 0.87 (9H, s, *Bu), 0.81 (3H, d, J  6.9 Hz, CH(OSi)CH(Ci/3)); 5C (100MHz, CDC13)
145.1 (s), 139.1 (s), 136.5 (d), 135.0 (s), 134.0 (s), 133.7 (s), 130.4 (d), 130.3 (d), 130.1 (d),
128.9 (d), 128.5 (d), 128.2 (d), 128.2 (d), 128.1 (d), 128.0 (d), 77.8 (d), 73.9 (d), 73.8 (t),
73.4 (t), 70.5 (t), 34.1 (t), 29.9 (t), 27.6 (q), 22.8 (t), 22.2 (q), 20.0 (s), 10.9 (q); m/z (+FAB) 
643 (M-H)+, 473, 443, 419, 389, 353, 333, 293, 273, 217, 197, 183, 135, 121, 109, 91, 71; 
found: C, 70.8; H, 7.6. C38H48C>5SSi requires C, 70.8; H, 7.5%.







To a stirred solution of alcohol 264 (390 mg, 0.80 mmol) in CH2CI2 (2.6 ml) was added 
Dess-Martin periodinane reagent (440 mg, 1.04 mmol). After 17 mins sat. aqueous NaHC03 
(25 ml) and Et20 (25 ml), was added then stirred for 5 mins. The organics were separated 
and the aqueous extracted with Et20 (4 x 20 ml). The organics were combined and washed 
with H2O (1 x 25 ml), sat. brine (3 x 25 ml), then dried (MgSC>4), filtered and evaporated 
under reduced pressure. The residual yellow oil was purified by FCC (50% Et20/petrol) to 
give the title compound 266 (385 mg, 99%) as a clear oil, [a]™ +5.1 (c 0.92 in CHC13);
V m ax(film ) 3069, 2933, 2857, 2709, 1729, 1589, 1472, 1454, 1427,1390, 1361,1111, 1027, 
1007, 822,740,702, 665 and 613 cm-1; 6h (270 MHz, CDC13) 9.71 (1H, s, CHO), 7.67-7.63 
(4H, m, SiPh), 7.43-7.18 (11H, m, Ph), 4.38 (2H, s, CH2OCtf2Ph), 4.22-4.13 (1H, m, 
CH2Ctf(OSi)CH(CH3), 3.25 (2H, t, J  6.3 Hz, OT2OCH2Ph), 2.39 (1H, dq, /  6.9 Hz and 3.0 
Hz, CH(OSi)Ci/(CH3)CHO), 1.63-1.24 (3H, m), 1.23-1.02 (6H, m, includes 1.09 (3H, d,J
6.8 Hz, CH(OSi)CH(C/73)), 1.02 (9H, s, 15 m); 6C (67.5MHz, CDC13) 204.9 (s), 138.4 (s),
136.2 (d), 135.9 (d), 135.8 (d), 135.5 (d), 135.5 (d), 134.1 (s), 133.1 (s), 129.8 (d), 129.6 (d),
128.2 (d), 128.0 (d), 127.6 (d), 127.4 (d), 127.4 (d), 127.1 (d), 72.9 (d), 72.7 (t), 69.7 (t),
50.5 (d), 33.9 (t), 29.2 (t), 26.9 (q), 22.2 (t), 19.3 (s), 7.0 (q); m/z (+FAB) 511 (M+Na), 487
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(M-H), 431, 373, 339, 325, 283,263, 239, 233, 223, 205,199,183,161,145,135,121, 105; 
observed: M+Na, 511.2668. C3iH4oNa03Si requires M+Na, 511.2644.





To a suspension of (methoxymethyl)triphenylphosphonium chloride (3.23 g, 9.42 mmol) in 
Et20 (30 ml) was added phenyl lithium (5.23 ml, 1.8M solution in cyclohexane/Et20, 9.42 
mmol). After 15 mins, the contents of the flask were cooled to -78°C before the dropwise 
addition of a pre-cooled (-78°C) solution of aldehyde 266 (1.83 g, 3.75 mmol) in Et20 (10 
ml) over 25 mins via cannula. After 35 mins the mixture was allowed to warm to RT, and 
stirred for 0.5 h before addition of HCIO4 (5 drops , 60% conc.). After ca. 15 mins, the 
mixture was cautiously quenched by addition of saturated aqueous NaHCC>3 (10 ml), and 
the organics were separated. The aqueous layer was extracted with Et20 (4 x 15 ml), the 
organics were combined, washed with H2O (1 x 10 ml), saturated aqueous brine (3 x 10 ml), 
then dried (MgSC>4), filtered and evaporated under reduced pressure. The resultant orange 
oil was taken up in THF (10 ml) and treated with TFA (0.75 ml) and H2O (2.5 ml). After 
stirring for 35 mins, the reaction was quenched by cautious addition of sat. aqueous 
NaHCC>3 (15 ml), and diluted with Et20 (10 ml). The organics were separated and the 
aqueous layers were extracted with Et20 (4x15 ml). The organics were combined, washed 
with H2O (1x15  ml), sat. brine (3 x 15 ml), then dried (MgSC>4), filtered and evaporated 
under reduced pressure. The residual orange oil purified by FCC (20% Et20/petrol) to give 
a mixture (1.41 g) of the co-running homologated aldehyde 265 and its corresponding bis- 
methoxy acetal 268 which was used directly in the next step as follows.
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Method A from aldehyde 265
To a cooled (0°C), stirred slurry of NaH (142 mg, @95%, 5.61 mmol) in THF (5 ml) 
containing 15-Crown-5 (0.2 ml, 0.56 mmol) was added a pre-mixed solution of crude 
aldehyde 265 (1.41 g, ca. 2.81 mmol) and diethylbenzylphosphonate (0.88 ml, 4.21 mmol) 
in THF (15 ml). The reaction was allowed to warm to RT and stirred for a further lh  20 
mins. The contents were then poured into 2M NaOH (10 ml) and extracted with CH2CI2 (4 
x 10 ml). The organics were combined and washed with H2O (1 xlO ml), saturated aqueous 
brine (3 x 10 ml), then dried (MgSC>4), filtered and evaporated under reduced pressure. The 
residual yellow oil was purified by FCC (20% Et20/petrol) to give the title compound 271 
(1.139 g, 52%) as a clear oil, [a ]*9 +29.0 (c 0.94 in CHCI3); vmax(film) 3068, 3026, 2931,
2856, 1589, 1495, 1472, 1454,1427, 1379, 1361, 1307, 1259, 1189, 1110, 1072, 1028, 966, 
939, 821, 740, 702 and 666 cm-1; 8h (270 MHz, CDCI3) 7.71-7.50 (4H, m, Ph), 7.42-7.18 
(16H, m, Ph), 6.27 (1H, d, J  15.8 Hz, CH2CHCOTh), 6.10-5.95 (1H, m, CH2CtfCHPh), 
4.40 (2H, s, PhCtf2OCH2), 3.70-3.61 (1H, m, CH2Ctf(OSi)CH(CH3), 3.26 (2H, t, J  6.5 Hz, 
PhCH2OCtf2), 2.50-2.38 (1H, m, Ctf2CHCHPh), 2.12-1.98 (1H, m, Ctf2CHCHPh), 1.80- 
1.60 (1H, m, CH(OSi)C/f(CH3)CH2), 1.53-1.00 (15H, m, includes 1.06 (9H, s, {Bu), 0.87 
(3H, d, J  6.9 Hz, CH(OSi)CH(Ctf3)); 5C (67.5 MHz, CDCI3) 138.9 (s), 138.1 (s), 136.3 (d),
135.1 (s), 134.6 (s), 131.1 (d), 130.4 (d), 129.7 (d), 129.6 (d), 128.6 (d), 128.5 (d), 127.8 (d),
127.7 (d), 127.6 (d), 127.0 (d), 126.1 (d), 76.5 (d), 73.0 (t), 70.4 (t), 38.0 (d), 36.7 (t), 33.6 
(t), 29.8 (t), 27.4 (q), 22.8 (t), 19.8 (s), 14.2 (q); m/z (+FAB) 577 (M+H), 549, 399, 369, 
351, 281, 221,199,183,137,117, 91; found: C, 81.4; H, 8.6. C39H480 2Si requires C, 81.2; 
H, 8.4%.
Method B from aldehyde 265
To a stirred suspension of benzyltriphenylphosphonium bromide (84mg, 0.19 mmol) in 
Et20  (0.6 ml), was added PhLi (115 pi, 1.8 M solution in cyclohexane:Et20 , 0.21 mmol) 
dropwise at RT. After 25 mins, a solution of aldehyde 265 (75 mg, 0.15 mmol) in Et20  (0.6 
ml) was added dropwise via cannula over 5 mins. After lh, the mixture was diluted with 
Et20  (20 ml) and filtered, then evaporated under reduced pressure. The residual yellow oil 
was purified by FCC (20% Et20/petrol) to give both the E/Z isomers of title compound 271 
as a 1.6:1 mixture (83 mg, 97%) as a clear oil.
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Method C from aldehyde 265
To a cooled (-78°C), stirred solution of benzylphenyl sulfone (109 mg, 0.47 mmol) in THF 
(1.0 ml) was added nBuLi (292 pi, 1.6 M solution in hexanes, 0.47 mmol). After 30 mins a 
solution of aldehyde 265 (196 mg, 0.39 mmol) in THF (1.0 ml) was added dropwise via 
cannula. After 25 mins, the mixture was partitioned between a saturated aqueous solution of 
NH4CI (10 ml) and CH2CI2 (10 ml). The organics were separated and the aqueous layer 
extracted with CH2CI2 (3 x 10 ml). The organics were combined, washed with saturated 
aqueous brine (1 x 10 ml) then dried (MgSC>4), filtered and evaporated under reduced 
pressure. The resulting crude (3-hydroxy sulfones were then treated with acetic anhydride 
(0.1 ml) and pyridine (0.2 ml) for 3h, before partitioning between a saturated aqueous 
solution of NH4CI (10 ml) and CH2CI2 (10 ml). The organics were separated and the 
aqueous extracted with CH2CI2 (3 x 10 ml). The organics were combined, washed with 2M 
HC1 (1 x 10 ml), H2O (1 x 10 ml), saturated aqueous Q 1SO4 (1 x 10 ml), saturated aqueous 
brine (2 x 10 ml) then dried (MgSC>4), filtered and evaporated under reduced pressure. The 
resultant crude P-acetoxy sulfones were treated with magnesium powder (30 mg, 1.2 mmol) 
and HgCl2 (catalytic) in anhydrous EtOH (2.0 ml) for 45 mins. The mixture was poured into 
cold 0.5M HC1 (5 ml) and extracted with Et20 (3 x 10 ml). The organics were combined, 
washed with H2O (1 x 10 ml), saturated aqueous NaHCC>3 (1 x 10 ml), H2O (1 x 10 ml), 
saturated aqueous brine (2 x 10 ml), then dried (MgSCU), filtered and evaporated under 
reduced pressure. The residual yellow oil was purified by FCC (20% Et20/petrol) to give 
both the E/Z isomers of title compound 271 as a 2.6:1 mixture (126 mg, 56%) as a clear oil.





To a stirred solution of 271 (56 mg, 0.10 mmol) in CH2CI2 (1.0 ml) was added boron 
trichloride-dimethyl sulfide complex (315|il, 2M solution in CH2CI2, 0.63 mmol) dropwise 
over 4 mins. After 1.5 h the mixture was quenched by addition of saturated aqueous 
NaHCC>3 (5 ml) and diluted with CH2CI2 (5.0 ml). The organics were separated and the 
aqueous layer extracted with CH2CI2 (4 x 5.0 ml). The organics were combined and washed 
with H2O (1 x 10 ml), saturated aqueous brine (3 x 10 ml), then dried (MgSC>4), filtered and 
evaporated under reduced pressure. The residual yellow oil was purified by FCC (50% 
Et20/petrol) to give the title compound 274 (45 mg, 95%) as a clear oil, [a]^ +38.5 (c 1.96
in CHCI3); vmax(film) 3353, 3069, 3024, 2932, 2857, 1472, 1457, 1427, 1388, 1361, 1110, 
1049, 965, 821, 740, 702, 665 and 612 cm-1; 5H (500 MHz, CDCI3) 7.73-7.70 (4H, m, Ph), 
7.45-7.41 (2H, m, Ph), 7.38-7.23 (8H, m, Ph), 122-119  (1H, m, Ph), 6.30 (1H, d, J  15.8 Hz, 
CH2CHCtfPh), 6.10-6.03 (1H, m, CH2C#CHPh), 3.71 (1H, dt, /  6.3 Hz and 2.7 Hz, 
CH2Ctf(OSi)CH(CH3), 3.41 (2H, dt, J 6.6 Hz and 1.1 Hz, CH2C/f2OH), 2.52-2.46 (1H, m, 
C//2CHCHPh), 2.12-2.05 (m , m, Ctf2CHCHPh), 1.75-1.70 (1H, m), 1.5M.36 (2H, m), 
1.31-1.22 (2H, m), 1.21-1.08 (11H, m, includes 1.10 (9H, s, '£«)), 0.92 (3H, d, J  6.8 Hz, 
CH(OSi)CH(Ctf3); 8c(!25MHz, CDCI3) 137.8, 136.1, 136.0, m .8 ,  134.3, 130.9, 130.1,
129.5, 129.4,128.4,127.5,127.3, 126.8, 125.9, 76.2, 62.7, 37.9, 36.5, 33.3, 32.5, 27.1, 22.1, 
!9.6, 14.0; m/z (+FAB) 509 (M+Na), 413, 301, 241, 197, 173, 137, 115, 91; found: C, 79.3; 
H, 8.9. C32H42C>2Si requires C, 79.0; H, 8.7%.




To a stirred solution of alcohol 274 (105 mg, 0.22 mmol) in CH2CI2 (2.1 ml) was added 
Dess-Martin periodinane reagent (110 mg, 0.26 mmol). After 5 mins “wet” CH2CI2 (0.5 ml) 
was added and after 15 mins the reaction was concentrated in vacuo before the addition of
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1:1 solution of saturated aqueous NaHCC>3 / 1M Na2S2C>3 (25 ml) and Et20 (25 ml), then 
stirred for 25 mins. The organics were separated and the aqueous extracted with Et20 (3 x 
20 ml). The organics were combined and washed with H2O (1 x 25 ml), saturated aqueous 
brine (3 x 25 ml), then dried (MgSC>4), filtered and evaporated under reduced pressure. The 
residual yellow oil was purified by FCC (50% Et20/petrol) to give the title compound 275 
(98 mg, 94%) as a clear oil, [a]J>7 +38.2 (c 0.86 in CHCI3); vmax(film) 3070, 3024, 2931,
2856, 2715, 1725, 1589, 1494, 1472, 1461, 1427, 1388, 1361, 1187, 1110, 1072, 966, 938, 
821, 740, 702 and 665 cm-1; 5H (500 MHz, CDCI3) 9.53 (1H, t, J  1.4 Hz, CHO), 7.70-7.67 
(4H, m, SiPh), 7.47-7.04 (11H, m, Ph), 6.28 (1H, d, J  15.8 Hz, CH2CHC//Ph), 6.06-6.00 
(1H, m, CH2C#CHPh), 3.70-3.63 (1H, m, CH2Ctf(OSi)CH(CH3), 2.52-2.45 (1H, m), 2.13-
2.01 (3H, m), 1.80-1.67 (1H, m), 1.48-1.33 (4H, m), 1.07 (9H, s ,1Bu), 0.88 (3H, d, J  6.8 Hz, 
CH(OSi)CH(C//3); 8c a25MHz, CDCI3) 202.3, 137.8, 136.1, 136.0, 131.1, 129.8, 130.0,
129.5, 128.4, 127.5, 127.5, 125.9, 109.6, 75.9, 38.0, 32.9, 27.1, 18.5, 14.1; m/z (+FAB) 485 
(M+H), 427 (M-tBu), 339, 221, 199, 183, 165, 145, 129, 123, 117, 105; observed: M+H, 
485.2891. C32H4i 0 2Si requires M+H, 485.2876




To a stirred solution of aldehyde 275 (76 mg, 0.16 mmol) in CH2CI2 (2.0 ml) was added
1,3-propanedithiol (16 pi, 0.16 mmol) followed by boron trifluoride etherate (4 pi, 0.03 
mmol). After 12 h, the reaction was concentrated in vacuo. The residual yellow oil was 
purified by FCC (10% Et20/petrol) to give the title compound 255 (90 mg, 100%) as a clear 
oil, [a ]”  +24.2 (c 1.6 in CHCI3); vmax(film) 3069, 3023, 2931, 2895, 2856, 1588, 1493,
1474, 1461, 1426, 1380, 1360, 1275, 1110, 1072, 1051, 1026, 966, 821, 740, 702 and 612
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cm-1; 5h (500 MHz, CDCI3) 7.70-7.67 (4H, m, Ph), 7.46-7.40 (2H, m, Ph), 7.39-7.32 (4H, 
m, Ph), 7.31-7.25 (4H, m, Ph), 7.21-7.16 (1H, m, Ph), 6.27 (1H, d, J  15.8 Hz, 
CH2CHC//Ph), 6.08-5.95 (1H, m, CH2CtfCHPh), 3.79 (1H, t, J  7.0 Hz, CH2SCtfSCH2),
3.70-3.64 (1H, m, CH2Ctf(OSi)CH(CH3), 2.83-2.72 (4H, m), 2.47-2.38 (1H, m, 
Ctf2CHCHPh), 2.11-2.02 (2H, m), 1.87-1.77 (1H, ra), 1.73-1.63 (1H, m), 1.52-1.41 (3H, 
m), 1.40-1.20 (3H, m), 1.08 (9H, s, '£«), 0.89 (3H, d, J  6.8 Hz, CH(OSi)CH(Ctf3); 5C 
(125MHz, CDC13) 137.8 (s), 136.0 (d), 134.8 (s), 130.9 (s), 130.0 (d), 129.5 (s), 129.4 (d),
128.4 (d), 127.5 (d), 127.4 (d), 126.7 (d), 125.9 (d), 76.0 (d), 47.3 (d), 37.6 (d), 36.6 (t), 35.2 
(t), 33.2 (t), 30.3 (t), 27.2 (q), 26.0 (t), 22.9 (t), 19.5 (s), 13.8 (q); m/z (+FAB) 573 (M-H)+, 
517 (M-tBu), 319, 281, 221, 199, 135, 117, 91, 73; observed: M+-‘Bu, 517.2101. 
C3iH370SiS2 requires M+-lBu, 517.2055.
Preparation of (3R, 4/?)-8-(benzyloxy)-4-(terf-butyidiphenylsilyIoxy)-3-methyIoctanol 








To a suspension of (methoxymethyl)triphenylphosphonium chloride (2.29 g, 6.68 mmol) in 
Et20  (25 ml) was added phenyl lithium (3.71 ml, 1.8M solution in cyclohexane/Et20 , 6.68 
mmol). After 15 mins, the contents of the flask were cooled to -78°C before the dropwise 
addition of a pre-cooled (-78°C) solution of aldehyde 266 (1.30 g, 2.66 mmol) in Et20  (7 
ml) over 20 mins via cannula. After 40 mins the mixture was allowed to warm to RT, and 
stirred for 0.5 h before addition of HCIO4 (5 drops, 60% conc.) and the reaction was
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followed closely by tic. After ca. 15 mins, the mixture was cautiously quenched by addition 
of saturated aqueous NaHCC>3 (10 ml), and the organics separated. The aqueous layers were 
extracted with Et20 (4 x 10 ml), the organics were combined, washed with H2O (1 x 10 ml), 
saturated aqueous brine (3 x 10 ml), then dried (MgSC>4), filtered and evaporated under 
reduced pressure. The residual orange oil was purified by FCC (20% Et20/petrol) to give a 
mixture (0.934 g) of the co-running homologated aldehyde 265 and its corresponding bis- 
methoxy acetal 268 which was used directly in the next step as follows. To a stirred solution 
of the impure aldehyde (0.934 g) in MeOH (15 ml) was added NaBH4 (140 mg, 3.720 
mmol). After lh, the reaction was quenched by addition of saturated aqueous NH4CI (5 ml) 
and the bulk of the MeOH removed by concentration in vacuo. The aqueous phase was 
extracted with CH2CI2 (4 x 25 ml). The organics were combined and washed with H2O (1 x 
25 ml), saturated aqueous brine (3 x 25 ml), then dried (MgS04), filtered and evaporated 
under reduced pressure. The residual yellow oil was purified by FCC (50% Et20/petrol) to 
give the title compounds 268 (0.225 g, 15%) and 299 (0.652 g, 49%) both as clear oils.
Less polar 268, [a]® -10.5 (c 0.90 in CHC13); vmax(film) 3069, 3047, 2932, 2856, 
1472, 1454,1427,1388,1362,1191,1110,1055,960, 822,740,702 and 613 cm-1; Sh (500 
MHz, CDCI3) 7.70-7.65 (4H, ra, Ph), 7.42-7.24 (11H, m, Ph), 4.39 (2H, s, PI1C/72OCH2), 
4.30 (1H, t, J  5.9 Hz, CH3OCHOCH3), 3.20-3.28 (8H, ra, PhCH2OCtf2 and 2x OC//3), 1.84 
-1.77 (1H, m), 1.76-1.67 (1H, m), 1.52-1.39 (2H, m), 1.37-1.24 (3H, m), 1.13-1.00 (11H, m, 
includes 1.04 (9H, s, 'Bu)), 0.89 (3H, d, J  6.8 Hz, CH(OSi)CH(CH3)CH2); 8c  (125MHz, 
CDCI3) 138.6 (s), 136.0 (d), 136.0 (d), 135.0 (s), 134.1 (s), 129.5 (d), 129.3 (d), 12 8.3 (d),
127.6 (d), 127.5 (d), 127.3 (d), 103.5 (d), 76.7 (d), 72.7 (t), 70.1 (t), 52.7 (q), 52.4 (q), 35.8 
(t), 33.6 (t), 33.3 (d), 29.5 (t), 27.1 (q), 22.4 (t), 19.5 (s), 13.9 (q); m/z (+FAB) 547 (M-H)+, 
537, 517 (M-OCH3), 503,485,459,445, 427, 409, 395, 383, 369, 353, 299, 261,239, 197, 
135,91; found: C, 74.8; H, 9.0. C34H48C>4Si requires C, 74.4; H, 8.8%.
More polar 299, [a]® -17.0 (c 0.92 in CHCI3); vmax(filrn) 3415, 3070, 2932, 2857,
1472, 1455, 1427, 1361, 1110, 1050, 822, 739, 702 and 664 cn r1 ; 8h (500 MHz, CDCI3)
7.70-7.65 (4H, m, Ph), 7.44-7.24 (11H, m, Ph), 4.40 (2H, s, PhCH2OCH2), 3.65-3.57 (2H, 
m), 3.56-3.47 (1H, m), 3.30-3.22 (2H, m), 1.79-1.67 (2H, m), 1.56 (1H, bs, OH), 1.47-1.38 
(3H, m), 1.37-1.29 (2H, m), 1.27-1.15 (1H, m), 1.13-1.02 (10H, m, includes 1.05 (9H, s,
187
<Bu)), 0.89 (3H, d, J  6.8 Hz, CH(OSi)CH(C//3)CH2); 8c  (125MHz, CDClj) 138.6 (s), 136.0 
(d), 134.6 (s), 134.1 (s), 129.6 (d), 129.5 (d), 128.3 (d), 127.6 (d), 127.5 (d), 127.4 (d), 127.3 
(d), 77.1 (d), 72.8 (t), 70.1 (t), 61.6 (t), 35.7 (t), 34.7 (d), 33.0 (t), 29.6 (t), 27.1 (q), 22.7 (t),
19.5 (s), 15.0 (q); m/z (+FAB) 505 (M+H), 487 (M-OH), 249,199,183, 165,135, 121,105, 
91,69; found: C, 75.8; H, 9.1. C32H4403Si requires C, 76.1; H, 8.8%.









To a stirred solution of alcohol 299 (100 mg, 0.20 mmol) in CH2CI2 (1 ml) was added acetic 
anhydride (80 pi, 0.85 mmol) followed by pyridine (100 pi, 1.24 mmol). After 15h, the
mixture was concentrated in vacuo and the residual yellow oil was purified by FCC (50% 
Et20/petrol) to give the title compound 284 (105 mg, 97%) as a clear oil, [a]™ -4.9 (c 0.90
in CHCI3); vmax(filrn) 3070, 2933, 2857, 1739, 1472, 1455, 1428, 1388, 1364, 1243, 1110, 
1044, 822, 740, 702 and 613 cm-1; 8H (500 MHz, CDCI3) 7.73-7.69 (4H, m, Ph), 7.47-7.30 
(11H, m, Ph), 4.46 (2H, s, PhCtf2OCH2), 4.10-4.04 (1H, m, CH2OAc), 4.03-3.97 (1H, m, 
CH2OAc), 3.67-3.62 (1H, m, Ctf(OSi)CH(CH3)CH2), 3.35-3.26 (2H, m, PhCH2OCtf2),
2.06 (3H, s, OAc), 1.97-1.88 (1H, m), 1.77-1.68 (1H, m), 1.56-1.07 (16H, m, includes 1.10 
(9H, s, ton), 0.90 (3H, d, J  6.8 Hz, CH(OSi)CH(Ctf3)CH2); 8C (125MHz, CDCI3) 171.1 (s),
138.6 (s), ,136.0 (d), 134.7 (s), 134.1 (s), 129.6 (d), 129.4 (d), 128.3 (d), 127.6 (d), 127.5 
m(d), 127.4 (d), 127.3 (d), 76.6 (d), 72.8 (t), 70.1 (t), 63.2 (t), 34.3 (d), 33.0 (t), 31.3 (t), 29.6 
(t), 27.1 (q), 22.5 (t), 21.0 (q), 19.5 (s), 14.1 (q); m/z (+FAB) 545 (M-H)+, 517, 485, 471, 
439, 429, 339, 323, 291, 261, 241, 221, 199, 181, 161, 135, 91; found: C, 75.0; H, 8.9. 
C34H46C>4Si requires C, 74.7; H, 8.5%.
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Preparation of (3'R, 4\R)-[4,-(tert-butyIdiphenylsilyloxy)-8'-hydroxy-3,-methyloct-l,-yI]
acetate 300
To a stirred solution of 284 (475 mg, 0.87 mmol) in CH2CI2 (7.0 ml) was added boron 
trichloride-dimethyl sulfide complex (2.6 ml, 2M solution in CH2CI2, 5.22 mmol) dropwise 
over 6 mins. After 22 mins, the reaction was cautiously quenched by addition of saturated 
aqueous NaHCC>3 keeping the pH<7. The organics were separated and the aqueous layer 
was extracted with CH2CI2 (3x5  ml). The organics were combined and washed with H2O 
(1 x 10 ml), saturated aqueous brine (3 x 10 ml), then dried (MgSCXO, filtered and 
evaporated under reduced pressure. The residual yellow oil was purified by FCC (70% 
Et20/petrol) to give the title compound 300 (363 mg, 92%) as a clear oil, [a -1.7 (c 0.90
in CHCI3); Vmax(film) 3434, 3070, 3047, 2933, 2858, 1740, 1472, 1462, 1427, 1389, 1365, 
1244, 1110, 1044, 822, 741, 703, 688 and 614 cm' 1 ; §h (500 MHz, CDCI3) 7.70-7.63 (4H, 
m, Ph), 7.46-7.32 (6H, m, Ph), 4.08-4.02 (1H, m, CH2OAc), 4.00-3.93 (1H, m, Ctf2OAc), 
3.60 (1H, dt, 76.2 Hz and 2.8 Hz, Ctf(OSi)CH(CH3)CH2), 3.40 (2H, t, 76.3 Hz), 2.02 (3H, 
s, OAc), 1.93-1.85 (1H, m), 1.74-1.65 (1H, m), 1.53-1.07 (7H, m), 1.05 (9H, s, Wu), 0.87 
(3H, d, 76.9 Hz, CH(OSi)CH(C^3)CH2); 5C (125MHz, CDCI3) 171.2 (s), 136.0 (d), 136.0 
(d), 134.8 (s), 134.1 (s), 129.6 (d), 129.4 (d), 127.5 (d), 127.4 (d), 76.5 (d), 63.2 (t), 62.7 (t),
34.4 (d), 32.9 (t), 32.5 (t), 31.4 (t), 27.1 (q), 22.0 (t), 21.0 (q), 19.5 (s), 14.2 (q); m/z (+FAB) 
457 (M+H), 439, 395, 381, 369, 323, 241, 221, 199, 161, 135, 81; found: C, 71.2; H, 9.0. 
C27H4oC>4Si requires C, 71.0; H, 8.8%.
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To a stirred solution of alcohol 300 (274 mg, 0.60 mmol) in CH2CI2 (8.0 ml) was added 
Dess-Martin periodinane reagent (331 mg, 0.78 mmol). After 11 mins H2O (1 drop) was 
added and after a further 35 mins the reaction was concentrated in vacuo before the addition 
of 1:1 solution of saturated aqueous NaHCC>3 / 1M £Ja2S2C>3 (25 ml) and Et20 (25 ml). The 
mixture was stirred for 30 mins. The organics were separated and the aqueous layer 
extracted with Et20 (3 x 20 ml). The organics were combined and washed with H2O (1 x 25 
ml), saturated aqueous brine (3 x 25 ml), then dried (MgS04), filtered and evaporated under 
reduced pressure. The residual yellow oil was purified by FCC (30% Et20/petrol) to give 
the title compound 301 (251 mg, 92%) as a clear oil, [a]™ -1.5 (c 0.90 in CHCI3);
V n i a x ( f i b n )  3070, 3048, 2958, 2932, 2857, 2715, 1739, 1472, 1462, 1427, 138 8, 1365, 1243, 
1110, 1043, 822, 741, 703, 688 and 613cm-l; 5H (500 MHz, CDCI3) 9.52 (1H, t, J 1.5 Hz, 
CHO), 7.70-7.64 (4H, m, Ph), 7.45-7.32 (6H, m, Ph), 4.09-4.01 (1H, m, CH2OAc), 4.00- 
3.93 (1H, m, CH2OAc), 3.61-3.56 (1H, m, Ctf(OSi)CH(CH3)CH2), 2.10-2.05 (2H, m 
C7/2CHO), 2.02 (3H, s, OAc), 1.95-1.87 (1H, m), 1.75-1.67 (1H, m), 1.50-1.28 (5H, m),
1.05 (9H, s, *Bu), 0.86 (3H, d, J  6.8 Hz, CH(OSi)CH(Ctf3)CH2); 5C (125MHz, CDCI3) 
202.2 (s), 171.1 (s), 136.0 (d), 135.9 (d), 134.5 (s), 133.9 (s), 129.7 (d), 129.6 (d), 127.6 (d),
127.5 (d), 76.2 (d), 63.1 (t), 43.5 (t), 34.5 (d), 32.5 (t), 31.1 (t), 27.1 (q), 21.0 (q), 19.5 (s),
18.5 (t), 14.3 (q); m/z (+FAB) 477 (M+Na), 455 (M+H), 397 (M-tBu), 337, 323, 241, 221, 
199, 181, 165, 149, 140, 121, 111; observed: M+H, 455.2600. C27H390 4Si requires M+H, 
455.2618.
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To a stirred solution of aldehyde 301 (89 mg, 0.20 mmol) in CH2CI2 (1.0 ml) was added
1,3-propanedithiol (19 pi, 0.20 mmol) followed by boron trifluoride etherate (5 pi, 0.04 
mmol). After 16 h, the reaction was concentrated in vacuo. The residual yellow oil was 
purified by FCC (30% Et20/petrol) to give the title compound 285 (93 mg, 87%) as a clear 
oil, [a]”  -12.4 (c 0.95 in CHCI3); vma*(film) 3069, 3047, 2932, 2895, 2856, 1739, 1472, 
1461, 1427,1388,1364, 1242, 1110, 1044, 822, 741,703,688 and 613 cm-l;8H (500 MHz, 
CDCI3) 7.70-7.65 (4H, m, SiPh), 7.45-7.35 (6H, m, SiPh), 4.05-3.98 (1H, m, Ctf2OAc), 
3.97-3.91 (1H, m, Cff2OAc), 3.78 (1H, t, J  7.0 Hz, CH2SCHSCH2), 3.58 (1H, dt, J  5.9 Hz 
and 2.8 Hz, C//(OSi)CH(CH3)CH2), 2.82-2.72 (4H, m), 2.11-2.04 (1H, m), 2.01 (3H, s, 
OAc), 1.89-1.77 (2H, m), 1.71-1.62 (1H, m, CH(OSi)CH(CH3)CH2), 1.52-1.39 (4H, m),
1.38-1.18 (4H, m), 1.05 (9H, s, lBu), 0.86 (3H, d, J  6.8 Hz, CH(OSi)CH(CH3)CH2); m/z 
(+FAB) 543 (M-H)+, 487, (M-‘Bu), 467, 445, 429, 409, 367, 323, 289, 271,241, 199, 181, 
155,95, 75; found: C, 66.2; H, 8.5. C3oH4403S2Si requires C, 66.1; H, 8.1%.
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To a stirred solution of acetate 285 (205 mg, 0.38 mmol) in MeOH (1.5 ml) was added 
K2CO3 (104 mg, 0.76 mmol). After lh, the mixture was filtered and concentrated in vacuo. 
The residual yellow oil was purified by FCC (loaded with 30% Et20/petrol containing 
MeOH (100 |il) to complete dissolution, then developed and eluted with 30% Et20/petrol) 
to give the title compound 286 (186 mg, 98%) as a clear oil, [a -21.0 (c 0.90 in CHCI3); 
Vmax(film) 3437, 3069, 3047, 2932, 2894, 2856, 1472, 1461, 1427, 1381, 1110,1054, 1006, 
822, 741, 703, 688 and 614 cm '1; SH (270 MHz, CDCI3) 7.65-7.55 (4H, m, SiPh), 1A0-126  
(6H, m, SiP/i), 3.70 (1H, t, J  6.9 Hz, CH2S CffSCH2), 3.58-3.37 (3H, m, 
Ctf(OSi)CH(CH3)CH2 and CH2OH), 2.74-2.63 (4H, m), 2.05-1.95 (1H, m), 1.84-1.06 
(20H, m), 0.99 (9H, s, Wu), 0.77 (3H, d, J  6.9 Hz, CH(OSi)CH(C^3)CH2); 6C (67.5 MHz, 
CDCI3) 136.0 (d), 134.5 (s), 134.0 (s), 129.6 (d), 129.5 (d), 127.5 (d), 127.4 (d), 76.7 (d),
61.4 (t), 47.2 (d), 35.9 (t), 35.1 (t), 34.3 (d), 32.9 (t), 30.2 (t), 30.2 (t), 27.1 (q), 26.0 (t), 23.0 
(t), 19.5 (s), 14.7 (q); m/z (+FAB) 503 (M+H), 501 (M-H)+, 445, 367, 295, 247, 229, 213, 




The following section contains experimental details for some of the compounds that deviate 
from the main synthetic route. They have not been fully characterised as they were 
generated as stereoisomeric mixtures, and hence difficult to characterise. They are included 
here as a reference for future workers.





To a cooled (0°C), stirred solution of aldehyde 275 (271 mg, 0.56 mmol) in CH2CI2 (0.8 
ml) containing zinc iodide (1 mg, catalytic amount) was added trimethylsilyl cyanide (115 
pi, 0.86 mmol). The reaction was allowed to warm to RT. After 0.5 h, THF (200 pi), TFA
s
(200 pi) and H2O (200 pi) were added and the mixture was stirred for 10 minutes. The 
mixture was then neutralised by addition of saturated aqueous NaHCC>3 and diluted with 
CH2CI2 (5.0 ml). The organics were separated and the aqueous extracted with CH2CI2 (4 x 
5 ml). The organics were combined and washed with H2O (1 x 10 ml), saturated aqueous 
brine (3 x 10 ml), then dried (MgSC>4), filtered and evaporated under reduced pressure. The 
residual yellow oil was purified by FCC (30% Et20/petrol) to give a 1:1 mixture of 
inseparable diastereoisomers 279 (250 mg, 88%) as a clear oil, Vniax(filni) 3444,3070,3024, 
2956, 2931, 2891, 2857, 2247, 1652, 1589, 1494, 1472, 1461, 1427, 1389, 1361, 1110, 
1072, 966, 821, 741, 703 and 613 cm-l;SH (270 MHz, CDCI3) 7.72-7.60 (8H, m, Ph), 7.47- 
7.15 (22H, m, Ph), 6.30 (2H, d, J  15.8 Hz, CH2CHCtfPh), 6.12-5.99 (2H, m, 
CH2CtfCHPh), 4.16-4.03 (2H, m, H O C i / ( C N ) C H 2), 3.72-3.62 (2H, m, 
CH2Ctf(OSi)CH(CH3), 2.56-2.43 (2H, m, CH2CHCHPh), 2.13-2.00 (2H, m, 
Ctf2CHCHPh), 1.94-1.82 (2H, m), 1.80-1.64 (2H, m, CH2CH(OSi)Ctf(CH3), 1.53-1.12 
(10H, m), 1.08 (18H, s, {Bu), 0.96-0.80 (3H, m, CH(OSi)CH(Cff3).
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Preparation of ethoxyethy! protected cyanohydrin 277
Eticy
OTBDPS OTBDPS
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279 277
To a cooled (0°C), stirred solution of cyanohydrin 279 (250 mg, 0.49 mmol) in CH2CI2 (2.0 
ml) containing pyridinium p-toluenesulfonate (catalytic amount) was added ethyl vinyl ether 
(94 pi, 0.98 mmol). The reaction was allowed to warm to RT and stirred for 2 h after which 
time more pyridinium p-toluenesulfonate (catalytic amount) and ethyl vinyl ether (94 pi, 
0.98 mmol) were added. After 3 h, finely powdered K2CO3 (10 mg) was added. After 10 h, 
the reaction was diluted with CH2CI2 (5 ml) and washed with saturated aqueous NaHCC>3 (1 
x 5 ml), H2O ( 1 x 5  ml), saturated aqueous brine ( 3 x 5  ml), then dried (MgSCU), filtered 
and evaporated under reduced pressure. The residual yellow oil was purified by FCC (10% 
Et20/petrol) to give a 1:1:1:1 mixture of diastereoisomers 277 (239 mg, 84%) as a clear oil, 
8h  (500 MHz, CDCI3) 7.74-7.61 (16H, m, Ph), 7.45-7.38 (8H, m, Ph), 7.37-7.30 (16H, m, 
Ph), 7.29-7.20 (16H, m, Ph), 7.19-7.13 (4H, m, Ph), 6.29 (4H, d, J  15.8 Hz, CH2CHC//Ph), 
6.08-5.98 (4H, m, CH2C//CHPh), 4.86-4.80 (2H, m, EtOC/7(CH3)OCH(CN)), 4.73-4.66 
(2H, m, EtOC/f(CH3)OCH(CN)), 4.24 (1H, t, J  6.5 Hz, EEOC//(CN)CH2), 4.18 (1H, t, J
6.5 Hz, EEOC//(CN)CH2), 4.00 (1H, t, J  6.5 Hz, EEOCtf(CN)CH2), 3.96 (1H, t, J  6.5 Hz, 
EEOCtf(CN)CH2), 3.72-3.64 (4H, m), 3.63-3.55 (4H, m), 3.53-3.37 (4H, m), 2.52-2.41 
(4H, m, C tf2CHCHPh), 2.10-1.97 (4H, m, CH2CHCHPh), 1.77-1.65 (4H, m, 
CH(OSi)Ctf(CH3)CH2), 1.60-1.10 (48H, m), 1.09-1.06 (36H, m, {Bu), 0.91-0.82 (12H, m, 
CH(OSi)CH(C//3)CH2.
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Cyanohydrin 279 (80 rag, 0.16 mmol) was treated with p-TsOH (catalytic amount) followed 
i by 2-methoxypropene (0.9 ml). After 5 mins, finely powdered K2CO3 (10 mg) was added
1
and after 5 mins, triethylamine (0.1 ml) was added. The mixture was concentrated in vacuo 
! and the residual yellow oil was purified by FCC (10% Et20/petrol) to give a 1:1 mixture of
diastereoisomers (73 mg, 82%) as a clear oil, 8h (270 MHz, CDCI3) 7.74-7.63 (8H, m, Ph), 
7.47-7.15 (22H, m, Ph), 6.29 (2H, d, J  15.5 Hz, CH2CHCffPh), 6.10-5.98 (2H, m, 
CH2CffCHPh), 4.21 (1H, t, J  6.3 Hz, -OCf/(CN)CH2), 4.12 (1H, t, J  6.3 Hz, 
-OC//(CN)CH2), 3.71-3.62 (2H, m, CH(OSi)CH(CH3)CH2), 3.16 (3H, s, OCJ/3), 3.15 (3H, 
s, OCH3), 2.55-2.42 (2H, m, 0 / 2CHCHPh), 2.11-1.98 (2H, m, O f2CHCHPh), 1.80-1.60 
(2H, m, CH(OSi)Cfl(CH3)CH2), 1.50-1.10 (24H, m), 1.08 (18H, s, <Bu), 0.89 (3H, d, 76.9 
Hz, CH(OSi)CH(Cff3)CH2) 0.88 (3H, d, J  6.9 Hz, CH(OSi)CH(OT3)CH2).
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199 2 0 0
To a vigorously stirred solution of diene 182 (0.50 g, 1.03 mmol) in lBuOH (1.5 ml) and 
H2O (1.5 ml) was added AD-mix-(3 (1.44 g) followed by K2S2O8 (278 mg, 1.03 mmol), 
(DHQD)2-PHAL (32 mg, 0.04 mmol), Os04 (catalytic) and CH3S 02NH2 (196 mg, 2.06 
mmol). After 2d, solid Na2S 03 (1.5 g) and EtO Ac were added and the mixture was stirred 
for 3h, then filtered and the solid residues re-extracted with EtOAc (x4). The filtrate and 
EtOAc extracts were combined, then dried (MgS04), filtered and evaporated under reduced 
pressure. The residue was purified by FCC (95% Et20/CH2Cl2, then increasing the polarity 
to 100% Et20 then 20% MeOH/EtOAc). The first compound eluted was the butenolide 198 
(70 mg, 13%), Sh (270 MHz, CDC13) 7.32-7.20 (15H, m, Ph), 6.10 (1H, s, CH=), 4.75-4.0 
(9H, m, 6x PhCi/2OCH2, PhCH2OCtf2, PhCH2OCH2CtfOH), 3.76 (1H, d, J  10.6 Hz, 
PhCH2O C tf2), 3-70 (1H, d, J  10.6 Hz, PhCH2OCtf2), 3.62-3.54 (1H, m, 
PhCH2OCtf2CHOH), 3.42-3.34 (1 H, m, PhCH2OCtf2CHOH), 2.93 (1 H, d, 74.8 Hz, OH); 
5C(100 MHz, CDC13) 171.4 (s), 169.2 (s), 137.3 (s), 137.23 (s), 137.20 (s), 128.5 (d), 128.0 
(d), 127.92 (d), 127.87 (d), 127.7 (d), 127.6 (d), 127.0 (d), 117.5 (d), 89.8 (s), 73.8 (t), 73.6 
(t), 73.2 (t), 70.5 (t), 70.1 (d), 69.1 (t), 66.1 (t), followed by the diol 196 (117 mg, 22%), 
5h (270 MHz, CDC13) 7.32-7.20 (15H, m, Ph), 5.98 (1H, t, J  6.2 Hz, CH=), 4.48-4.38 (7H, 
m, includes 4.48 (2H, s, PhCtf2OCH2), 4.43 (2H, s, PhCtf2OCH2) and 4.40 (2H, s,
196
PhCtf2OCH2) ), 4.28 (1H, s, CHOH or 3° OH), 4.14-3.91 (6H, m, 2x PhCH2OCtf2, 
C 02OT2CH3), 3.81-3.41 (3H, m, includes 3.81 (1H, d, 79.3 Hz, PhCH2OCtf2), 3.65 (1H, 
d, 7 9.3 Hz, PhCH20 CH2) ), 1.12 (3H, t, 77.0 Hz, CQ2CH2C »3); 5c(67.5 MHz, CDC13) 
172.0 (s), 138.0 (s), 137.6 (s), 137.5 (s), 130.2, 128.22, 128.18, 127.7, 127.63, 127.58, 
127.4, 76.5 (s), 73.7 (d), 73.5 (t), 72.4 (t), 72.1 (t), 66.1 (t), 64.8 (t), 61.2 (t), 13.8 (q), and 
then the triols 199 and 200 as a mixture.





























To a vigourously stirred solution of diene 201 (0.622 g, 1.1 mmol) in lBuOH (1.5 ml) and 
H20  (1.5 ml) was added AD-mix-p (1.44 g) followed by K2S20 s  (594 mg, 2.2 mmol,), 
(DHQD)2-PHAL (32 mg, 0.04 mmol), K20 s0 2(0 H)4 (catalytic) and CH3S0 2NH2 (196 mg,
2.06 mmol). After 7d, solid Na2S 03 (1.5 g) and EtOAc were added and the mixture stirred 
for 3h, then filtered and the solid residues re-extracted with EtOAc (x4). The filtrate and 
EtOAc extracts were combined and dried (MgS04), filtered and evaporated under reduced 
pressure. The residue was purified by FCC (50% Et20/petrol) to give an inseparable mixture
197
of the diols 202 and 203 (190 mg total) and an inseparable mixture of the tetrols 204 and
302 (57 mg, 8%) all as clear oils.




A mixture of tributyltin hydride (263 |il, 0.98 mmol), propargylic alcohol 149 (200 mg, 0.98 
mmol), and AIBN (1.6 mg, 0.01 mmol) were heated at 85°C under N2 for lh 15mins and 
then allowed to cool to RT. The mixture was purified by loading directly onto silica gel 
(10% Et20/petrol) to give the two title compounds 152 and 153 (405 mg, 89%) as an 
inseparable mixture, vmax(fihn)/cnrl 3357, 2956, 2879, 2855, 1463, 1397, 1376, 1253, 
1088, 1004, 836, 776 and 665; 5H(400 MHz, CDCI3) 6.46-6.42 (1H, m, CH=), 6.36-6.42 
(1H, m, CH=), 4.28-4.20 (4H, m, CH2), 4.15-4.07 (4H, m, CH2\  1.60-1.30 (36H, m, CH2), 
0.90-0.75 (36H, m, CJf3, *Bu); 8C(100 MHz, CDCI3) 145.5 (s), 140.0 (d), 136.5 (d), 70.2 (t), 
69.9 (t), 65.4 (t), 64.9 (t), 29.5 (t), 27.7 (t), 26.3 (s), 23.0 (s), 18.8 (s), 14.0 (q), 10.8 (t), 10.6 
(t).
Synthesis of the vinyl iodides 143 and 147 from their corresponding vinyl stannanes.
152 147
To a cooled (4°C), stirred solution of the stannanes 152 and 153 (249 mg, 0.54 mmol, as a 
1:1 mixture of isomers) in CCI4 (4 ml) was added a pre-cooled (0°C) solution of iodine (410 
mg, 1.61 mmol) in CCI4 (6 ml), dropwise via cannula. After 8 mins a saturated aqueous
solution of sodium thiosulfate (5 ml) was added and then the mixture was extracted with 
Et20 (3 x 10 ml). The organics were dried (MgSC>4), filtered and evaporated under reduced 
pressure. The residue was purified by FCC (10% Et20/petrol) to give the title compounds 




5h (270 MHz, CDC13) 7.75-7.67 (5H, m, Ph), 7.48-7.37 (5H, m, Ph), 6.23 (1H, tt, /  5.1 Hz 
and 1.5 Hz, CH2OT=), 4.32 (2H, dt, J  5.3 Hz and 1.3 Hz, SiOCtf2CH=), 4.19 (2H, d, J  1.3 
Hz, CH=C(I)C//2OH), 1.85 (1H, bs, OH), 1.07 (9H, s, lBu).
OAc
TBDPSC
6h (270 MHz, CDCI3) 7.68-7.65 (5H, m, Ph), 7.47-7.36 (5H, m, Ph), 6.26 (1H, t, J  5.1, 
CH2Ctf=), 4.72 (2H, s, CH2 OAc), 4.30 (2H, d, /  5.1 Hz with further splitting, 
SiOC//2CH=), 2.12 (3H, s, CH3CO), 1.06 (9H, s, lBu).
TBSO
5h (270 MHz, CDCI3) 6.17 (1H, tt, J  5.0 Hz and 1.3 Hz, CH=), 4.27 (2H, t, J  1.3 Hz, 
HC=C(I)CJ/2OH), 4.25-4.23(2H, m, SiOCtf2CH=), 1.97(1H, bs, OH), 0.90 (9H, s, lBu),
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8h (400 MHz, CDCI3) 6.26-6.22 (1H, m, CH=), 4.70-4.68 (2H, d, CH2OAc), 4.27-4.25 (2H, 
s, Ctf2OSi), 2.08 (3H, s, CH3CO), 0.92 (9H, s, tBu), 0.10 (6H, s, Me2Si).
1 cozEt
160
5h (270 MHz, CDCI3) 6.80 (1H, t, 7 1.8 Hz, CH=), 4.36 (2H, dd, 7 4.8 Hz and 1.3 Hz, 





5h (270 MHz, CDCI3) 7.36-7.22 (20H, m, Ph), 5.86 (1H, t, 7 6.3 Hz, CH=), 5.67 (1H, t, 7
6.4 Hz, CH=), 4.47 (2H, s, PhCtf20),4.454 (2H, s, PhCtf20), 4.450 (2H, s, PhCtf20), 4.37 
(2H, s, PhC//20 ), 4.20 (2H, d, 7 6.4 Hz, PhCH2OCH2), 4.12-4.07 (4H, m, 2x 
PhCH2OCH2), 4.07 (2H, s, PhCH2OCH2); 5C(100 MHz, CDCI3) 141.5 (s), 138.3 (s), 138.2 
(s), 138.1 (s), 138.0 (s), 136.7 (s), 136.6 (s), 131.1 (d), 128.6 (d), 128.5 (d), 128.4 (d), 128.3 
(d), 128.2 (d), 128.1 (d), 127.9 (d), 127.7 (d), 127.6 (d), 127.5 (d), 127.1 (d), 72.8 (t), 72.3 




8H (270 MHz, CDCI3) 7.40 -7.18 (15H, m, Ph), 6.01 (1H, d, J  2.8 Hz, H6), 5.11 (1H, d, 7
2.8 Hz, H I), 4.57 (1H, d, J  12.1 Hz, one of PhC//2OCH2), 4.51 (1H, d, 7 12.1 Hz, 
PhC7/2OCH2), 4.48-4.29 (5H, m, includes, 4.43 (1H, t, 74.6 Hz, 7/3), 4.19 (1H, s, 4-077), 
3.84 (1H, dd, 7 11.1 Hz and 3.8 Hz, PhCH2OC7/2), 3.82 (1H, d, 710.1 Hz, PhCH2OCff2), 
3.69-3.58 (3H, m, PhCH20CT72), 3.54 (1H, d, 710.1 Hz, PhCH2OC772), 2.15 (3H, s, OAc),
2.05 (3H, s, OAc), 1.54 (3H, s, Cl'-C773); 8c  (100MHz, CDCI3) 170.0 (s), 169.5 (s), 138.2 
(s), 137.6 (s), 137.0 (s), 128.4 (d), 128.3 (d), 128.3 (d), 128.0 (d), 127.7 (d), 127.7 (d), 127.6 
(d), 127.6 (d), 103.5 (s), 85.0 (s), 81.2 (d), 77.7 (d), 74.1 (t), 73.5 (t), 73.1 (d), 73.0 (t), 71.7 
(s), 70.0 (t), 69.3 (t), 22.6 (q), 20.9 (q), 20.7 (q).
AcO
8 h  (400 MHz, CDCI3) 7.38-7.15 (15H, m, Ph), 5.61 (1H, d, 74.4 Hz, H6 or H7), 5.20 (1H, 
d, 7 4.4 Hz, H6 or H7), 4.85 (lh, dd, 7 6.4 Hz and 4.4 Hz, H3), 4.47 (2H, s, PhC//20CH2), 
4.45 (1H, d, 7 11.2 Hz, PhO720CH2), 4.34 (1H, d, 711.2 Hz, PhC//2OCH2), 4.32 (1H, d, 7
11.7 Hz, PhCT/2OCH2), 4.24 (1H, d, 7 11.7 Hz, PhC//2OCH2), 3.97 (1H, d, 7 10.2 Hz, 
PhCH2OCH2 @C4 or C5), 3.77 (1H, d, 710.2 Hz, PhCH2OCtf2 @C4 or C5), 3.64 (1H, dd, 
7 10.2 Hz and 4.4 Hz, PhCH2OCtf2 @C3), 3.51 (1H, s, 5-0H), 3.41 (2H, s, PhCH2OCH2 
@C4 or C5), 2.11 (3H, s, OAc), 1.95 (3H, s, OAc), 1.46 (3H, s, C l'-C //3); 8c  (100MHz, 
CDCI3) 169.8, 169.6, 138.1, 137.4, 137.0, 128.6, 128.4, 128.3, 128.3, 128.1, 128.0, 128.0, 





V m a x ( f i l m )  3069, 2931, 2856, 1589, 1471, 1454, 1427, 1360, 1199, 1110, 1006, 822, 739, 
701, 665 and 612 cm-1;5H(270 MHz, CDCI3) 7.72-7.62 (4H, m, SiPh), 7.46-7.21 (11H, m, 
Ph), 4.39 (2H, s, P h a / 2OCH2), 3.76 (1H, dt, J  8.6 Hz and 2.6 Hz, CH2Ctf(OSi)CH(CH3), 
3.39 (1H, dd, J  9.2 Hz and 6.3 Hz, one of CHC//2I), 3.22 (2H, t, J  6.3 Hz, PhCH2OCff2),
3.09 (1H, dd, J  9.2 Hz and 7.9 Hz, CHCtf2I), 1.99-1.81 (1H, m, CH(OSi)Ctf(CH3)Cff2I), 
1.50-1.05 (6H, m, PhCH2OCH2CH2CH2CH2), 1.04 (9H, s, <Bu), 1.01 (3H, d, J  6.9 Hz, 
CH(OSi)CH(CH3)).
n
S .  . S
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VmaxCfihn) 3416, 2932, 2851, 1611, 1512, 1461, 1421, 1364,1301, 1247,1173,1089, 1033, 
820 and 666 cm-1; SH (500 MHz, CDC13) 7.26 (2H, d, J 8.4 Hz, Ar), 6.88 (2H, d, J 8.4 Hz, 
Ar), 4.44 (2H, s, ArCtf2OCH2), 4.05 (1H, t, J 6.9 Hz, CH2SCHSCH2), 3.81 (3H, s, 
ArOCH3), 3.58-3.50 (2H, m, one of ArCH2OCH2 and CH2C7/(OH)CH(CH3)CH2), 3.48- 
3.42 (1H, m, ArCH2OCff2) 2.92-2.79 (4H, m, -Ctf2SCHSCtf2CH2-), 1.91-1.81 (1H, m, 
-CH2SCHSCH2CH2-), 1.80-1.36 (9H, m), 0.86 (3H, d, J  6.5 Hz, CH(OSi)CH(C//3)CH2); 
8C (125 MHz, CDC13) 159.2 (s), 130.1 (s), 129.4 (d), 113.8 (d), 74.0 (d), 72.7 (t), 68.0 (t), 
55.3 (q), 47.5 (d), 36.1 (d), 35.5 (d), 33.6 (t), 30.5 (t), 26.0 (t), 23.6 (t), 13.3 (q).
O T B S
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Vmaxtfilm) 3070, 2930, 2894, 2856, 1471, 1426, 1388, 1360, 1255, 1110, 1048, 1006, 834, 
775, 740, 702, and 665 cm-1; 8h (500 MHz, CDCI3) 7.69-7.65 (4H, m, SiPh), 7.43-7.34 
(6H, m, SiPh), 3.75 (1H, t, 7 7.0 Hz, CH2S CHSCH2), 3.58-3.50 (3H, m, 
Ctf(OSi)CH(CH3)CH2 and Ctf2OTBS), 2.82-2.73 (4H, m), 2.10-2.04 (1H, m), 1.77-1.64 





8h (500 MHz, CDC13) 9.60 (1H, s, CHO), 7.33-7.20 (13H, m, Ph), 7.15-7.13 (2H, m, Ph), 
4.83 (1H, s, CtfCHO), 4.64-4.58 (2H, m, includes 4.62 (1H, d, 7 12.4 Hz, one of 
PhCH2OCH2 and PhCH2OCH2Ctf), 4.44 (1H, d, 7 12.4 Hz, PhCtf2OCH2), 4.33 (2H, s, 
PhCH2O CH 2), 4.21 (2H, s, PhCW2O C H 2), 3.97 (1H, dd, 7 10.9 Hz, and 3.0 Hz, 
PhCH2OCT2CH), 3.68 (1H, d, 79.9 Hz, PhCH2OCtf2), 3.65 (1H, dd, 710.9 Hz and 7.7 Hz, 
PhCH2OCT2CH), 3.56 (2H, s, PhCH2OCH2), 3.37 (1H, d, 7 9.9 Hz, PhCH2OCH2), 1.52 
(3H, s, Ctf3), 1.43 (6H, s, 2x 0 7 3), 1.42 (3H, s, CH3).
2 0 3
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